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Scientists have been fascinated by enzymatic catalysis for centuries and still marvel at the 
efficiency and selectivity with which these highly evolved molecular machines are able to 
catalyze complex reactions. For chemists, understanding the precise catalytic mechanisms 
can open up new possibilities in synthetic chemistry. From a medicinal standpoint, mechanistic 
knowledge provides valuable information on how enzymes can be targeted by drugs, as the 
molecular basis for many diseases lies in enzymatic malfunction. Among the different 
techniques used by researchers to investigate enzymatic catalysis, chemical probes are an 
indispensable tool. By synthetically inserting chemical changes into the substrate of a target 
enzyme, a wealth of information can be gained on structural and mechanistic features. 
In this thesis we investigate three enzymes with the help of chemical probes. The first and 
second chapters focus on the first two steps in the biosynthetic pathway of ergothioneine, an 
essential thiohistidine with antioxidant properties. The third chapter focuses on a key enzyme 
in the maturation of sulfatases, inserting a unique and crucial catalytic residue into the latter’s 
active site. 
In the first chapter, we shed light on the molecular toolbox of the SAM-dependent 
methyltransferase EgtD. This enzyme catalyzes the first step in the synthesis of ergothioneine, 
the processive methylation of histidine to Nα,Nα,Nα-trimethyl histidine. By labelling the 
substrates with stable isotopes, we have created probes enabling us to decipher the molecular 
strategies which allow this enzyme to carry out three consecutive methylation steps with nearly 
equal efficiency. 
In the second chapter we investigate the sulfoxide synthase EgtB, a non-heme iron dependent 
enzyme catalyzing the second step in ergothioneine biosynthesis. Interestingly, this system 
can potentially catalyze two distinct reactions, namely C-S bond formation and thiol 
dioxygenation. The factors governing this bifurcation in reactivity were investigated using 
substrate analogs with inhibitory properties. 
In the third and final chapter we examine the formylglycine generating enzyme (FGE), a 
copper-dependent enzyme catalyzing oxidative C-H bond cleavage of a cysteine residue in 
the active site of sulfatases. By synthesizing substrate peptides carrying stereoselective 
deuterium-labels we have identified the rate limiting step of this reaction and have gained 









1.1 The Enigma of Enzymatic Catalysis 
Enzymes can be considered the chemists of Nature, they are able to accelerate reactions by 
many orders of magnitude. It is hard to overstate the importance of the enhancement in rate 
that can be achieved by enzymes over the uncatalyzed reaction, as it is ultimately what makes 
life possible. Some of these reactions are so slow in the absence of enzymes, that the rates 
are hard to fathom and are indeed some of the lowest ever measured. For example, the half-
time for arginine decarboxylation is estimated to be 1.1 billion years in neutral solution (2 x 10-
17 s-1).1 The pyridoxal-dependent arginine decarboxylase from Escherichia coli accomplishes 
the same reaction with a kcat of 1.4 x 103 s-1, resulting in an enhancement in rate of a baffling 
19 orders of magnitude (kcat/knon = 7 x 1019).2 While this enzyme uses a cofactor (PLP) to 
achieve this amazing feat, others do not and can catalyze reactions solely by interactions with 
their amino acid side-chains. But what is the chemical basis for this catalytic efficiency and 
how can it be elucidated? In order to understand this, enzymologists make use of a broad array 
of methods, with which it is possible to gain insights into the precise chemical steps in a given 
catalytic cycle. One of the most important advances has been the emergence of X-ray crystal 
structures of proteins, which give an accurate picture of an enzyme and its active site(s) in 
particular. While X-ray crystal structures give a wealth of information on the coordination of 
substrates and reactive groups, they ultimately provide a rather static view of the target 
enzyme. In order to reveal the dynamics of these processes, researchers turn to kinetic 
analysis, tracking enzymatic turnover as a function of time. One very powerful method with 
which one can gain deeper insights into the mechanistic details is by altering the substrate of 
the enzyme of interest. By decorating the basic scaffold of a substrate with different functional 
groups or isotopic labels, one can alter its reactivity. Subsequent analysis of reaction rates and 
alternative products offers keys for a detailed understanding of the activity of these truly 
amazing catalysts. The knowledge gained from these data is of utmost importance in the 
design of new drugs as well as new synthetic catalysts used by chemists around the world on 
a daily basis. 
In the following we will highlight one classic and one more recent example of enzyme 
mechanisms, which have been elucidated with the help of brilliantly designed experiments 





1.2 Isopenicillin N Synthase 
The discovery of penicillin in 1928 by Alexander Fleming was arguably one of the most 
significant advances in modern medicine, paving the way for the introduction of antibiotics into 
our health system. While penicillins constitute a wide array of structures, all contain the central 
β-lactam moiety, which is responsible for the inhibition of cell wall biosynthesis in the target 
bacterial organism. The precise structure of penicillin was the subject of much debate and the 
β-lactam ring was only conclusively shown to be a structural feature of the molecule by 
crystallographic data put forth by Dorothy Crowfoot Hodgkin in 1945 for which, among other 
achievements, she received the Nobel Prize in 1964.3 For chemists the bicyclic core structure 
containing the thiazolidine ring and the highly strained four-membered β-lactam ring is of high 
interest and a challenging target for synthesis as it contains multiple stereocenters along with 
the labile, distorted amide bond in the four-membered ring. The first total synthesis of penicillin 
V (1 in Figure 1) was published by John Sheehan in 1957 after the development of the N,N’-
dicyclohexylcarbodiimide (DCC)-mediated coupling of carboxylic acids with amines to form 
amides, which solved the problem of closing the β-lactam ring.4,5 
 
Figure 1 Structure of the bicyclic core of penicillin containing the four-membered β-lactam ring and the five 
membered thiazolidine ring. 
What chemists had struggled with for many years and required multiple chemical 
transformations to achieve, Nature had worked out how to accomplish in one single step: the 
enzyme isopenicillin N synthase (IPNS) catalyzes both ring closures starting with the linear 
tripeptide L-δ-(α-aminoadipoyl)-L-cysteinyl-D-valine (LLD-ACV, 4). This non-heme iron-
dependent oxidase harnesses the full four-electron oxidizing power of dioxygen without the 
need for additional electron donors or oxidizable co-substrates.6 Four hydrogen atoms are thus 
abstracted from the linear peptide, converting one equivalent of oxygen into two equivalents 




Figure 2 Double ring-closure of the linear tripeptide L-δ-(α-aminoadipoyl)-L-cysteinyl-D-valine (LLD-ACV) forming 
isopenicillin N (3) as catalyzed by the iron-dependent oxidase isopenicillin N synthase (IPNS) with the four 
abstracted hydrogens highlighted in red. 
One of the pioneers elucidating the biosynthesis of penicillins by IPNS is Sir Jack Baldwin, 
who with his research group at the University of Oxford, published a plethora of research 
articles on the topic.7 By designing brilliantly crafted, chemically modified tripeptide substrates 
they were able to gain many important insights into the reaction mechanism before any crystal 
structures of IPNS was reported with or without substrate bound to the active site.8,9 Different 
segments of the substrate were altered, and the countless variants were tested for their viability 
as substrates, with precise analysis of the rate of formation and structures of the corresponding 
products, if indeed the substrates were accepted by the enzyme. A selection of the 
experiments conducted, along with the respective findings, shall be highlighted in the following 
sections. 
 
1.2.1 Mapping of the Active Site of IPNS with Aminoadipoyl Sidechain Variants 
Variations of the δ-L-α-aminoadipoyl chain, which is not directly involved in the formation of 
the bicyclic system, proved to be generally very well tolerated by the enzyme.10 The 
circumstance that most of the accepted variants contained a carboxylate group six carbons 
removed from the ε-carbonyl group led to the hypothesis that this group must be stabilized by 
H-bonding interactions with a remote Arg or Lys residue of the active site of the enzyme. Even 
quite bulky substrates containing aromatic “linkers” between carboxylate and ε-carbonyl were 
accepted for turnover (7 and 8). On the other hand, the acceptance of both L- and D-isomers 
(5 and 6 respectively) at the aminoadipoyl terminus and the acceptance of adipic acid 
suggested that the amino group is not significantly involved in binding to the residues of the 
catalytic site of the enzyme. In contrast, substrates lacking the carboxylate group (9 and 10) 




Figure 3 A selection of side chain variations of the δ-L-α-aminoadipoyl moiety in the linear peptide LLD-ACV, the 
rest of the peptide is analogous to that shown in the previous figure. The side chain on the top left is that of the 
natural substrate. 
When the crystal structure of IPNS in complex with the substrate was eventually published 
roughly ten years later, it corroborated these findings nicely, showing that the carbon chain is 
in an extended conformation and that Arg87 hydrogen bonds to the carboxylate group at a 
distance of 2.8 Å. The closest polar group to the α-amine is the hydroxyl group of Thr331, the 
two groups are however well outside the range for H-bonding (5.6 Å).9 
 
1.2.2 Variations on L-Cysteinyl and Kinetic Isotope Effects 
Modifications of the second residue, the L-cysteinyl moiety, were generally poorly tolerated or 
not tolerated at all. This was to be expected as this key residue is crucially involved in both 
ring-closure steps and led the authors to conclude that many interactions between the enzyme 
and this portion of the substrate took place. A set of experiments with stereospecific deuterium-
labels on Cβ of the cysteine however revealed some compelling findings (Figure 4).11 
 
Figure 4 Conversion of stereospecifically deuterated variants of LLD-ACV to the corresponding products by IPNS 
with retention of the stereochemistry on Cβ. The R group is the same as that depicted in Figure 2. 
Firstly, complete retention of the stereochemistry on Cβ was observed demonstrating that 
hydrogen abstraction is stereospecific. Secondly, the specificity of the abstraction was 
unaffected by a kinetic isotope effect (KIE) meaning that although this hydrogen abstraction is 
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rate limiting, the enzyme still preferentially abstracts the pro-S hydrogen.12 These findings too 
were later corroborated by a quaternary crystal structure (IPNS-FeII-ACV-NO), where the pro-
S hydrogen points in the direction of a molecule of NO bound to the iron center and serving as 
a placeholder for the abstracting oxygen species.9 
 
1.2.3 Sequence of Ring Closures Elucidated by Kinetic Isotope Effects 
Initially, the question of which ring closure takes place first was addressed by synthesizing the 
two most likely intermediates for each case and testing their viabilities as substrates or 
inhibitors. If C-H abstraction from Cβ of valine is the first step (pathway a in Figure 5) one 
would expect a seven-membered ring as an intermediate (15). This potential intermediate was 
synthesized, but behaved neither as a substrate nor as an inhibitor.13 The second possible 
intermediate (16), where the β-lactam ring is formed first was more difficult to synthesize and 
could not be assessed as a substrate due to its inherent instability at physiological pH.14 
 
Figure 5 Reaction scheme for the order of ring closure(s) catalyzed by IPNS. The R group is the same as that 
depicted in Figure 2. 
Since all other attempts of characterizing possible intermediates failed,15,16 other techniques 
needed to be applied in order to gather mechanistic information. As discussed above, a KIE 
had been observed upon hydrogen abstraction from Cβ of the cysteinyl residue. Additionally a 
second, larger KIE was observed for the second C-H bond cleavage step from Cβ of the D-




Figure 6 Deuterated substrates and the kinetic isotope effects observed for the conversion of each into the 
respective products. The R group is the same as that depicted in Figure 2. 
In a first series of experiments a 1:1 mixture of deuterated tripeptide (either on Cβ of the 
cysteinyl or valinyl residue) and unlabeled peptide were reacted with IPNS and the ratio of 
labelled and unlabeled starting material were compared at different time points. Only in the 
case where the deuterium label was on the cysteinyl residue was an enrichment of the 
deuterated species observed; the KIE is hence an effect on kcat/KM.18 In contrast to this finding, 
all three labelled substrates shown in Figure 6 showed significant KIEs on kcat where a single 
substrate was used at saturating concentration. These findings led the researchers to form 
three major conclusions: 
a) The reaction occurs stepwise and not in one concerted step. 
b) Cleavage of the C-H bond on the cysteinyl residue takes place first, but must be similar 
in energy to the activation barrier for the second C-H bond cleavage step. 
c) The intermediate formed remains bound to the enzyme active site. 
This last point was consistent with the finding of Baldwin et al.15 as well as others16 that no 
intermediate could be detected, let alone isolated. 
 
1.2.4 Variations on the D-Valinyl Moiety 
The most exhaustive studies were conducted on the third amino acid in the tripeptide substrate, 
yielding a large amount of data and offering further valuable insights into the active site and 
the mechanism of ring closure. Some of the most important results shall be presented 
hereinafter. 
When valine was substituted by α-aminobutyrate (20) a mixture of three products (21, 22, 23 
– ratio: 1:7:3) was formed, at first prompting the researchers to speculate whether a mixture of 
enzymes was responsible for this multiplicity of products. It was however shown that this was 
not the case and that IPNS can indeed catalyze branched pathways; the products 21 and 23 




Figure 7 Distribution of products formed from the tripeptide LLD-ACV where valine was substituted by α-
aminobutyrate. The R group is the same as that depicted in Figure 2. 
When the stereochemistry of C-S bond formation was determined, a further surprising result 
was obtained. Reaction of both the (3R)- and (3S)-deuterated variants of 20 (24 and 25, 
respectively) with IPNS both resulted in the same monodeuterated product 26 (Figure 8). 
 
Figure 8 Single monodeuterated product formed from both deuterated α-aminobutyrate variants of the linear 
tripeptide substrate. The R group is the same as that depicted in Figure 2. 
This behavior could be accounted for by a carbon radical forming on C3 after a substantial 
KIE, making hydrogen abstraction much more favorable than deuterium abstraction. A 
subsequent rapid equilibration (rotation around C2-C3) and slower ring-closure would result in 
the observed stereochemistry.  Since a radical mechanism had been proposed previously,20 it 
was attempted to validate this hypothesis using the cyclopropylcarbinyl test. As radicals of the 
latter mentioned species undergo rapid ring opening to the corresponding homoallyl radical, a 
tripeptide containing such a group (27) was synthesized and tested as a substrate. As could 
be predicted by a radical mechanism, a mixture of products (28 and 29) was formed, thus 
confirming what had been surmised from the results of the experiments described above. 
 
Figure 9 Distribution of products formed from the tripeptide LLD-ACV where valine was substituted by a cyclopropyl-




1.2.5 Proposed Catalytic Mechanism of IPNS, Then and Now 
Along with some additional findings not presented in this summary, a catalytic cycle was 
proposed for the two cyclization reactions, where a highly reactive FeIV-oxo species is formed 
during the first ring closure.7,17 This species would then be of sufficient energy to perform the 
less favorable H-abstraction from Cβ of the D-valinyl segment as shown below in Figure 10. 
 
Figure 10 The catalytic mechanism of both ring closures by IPNS as proposed by Baldwin et al.17 The R group is 
the same as that depicted in Figure 2. 
In the decades that followed, countless more experiments were conducted by many research 
groups including the solving of X-ray crystal structures, DFT and QM/MM calculations as well 
as spectroscopic studies. These contributions further refined the proposed mechanism, but to 
this day the basic consensus remains unchanged. Most recently, by a combination of rapid-
freeze-quench Mössbauer spectroscopy and UV-Vis spectroscopy, both abstracting iron 
intermediates could be detected.21 The newest iteration of the catalytic mechanism is shown 
in Figure 11, the two hydrogen abstracting FeIII-superoxo and FeIV-oxo species are displayed 




Figure 11 Proposed mechanism for the catalytic cycle of IPNS. The R group is the same as that depicted in Figure 
2. 
After sequential binding of the tripeptide and oxygen to the iron center, the first part of the 
catalytic cycle is initiated by hydrogen abstraction from Cβ of cysteine (B). After an inner-
sphere electron transfer from the thiyl radical to FeIII (C) an intermediate thioaldehyde 
coordinated to an FeII-hydroperoxo species is formed (D). This species can then abstract the 
amide hydrogen from valine; stereocontrolled attack of this deprotonated amide onto the iron-
coordinated thioaldehyde forms the four-membered β-lactam ring and completes the first half 
of the catalytic cycle. Loss of the first equivalent of water with the first two abstracted hydrogen 
atoms leads to the highly reactive FeIV-oxo (ferryl) complex (F), which in turn initializes the 
second half of the catalytic cycle via abstraction of the Cβ hydrogen of valine. The generated 
radical then attacks the iron-coordinated sulfur (G), forming the thiazolidine ring which remains 
bound to the iron center (H) before being released upon displacement by the original Gln 
ligand, returning the enzyme to its resting state (A). 
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A complete picture of this catalytic cycle could not have been obtained without the help of 
crystallographic, spectroscopic and computational techniques. However, it was the assiduous 
work of the chemists and enzymologists who designed and crafted the molecular tools, 
analyzed the data and came up with hypotheses based on chemical rationale that contributed 
an indispensable amount of knowledge to the understanding of this enzyme. 
 
 
1.3 Terpene Cyclases 
For a more recent example of synthetically altered substrates used as probes for enzyme 
catalysis, we will turn to the catalysis performed by terpene cyclases and particularly the 
research group of Jeroen Dickschat. Along with his co-workers, he has developed some 
ingenious approaches of using stable isotope labelling to elucidate natural product structures 
as well as the mechanism of the enzymes involved in their biosyntheses. While this technique 
has been applied to a broad variety of natural products,22 terpenes are of particular interest as 
they are a large class of natural products and have very intricate, stereospecific, often 
(poly)cyclic structures, which arise from some of the most complex enzymatic conversions 
found in Nature.23 Terpenes were originally discovered in plants, starting in the late 19th 
Century with the pioneering work of Otto Wallach, who also noted that all products of this class 
are made up of repeating units of isoprene.24 Only in the second half of the 20th Century did it 
become evident that terpenes were also produced by fungi and bacteria. Even more recently, 
this ubiquitous class of natural product has been discovered in certain eukaryotic 




Figure 12 Chemical structures of a selection of naturally occurring terpenes. Monoterpenes are biosynthesized 
from geranyl pyrophosphate (n = 1), sesquiterpenes are biosynthesized from farnesyl pyrophosphate (n = 2) and 
diterpenes are biosynthesized from geranyl geranyl pyrophosphate (n = 3). 
 
In a recent publication by Dickschat et al. the products and the mechanisms of cyclization were 
elucidated for two different bacterial diterpene cyclases using a combination of stable isotope 
labelling and NMR spectroscopy (Figure 13).26 A putative terpene cyclase from Streptomyces 
violens was recombinantly produced and shown to convert geranyl geranyl pyrophosphate 
(GGPP) into a diterpene hydrocarbon, while geranyl (GPP) and farnesyl pyrophosphate (FPP) 
were not turned over. The structure of the product was identified as (-)-spiroviolene (30) by 
NMR spectroscopy, albeit with unclear absolute configuration, and the enzyme was termed 




Figure 13 Proposed cyclization of GGPP to form 1 as catalyzed by spiroviolene synthase (SvS). The numeration 
of all carbon atoms in 1 corresponds to their origin from GGPP. The star (*) indicates a 1,3-hydride shifts. 
In the proposed biosynthetic pathway, the reaction is initiated by two concerted ring closures 
of GGPP, forming the bicyclic cationic intermediate 31. A subsequent double Wagner-
Meerwein rearrangement and further cyclization step results in the tricyclic species 32. Further 
cyclization and rearrangements lead to 33 and 34 respectively, followed by a ring contraction 
to form the spirocyclic cation 35. Finally a 1,3-hydride migration leads to 36, deprotonation of 
which results in the final product 30. 
Using a clever combination of synthetic and biosynthetic techniques, all 20 isotopomers of 
(13C1)GGPP were synthesized and converted to the corresponding products with SvS in order 
to assign where the different carbons originating from the starting material were located in the 
product. All carbons were determined to be in the expected positions predicted by the proposed 
mechanism shown in Figure 13. Next, the absolute stereochemistry of the product was 
assigned with GGPP carrying a stereoselectively introduced deuterium label on a 13C-labelled 
methylene-group. These in turn were synthesized in situ by the GGPP synthase (GGPPS) from 
isoprene pyrophosphate (IPP) and (R)- or (S)-(1-13C, 1-2H)FPP and directly converted to the 
spiroviolene product by SvS as shown in Figure 14. Considering that elongations of IPP by 
oligoprenyl diphosphate synthases are known to invert the configuration at C1,27 the absolute 
stereochemistry of the product could be deduced based on an HSQC analysis of the product. 
The same experiment was repeated with the 2H/13C-label in a different position, resulting in the 




Figure 14 Synthesis of (R)- and (S)-(5-13C, 5-2H)GPP from (R)- or (S)-(1-13C, 1-2H)FPP and IPP by GPPS, followed 
by cyclization to 30 by SvS. The red dot indicates the position of the 13C-label. 
Next, the proposed 1,3-hydride shift (35 to 36 in Figure 13) was investigated using (3-13C, 
2-2H)GGPP as shown in Figure 15. With this starting material, the deuterium would be located 
on the 13C-labelled carbon atom in the final product if indeed the purported shift took place. As 
predicted, this was the case, which was underlined by a triplet in the 13C NMR spectrum, 
caused by 2H-13C spin coupling in the product. 
 
Figure 15 1,3-Hydride shift of deuterium onto the 13C-labelled carbon, starting from (3-13C, 2-2H)GGPP 
Lastly, the stereochemistry of the final deprotonation step was examined, using 
stereoselectively deuterium-labelled (R)- and (S)-(1-2H)GGPP (Figure 16). In the case of the 
S-enantiomer, loss of deuterium was detected by GC/MS whereas loss of protium was 
detected for the R-enantiomer as a mass difference of 1 Da. It is thus the hydrogen syn to the 
migrating hydride that is abstracted and the authors suggest that the abstracting base is the 
diphosphate anion that is eliminated from C1 of GGPP in the initial ring closure (Figure 13). 
They argue that since it leaves C1 towards the back of the projection plane, it is ideally 
positioned for this final proton abstraction, the stereochemistry of which has been confirmed. 
 
Figure 16 Stereochemistry of the final deprotonation step, showing how HS is abstracted by an unknown base (B-). 
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With the sequence of SvS, a BLAST search was conducted, aiming to identify closely related 
enzymes. Among others these included the cyclases for tsukubadiene (37) and cyclooctat-
7(8),10(14)-diene (38), the latter of which displayed a similar structure to cyclooctat-9-en-7-ol 
(39) from a phylogenetically distant cyclase 
 
Figure 17 Structures of tsukubadiene (37), cyclooctat-7(8),10(14)-diene (38) and cyclooctat-9-en-7-ol (39). The first 
two terpenes are produced by enzymes closely related to SvS, while the last is not. 
Since the cyclization mechanisms for 38 and 39 can be assumed to be quite similar and the 
cyclization of 39 is known to proceed through a unique cyclopropyl intermediate,28 the 
mechanism for cyclization of 37 was investigated starting from a similar hypothesis. 
The enzyme tsukubadiene synthase (TdS) from Streptomyces tsukubanensis was 
recombinantly produced and an analogous series of experiments was conducted as described 
above. After showing that the enzyme produces 37 from GGPP, the relative and absolute 
stereochemistry was determined by extensive NMR spectroscopy. A mechanism was 




Figure 18 Proposed cyclization of GGPP to form 37 as catalyzed by tsukubadiene synthase (TdS). The numeration 
of all carbon atoms in 37 corresponds to their origin from GGPP. The stars (*) indicate 1,2-hydride shifts.  
The catalytic cycle is initiated by the same two ring closures as described above, resulting in 
the conversion of GGPP to 40, a diastereomer of 31. Ring expansion and contraction by 
Wagner-Meerwein rearrangement, a 1,2-hydride migration and 7,9- as well as 2,6-cyclization 
lead to the formation of 41. Two additional 1,2-hydride migrations take place via 42 to give 
intermediate 43. A cyclopropane ring rearrangement produces 44, similar to what was 
proposed for the biosynthesis of 39.28 A subsequent ring opening gives 45, followed by a 
further 1,2-hydride migration forming 46 and finally deprotonation to yield the product 37. 
As for spiroviolene (30), the mechanism was confirmed by identifying the positions of each 
carbon in both the substrate and the product by converting all 20 isotopomers of (13C1)GGPP 
to the product. The absolute stereochemistry of the product was determined by HSQC using 
stereospecifically deuterated substrates. The 1,2-hydride shift from 40 to 41 was confirmed by 
2H/13C-labelling of the substrate and NMR analysis of the product and the two 1,2-hydride shifts 
from 41 to 42 and 42 to 43 were confirmed in the same manner. Finally, the stereochemistry 
of the final deprotonation step was investigated with (R)- and (S)-(1-2H)GGPP, leading to the 
conclusion that HS is abstracted just as in the case of spiroviolene (30). Again, the phosphate 
anion lost in the first cyclization step is an ideal candidate as a base for the same reasons 
described for the final deprotonation of 36 to 30. 
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In summary, Dickschat et al. have shown just how useful stable isotope labelled substrates 
are for the elucidation of terpene cyclization. Detailed insights into the mechanism were 
obtained by tracking every single carbon atom from the linear precursor to the polycyclic 
products and the absolute stereochemistry was solved by incorporation of stereospecific 
deuterium labels. It is of particular interest to note that the intermediate bicyclic cations formed 
after the initial cyclization reaction (31 and 40) are in fact diastereomers. Only the further 
course of the reaction, determined by the folding and positioning of the intermediates in the 
active site, yields the structurally quite diverse products 30 and 37. In the final deprotonation 
steps, leading from 36 to 30 and from 46 to 37, nonetheless take place from the same face in 
which the diphosphate is eliminated from the starting material. This in turn provides further 
evidence that the latter does in fact act as the base in the final step. 
As in the case of IPNS and the research conducted by Baldwin et al. a wealth of information 
was gained by intelligently crafting appropriate synthetic probes, followed by careful analysis 
of the results based on chemical rationale. 
 
 
1.4 Biosynthetic Transformations Investigated in this Thesis 
1.4.1 Biosynthesis of Thiohistidines; Ergothioneine and Ovothiol 
Ergothioneine (ET in Figure 19) is a redox-active sulfur-containing betaine produced in 
cyanobacteria,29 mycobacteria and fungi.30 In humans it is actively taken up from dietary 
sources by the specific ergothioneine transporter protein OCTN1.31 Polymorphisms in the gene 
SLC22A4, encoding for OCTN1, have been linked to rheumatoid arthritis,32 ulcerative colitis,33 
Type I diabetes34 and Crohn’s disease.35 In certain tissues such as erythrocytes, seminal fluid, 
liver and kidney it is accumulated to near millimolar concentrations and in millimolar 
concentration in the lens of the human eye. Although the physiological role of ergothioneine in 
humans has not yet been fully elucidated, it is thought to play a role in protection from oxidative 
stress, as it was shown to be an antioxidant in vitro.36 The enzymes involved in the biosynthesis 
of ergothioneine by Mycobacterium smegmatis were discovered in 2010 and are summarized 
in Figure 19.30 The first step is the processive trimethylation of histidine by the SAM-dependent 
methyltransferase EgtD, resulting in the histidine betaine hercynine (TMH). This is followed by 
the remarkable C-S bond formation between hercynine and γ-glutamyl cysteine on the 2-
position of the imidazole ring by the iron dependent sulfoxidase EgtB (47). Subsequently, the 
glutamyl-rest is cleaved by EgtC (48) and the oxidized cysteinyl moiety is removed by the PLP-
dependent EgtE, forming pyruvate and ammonia as leaving groups to give the final product 
19 
 
ergothioneine. In the fungus Neurospora crassa, a shorter synthetic route was discovered 
where an alternate variant of EgtB directly adds cysteine to the histidine scaffold.37 
Ovothiol A (OA in Figure 19) is a related thiohistidine first discovered in sea-urchin eggs and 
thought to protect them from oxidative stress.38 Later on it was also identified in several human 
pathogens such as Leishmania donovani and Trypanosoma cruzi.39,40 A biosynthetic pathway 
for ovothiol A in Erwinia tasmaniensis was elucidated in 2011, involving two enzymes; OvoA 
and OvoB.41 The first and key step in ovothiol biosynthesis is catalyzed by OvoA and involves 
C-S bond formation between the thiol of cysteine and C-5 of the imidazole ring of histidine (49). 
This step is analogous to the second step in ergothioneine biosynthesis, catalyzed by EgtB. In 
the second step, the PLP dependent OvoB cleaves the cysteinyl moiety resulting in 5-
thiohistidine (50), which is finally methylated on Nπ by the SAM-dependent methyltransferase 
domain of OvoA. 
 
Figure 19 Biosynthetic pathways for the sulfur-containing antioxidants ergothioneine (ET) and ovothiol A (OA). 
By using synthetically modified substrates we have furthered our understanding of two key 
enzymes in the biosynthesis of ergothioneine: EgtD and EgtB. In the first case, we synthesized 
13C-labelled substrates, which enabled us to investigate the binding mode of EgtD and 
characterize its strategies for substrate activation and catalysis. In the second case we 
synthesized unreactive substrate analogs with a modification on the 2-position of the imidazole 
ring, granting us novel insights into the reactivity of the catalytic iron center. Importantly, our 




1.4.2 Active Site Mapping of the Copper-Dependent Formylglycine Generating Enzyme 
The formylglycine generating enzyme (FGE) is a copper-dependent enzyme, catalyzing the 
key step in the maturation of sulfatases, an enormously important class of enzymes in the 
metabolism of sulfate-esters. Mutations in the gene encoding FGE (SUMF1) have been linked 
to multiple sulfatase deficiency, a fatal orphan disease. Introduction of the unique formylglycine 
residue by FGE in the active site of sulfatases insures the latter’s catalytic activity. 
Formylglycine is generated from a cysteine residue in a specific recognition sequence, which 
has also been engineered into other recombinant proteins, making FGE an attractive tool for 
biorthogonal conjugation reactions.  
 
Figure 20 Schematic view of the generation of formylglycine from cysteine by FGE. 
By synthesizing peptide substrates carrying a stereospecific deuterium label, we have created 
tools which have allowed us to characterize the rate limiting step of this reaction and effectively 




2 Molecular Strategies of EgtD, a SAM-Dependent 
Methyltransferase 
Abstract 
Ergothioneine is an aromatic amino acid betaine derived from histidine, discovered over 100 
years ago.42,43 In this chapter we focus on the first step of the biosynthesis of ergothioneine, 
the cooperative trimethylation of histidine by the SAM-dependent methyltransferase EgtD.30 A 
particular focus is placed on the binding mode of the methyl groups in its substrates and methyl 
donor. We aimed to elucidate the mechanism of this multistep reaction using a combination of 
X-ray crystallography, enzyme kinetics and NMR spectroscopy. By synthesizing compounds 
with specific 13C-labels on the methyl groups of interest, we created powerful tools to analyze 
binding modes of the methyl donor as well as the respective acceptors via NMR.44 
Herein we present a comprehensive description of the molecular mechanism that allows EgtD 








2.1.1 SAM-Dependent Methyltransferases 
S-Adenosyl methionine (SAM) is a ubiquitous methyl group donor and is found in all kingdoms 
of life.45 While some enzymes utilize SAM to form a 5’-deoxyadenosyl radical,46 the largest 
group of SAM-dependent enzymes is that of SAM-dependent methyl transferases (MT), which 
catalyze methylation reactions. The targets of this reaction range from large macromolecules, 
such as proteins in post-translational modification, to small molecules.47 In order to achieve 
maximal catalytic efficiency for this textbook SN2-reaction, the coordination and positioning of 
the transferred methyl group in the active site of MTs is of particular interest.48 
 
Figure 21 Basic methylation reaction catalyzed by a SAM–dependent methyltransferase. The methyl group from 
SAM is transferred onto a suitable acceptor (A) generating S-adenosyl homocysteine (SAH). 
 
2.1.2 Catechol O-Methyltransferases 
One system where the mechanism of methyl transfer from SAM onto the respective acceptor 
has been studied in great detail using a variety of experimental techniques is the enzyme 
catechol O-methyltransferase (COMT), which catalyzes methyl transfer from SAM onto 
dopamine and related catechols.49 
 




Several theories exist on how this methyltransferase achieves its catalytic efficiency, speeding 
up the uncatalyzed reaction by an impressive factor of approximately 1016. One of the first 
findings was that secondary KIEs with a deuterated methyl substrate were more inverse in the 
enzyme than in a model small molecule system in solution. These findings were interpreted as 
evidence that the transition state in the model system, e.g. in solution, was less organized than 
in the enzyme. An inverse KIE of this type is observed if the vibrational modes of the methyl 
hydrogens are more constrained in the transition state, leading to destabilization of the 
deuterated species. This led to the proposal by Schowen et al. of transition state (TS) 
compression as an explanation for increased catalysis in the active site.50 It should however 
be noted, that this idea has been challenged when it could not be supported by QM/MM 
calculations put forth by Ruggiero et al.51 More recently, Klinmann et al. conducted a 
combination of experiments with point mutations in the active site and their effect on secondary 
KIEs, also arguing for active site compaction.52 They suggested that the enzyme creates 
transient active site configurations that are stiffer than the activated complex in solution by 
dynamic movements in the enzyme. In a second study mutants of Tyr68, a conserved active 
site residue located behind the reactive sulfur of SAM, were compared to the wild type enzyme. 
Binding isotope effects and computational models indicated stabilization by possible hydrogen 
bonding to the methyl group and increase in the methyl donor-acceptor distance in the order 
WT<Y68F<Y68A<solution, which in the opinion of the authors represented further evidence of 
active site compaction.53 Other earlier theories, such as the concept of a cratic effect have 
been corrected to account for electrostatic factors.54 Cratic refers to the free energy required 
to align reacting groups into a geometry enabling a facile reaction.55 Subsequently however, 
Warshel et al. argued that indeed the influence of electrostatic preorganization is the dominant 
factor that accounts for the origin of the catalytic power of COMT.56 By presenting a 
computational model that can reproduce all the previously obtained experimental observations, 
they contradicted the NAC, compression and entropic models. In what amounts to a veritable 
argument between the most respected female enzymologist and a Nobel Prize laureate 
accusing each other of unjustly dismissing experimental evidence53 and misinterpreting 








2.1.3 Lysine Methyl Transferases 
2.1.3.1 SET Domain Lysine Methyltransferases 
Another interesting case where the precise molecular mechanisms promoting catalysis have 
been studied in great depth are lysine methyl transferases (KMTs). Methylation of protein 
lysine is a prominent post translational modification and among other things responsible for 
the methylation of histones, the protein components of chromatin which allow for the dense 
packing of DNA in eukaryotic cells.58 Of the characterized proteins responsible for lysine 
methylation, all are SAM-dependent and all but one contain a so-called SET-domain (Su(var)3-
9, Enhancer-of-zeste and Trithorax, not to be confused with the acronym for single electron 
transfer).59 A decade ago it was suggested that the coordination of the methyl group on SAM 
in the SET domain is reliant on C-H∙∙∙O hydrogen bonds and that these facilitate methyl transfer 
from the donor to the acceptor.60 The SAM-dependent lysine methyltransferase SET7/9 was 
shown to coordinate the methyl group of its co-factor SAM via C-H∙∙∙O bonding by a 
combination of NMR, crystallographic data and computational studies.44 In this study by 
Horowitz et al. the transferrable methyl group in 13C-methyl labelled SAM displayed a 
significant downfield shift along the proton axis of 0.8 ppm from the unbound (3.0 ppm) to the 
bound (3.8 ppm) spectrum. Calculation of the expected bound shift matched the measured 
values with an accuracy of 0.1 ppm. Some clues pointing to the possibility that C-H∙∙∙O bonds 
were involved in substrate binding could be found in the crystal structure. 
 
Figure 23 Crystal structure of SAM (in purple) bound to SET7/9 (PDB: 1N6A). The C∙∙∙O distances between the 
methyl group on SAM and the coordinating oxygen atoms are 3.7 Å (Gly269), 3.0 Å (His293) and 3.5 Å (Tyr335)61 
The C∙∙∙O distances between the methyl group on SAM and two backbone carbonyls (Gly269 
and His293) and an invariant tyrosine (Tyr335) were <3.7 Å and hence appropriate for 
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hydrogen bonding to occur.60 Hydrogen bonds can form since the sulfonium cation in SAM is 
positively charged and withdraws electrons from the neighboring methyl group, polarizing the 
latter’s C-H bonds. Finally, the angles between the three aforementioned residues were all 
close to 120°, approaching the CH3-group in roughly trigonal coordination. It should be noted 
that in contrast to most other SET proteins, SET7/9 is exclusively a monomethylase.62 This is 
largely due to steric constrictions in the active site, which prevent further methylation reactions 
from occurring.63 Although a crystal structure of the SET7/9-SAH-MeLys ternary complex has 
been solved (PDB: 1O9S), no direct evidence for C-H∙∙∙O hydrogen bonding to the methyl 
group on the acceptor exists besides the structure. 
2.1.3.2 C-H∙∙∙O Bonds 
In addition to the more classical hydrogen bonds between N and O donors/acceptors, it was 
shown that carbon can act as hydrogen bond donors roughly 40 years ago.64 Weak hydrogen 
bonding can even be observed for aliphatic carbons,65 but when there is an adjacent polarizing 
atom the strength of these bonds can rival those formed by conventional donors/acceptors (N 
and O).66 Since their discovery, this class of hydrogen bond has received more and more 
attention and has been shown to be important for enzyme stability and catalysis,67 as well as 
stabilizing of nucleic acid structure68 and interactions with methyl groups in small 
molecules.69,70  
Methods of characterizing this type of interaction are somewhat limited, as crystal structures 
often fail to predict the exact position of hydrogen atoms. Many other current methods of 
identifying and characterizing C-H∙∙∙O bonds are not easily applicable for protein-substrate 
interactions and obtaining experimental evidence remains a challenge.71–73 One powerful tool 
for the description of these elusive connections is NMR-spectroscopy, where a substantial 
downfield 1H chemical shift change can be observed upon binding.74 In a number of systems 
C-H∙∙∙O bonds have been characterized by NMR. Several recent examples include i) serine 
protease, where C-H∙∙∙O bonds within the enzyme where described;75 ii) maltose anomers, 
which were analyzed by solid state NMR and computational studies;76 iii) Gly- and Ala-
dipeptides, whose spectroscopic patterns were elucidated by purely computational studies.77  
 
2.1.4 Glycine Betaine 
As discussed above, any polarized methyl group can potentially engage in C-H∙∙∙O bonds. One 
ubiquitous class of natural products containing such polarized methyl groups is that of 
betaines. In the following section, some of the strategies of enzymes and proteins for betaine 
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binding shall be discussed based on the example of one of the most widespread exponents of 
this class of natural products. 
Trimethyl glycine or glycine betaine was the first betaine to be discovered almost 150 years 
ago. Extracted from the common beet (Beta vulgaris, hence the name betaine) and from 
molasses in the year 1869 by Carl Scheibler,78 it has since been discovered in most living 
organisms such as microorganisms, plants and mammals,79,80 acting as an osmolyte,81 a 
methyl donor in homocysteine metabolism82 and possibly an antioxidant.83 In humans, glycine 
betaine is taken up through an array of dietary sources such as seafood, wheat germ or bran 
and spinach.79  There are two possible biosynthetic routes in organisms that produce it and 
these will be examined in more detail with particular emphasis on how the trimethylammonium 
group is bound by proteins. Importantly, the respective proteins utilize significantly different 
binding modes depending on whether transport of the target molecule or catalysis is the main 
function. 
2.1.4.1 Glycine Betaine Biosynthesis by Choline Oxidation 
The most common pathway for betaine biosynthesis is by oxidation of choline, either by a 
single enzyme or a two-enzyme system.84 In order to accumulate choline in the cells, 
membrane-bound transporter proteins are necessary. The Gram-positive bacteria Bacillus 
subtilis, where glycine betaine serves as the preferred osmoprotectant,85 takes up choline 
through the specific transporters OpuB and OpuC.86 Following uptake, choline is oxidized to 
glycine betaine by the concerted actions of the alcohol dehydrogenase GbsB and the glycine 
betaine aldehyde dehydrogenase GbsA.87 As shown in Figure 24, betaine aldehyde is the 
intermediate product. 
 
Figure 24 The biosynthetic pathway of glycine betaine (53) from choline (51) via the intermediate glycine betaine 
aldehyde (52) by the alcohol dehydrogenase GbsB and the betaine aldehyde dehydrogenase GbSA. 
The OpuB transporter (EC 3.6.3.32) from B. subtilis contains the two-domain trimethylcholine 
transporter protein OpuBC. The trimethylammonium group of the choline ligand is 
accommodated and coordinated by an aromatic cage, formed by two tyrosine residues from 
each domain, via cation-p interactions (Tyr71 and Tyr221 of domain I and Tyr117 and Tyr197 




Figure 25 Active site of the choline transporter OpuB showing the trimethylammonium moiety of choline bound by 
the aromatic cage formed by four tyrosine residues. (PDB: 3R6U) 
Aromatic cages are typically formed by the side-chains of 2-4 electron rich aromatic amino 
acids (Phe, Tyr, Trp) often supplemented by at least one acidic sidechain.  The basis for the 
binding of trimethylammonium or other positively charged residues in aromatic cages are 
cation-p interactions. This was first demonstrated by Dougherty et al. by creating a completely 
synthetic receptor for the neurotransmitter acetylcholine, which bound the substrate with a 
comparable affinity (KD = 50 µM) as the biological recognition sites.89 Prior to these findings it 
was thought that anionic residues were largely responsible for binding of positively charged 
quaternary ammonium compounds. Cation- p interactions were subsequently found to be a 
widespread motif among proteins.90 
2.1.4.2 Glycine Betaine Biosynthesis by Trimethylation of Glycine 
An alternative synthetic pathway towards glycine betaine is the SAM-dependent trimethylation 
of glycine, which is rarely encountered due to the fact that it is an energetically much more 
costly synthetic path and has only been observed in a few organisms.91,92 Crystal structures 
for sarcosine methyltransferase from A. halophila (PDB 5HIM)93 and G. sulphuraria (PDB 
2O57) have been solved, albeit without (trimethyl)glycine, making predictions of the binding 
mode difficult. Recently however, the crystal structure of glycine sarcosine N-
methyltransferase (MpGSMT) from M. portucalensis was solved, albeit in a catalytically 
inactive form.94 Construction of a homology model revealed three key residues containing 
oxygen atoms arranged triangularly between the methyl group of SAM and the amino group of 
the substrate (the phenolic oxygen atoms of Tyr26 and Tyr185 and the main-chain carbonyl 





Figure 26 Top: schematic view of the homology model active site of MpGSMT and GNMT. Bottom: Biosynthetic 
pathway of glycine betaine (53) from glycine (54) in the halophilic archaeon M. portucalensis. MpGSMT adds the 
first and second methyl groups to glycine and sarcosine, while MpSDMT (sarcosine dimethylglycine N-
methyltransferase) adds the second and third methyl groups to sarcosine and dimethylglycine. In total three 
equivalents of SAM are consumed, generating three equivalents of SAH.95 
The distance between the methyl-accepting nitrogen and the SAM-methyl carbon was 
approximately 2.7 Å and these residues were thought to assist catalysis. Introduction of the 
point mutations Y26F and Y185F reduced the activity of the enzyme by 74- and 5-fold, 
respectively. The precise role of these residues in catalysis can only be speculated on, but it 
is quite possible that these interactions in fact constitute C-H∙∙∙O hydrogen bonds as discussed 
in Section 2.1.3.2. 
As an additional relevant piece of information, it should be noted that QM/MM simulations 
revealed that in aqueous solution water molecules surrounding the methyl groups of the 
trimethylammonium moiety are oriented in a way that suggests they sense the presence of the 
positively charged N atom and engage in C-H∙∙∙O bonding.96 On the one hand this confirms 
that the positive charge is delocalized among the three methyl groups, on the other hand the 
resolvation of this group may facilitate release of the product from the respective active site of 
the enzyme. 
 
2.1.5 EgtD: The First Enzyme in the Biosynthesis of Ergothioneine 
The first step in the biosynthesis of ergothioneine is the cooperative trimethylation of L-histidine 
by the SAM dependent methyl transferase EgtD, yielding hercynine (Nα,Nα,Nα-trimethyl-L-
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histidine, TMH). This is then subsequently processed by the enzymes EgtB, EgtC and EgtE to 
give the final product ergothioneine (ET) as shown in Figure 27. 
 
Figure 27 Biosynthetic pathway for the synthesis of ergothioneine from histidine. 
At the outset of this project, the EgtD-SAH-DMH ternary complex had been solved at a 
resolution of 1.5 Å (Figure 8; PDB: 4PIO).97 Of particular interest to us was the coordination of 
the Nα-methyl groups of DMH and their implications for the catalytic mechanism. Of the two 
Nα-methyl groups, one is in close proximity to the side-chain oxygen atoms of Thr163 (3.5 Å) 
and Tyr39 (3.6 Å) and the phenyl ring of Phe47 (3.9 Å), for the following discussion this position 
will be referred to as Me1. 
    
Figure 28 Left: ideal distances and angles for C-H∙∙∙O hydrogen bonding to take place between three carbonyls 
and a methyl group. Right: distances and angles between Me1 of DMH and the side-chain oxygen atoms of Thr163 
(3.5 Å) and Tyr39 (3.6 Å) and the phenyl ring of Phe47 (3.9 Å). (PDB: 4PIO) 
This methyl group points in the direction of the thioether-sulfur of SAH, the crystal structure 
thus represents a snapshot of the catalytic cycle when the second methyl group has been 
transferred from SAM to MMH, forming DMH. Upon closer inspection of the coordination of 
Me1 it is evident that multiple conditions for C-H∙∙∙O hydrogen bonding are fulfilled. The C∙∙∙O 
distances of 3.5-3.9 Å are around the Van der Waals cutoff distance of ≥3.7 Å98 and the angles 
between the hypothesized bonds are close to 120° as shown in Figure 28. 
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The second methyl makes close contact to the backbone carbonyl of Gly161 (3.0 Å) at an 
angle of almost 180°, this binding position will be referred to as Me2. A third position for methyl 
binding, named Me3 hereinafter, was characterized in more detail in the dissertation of Laëtitia 
Misson, who demonstrated that an active site asparagine (Asn166) is crucial for catalysis. 
Orientation and coordination of Gly161 and Asn166 to DMH are shown on the left in Figure 
29.99 The nomenclature for all three methyl group is illustrated on the right in Figure 29 for 
clarity. 
  
Figure 29 Left: Distances between Me2 of DMH and the backbone carbonyl of Gly161 (3.0 Å) and between the 
amide and carbonyl of Asn166 and the carboxylate and Nα- of the substrate (2.9 Å and 2.7 Å respectively). (PDB: 
4PIO) Right: Coordination of all three methyl groups of TMH in the active site of EgtD. (Unpublished structure) 
In the last and most efficient methylation step from DMH to TMH (see also Table 1 in Section 
2.3.3), Asn166 is proposed to have two essential roles. It acts both as the catalytic base, which 
deprotonates Nα, and coordinates the methyl group from position Me1 to Me3, moving the 
latter away from the incoming methyl group on the final equivalent of SAM, which binds to 




Figure 30 The proposed roles of Asn166 and the backbone carbonyl of Gly161 in the final methyl transfer from 
SAM onto DMH to form TMH. In the first step Asn166 acts as a catalytic base, deprotonating Nα. After passing on 
the proton to a different base (B-) in the active site, it coordinates one methyl group in position Me3 allowing for 
nucleophilic attack of the lone pair of Nα on the methyl group of SAM. During this process Gly161 constantly 
coordinates the other methyl group in position Me2, possibly increasing the nucleophilicity of Nα by a C=O∙∙∙σ* 
interaction. The coordination in position Me1 is omitted for clarity. 
A concept which should be considered in this catalytic step especially is that of differential 
binding. This model predicts that binding affinity is higher for the transition state than for the 
substrate, thus facilitating catalysis.100,101 While this is certainly a possibility, we propose an 
alternative hypothesis for the role of the carbonyl interactions with Me2 and Me3, namely that 
they render Nα more nucleophilic. By drawing away electron density from the methyl carbon 
via n→σ* interactions, a partially positive charge is formed on the carbon center, which in turn 
creates a partial negative charge on the amine. This effect would increase the electron density 
on the nitrogen, making it a stronger nucleophile as shown with the example of Gly161 and 
Me2 in Figure 31.    
 
Figure 31 Coordination of Me2 in DMH by Gly161 in the active site of EgtD, rendering the former more nucleophilic. 
A comparable case is observed in Lewis acid-base complexation, where binding of a Lewis 








2.2 Aim of this Chapter 
Based on available kinetic and structural information, we hypothesized that two types of 
interactions are involved in the activation of the transferrable methyl group. The first of these 
is by solvation of said group by C-H∙∙∙O bonds, in analogy to the elegant study by Horowitz et 
al.on SET7/9.44 The second, more unorthodox proposal involves activation of the methyl 
acceptor by enhancing the nucleophilicity of the accepting N-center via carbonyl n→σ* 
interactions.102 We thus designed a series of experiments to test if one or both of these 
hypotheses could be valid. 
By synthesizing compounds with specific 13C-labels on the methyl groups transferred form the 
donor to the acceptor, we created probes to analyze binding modes of the methyl donor as 
well as the respective receptors. The results we have obtained complement the existing crystal 
structures nicely and offer unique insights into the catalytic mechanism. The advantage of 
NMR spectra over crystal structures is that the former is measured in solution and allows for 
examination of electronic consequences of the structural observations. Our findings have 
helped us to gain a better understanding of how EgtD manages to methylate all its substrates 
with similar catalytic efficiency. 
For the following discussion of methyl group binding sites we shall use the annotations 
introduced in the previous section and summarized again in Figure 33. 
 
Figure 33 Proposed mechanism of the third and final methylation step catalyzed by EgtD. The three binding sites 
are annotated as follows:  Me1 is the binding site coordinating the transferred methyl group formed by the C-H∙∙∙O 
bonding triangle consisting of Tyr39, Phe47 and Thr163. Me2 is the binding site with coordination to the backbone 
carbonyl of Gly161. Me3 is the binding site with coordination to the sidechain carbonyl of Asn166, which also acts 
as a catalytic base in the deprotonation steps.  
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2.3 Results and Discussion 
2.3.1 Chemical Synthesis of Labelled Compounds 
Synthesis of 13C-labelled compounds was carried out using previously published strategies 
and commercially available starting materials. The 13C-methyl groups were inserted either 
using 13C-formaldehyde or 13C-methyl iodide. 13C-DMH (55) and 13C-DMW (56) were 
synthesized by reductive amination with 13C-formaldehyde and NaCNBH3,103 13C-TMH (57) 
was synthesized from 13C-DMH with 13C-methyl iodide.104 For the synthesis of 13C-MMH (58) 
it was necessary to first introduce a benzyl protecting group on Nα.105 The resulting secondary 
amine could be methylated by the usual reductive amination procedure and the benzyl group 
subsequently removed by hydrogenation (61 and 62 in Figure 34). 
 
 
Figure 34 Top: Chemically synthesized substrates for EgtD. Bottom: Reagents and conditions for the synthesis of 
57: (a) benzaldehyde, NaOH, NaBH4, MeOH, 0 °C, 2 h, 93 %; (b) 13C-formaldehyde, NaCNBH3, AcOH, water, 16 
h, 82 %; (c) H2, Pd/C, MeOH, 16 h, 88 %. 
Of the two non-labelled compounds, α-chloro-L-histidine 59 was synthesized in one step by 
diazotization of the primary amine, followed by substitution with chlorine, similar to a 
Sandmeyer reaction. The second non-labelled compound α-methyl-D/L-histidine 60 was 




All compounds were obtained in >98 % purity and stock solutions were prepared in D2O, 
determination of the concentration was calculated from an internal standard of t-BuOH. 
2.3.2 Enzymatic Synthesis of 13C-Labelled SAM 
SAM can be efficiently synthesized enzymatically on a preparative scale from methionine and 
ATP using SAM synthetase (EC 2.5.1.6).108,109 This enzyme catalyzes the direct attack of the 
methionine sulfur onto the C-5’ of ATP and has been used to synthesize a variety of labelled 
analogues of SAM such as Se-SAM,110 36S-SAM111 or 13C-SAM.44 
 
Figure 35 Basic reaction for the formation of SAM by the SAM synthase MetK from ATP and Met. 
Using the reaction conditions detailed in the legend of Figure 36 it was possible to convert 40 
% of the limiting starting material (13C-Met) into 13C-SAM. The reaction was monitored by IE-
HPLC and seemed to reach a plateau after about 2-6 hours. Addition of more enzyme (t = 
1000 min) did not result in additional production of SAM, which could be due to inhibition by 
pyrophosphate.112  
 
Figure 36 Consumption of ATP versus formation of SAM by the SAM synthase MetK. Conditions: 4 µM MetK, 10 
mM Met, 13 mM ATP, 26 mM MgCl2, 50 mM KCl, 1 mM EDTA, 8 % β-mercaptoethanol in 100 mM Tris at pH 8. 
Reactions were quenched by adding 40 µL of the reaction mixtures to 20 µL 1 % TFA before injecting 20 µL into 
the HPLC. 
At a total reaction volume of 750 µL and after purification by RP-HPLC, the product was 
obtained in an overall yield of 34 %. Analysis by 1H- and 13C-NMR showed very high purity and 






























confirmed that only one 13C-labelled species was present in the product. The shift of 23.5 ppm 
for the methyl group corresponds well with the reported literature value of 24.6 ppm, whereas 
no remaining 13C-methionine could be detected at 15.2 ppm.108 
 







2.3.3 Binding of DMH to EgtD 
EgtD produces almost 90 % TMH when incubated with one equivalent of histidine and one 
equivalent of SAM. This is explained by the increased affinity for the methylated histidine 
variants and not by the increased catalytic efficiencies, all shown in Table 1. The affinity for 
each of the three substrates increases again upon addition of a saturating amount of SAH, 
most drastically for histidine by 8-fold. The KD-values for SAH and SAM were determined to be 
210 ± 20 µM and 270 ± 20 µM respectively.97 
Table 1 Kinetic parameters of EgtD for the three processive methylation steps and KD values as determined by 
isothermal calorimetry titration.97 
  kcat [s-1] (a) kcat/KM [M-1s-1] (a) KD [µM] (b) KD [µM] (c) 
His 0.58 5'300 290 ± 14 37 ± 1 
MMH 0.23 13'000 70 ± 30 14 ± 7 
DMH 0.43 17'000 4 ± 2 2 ± 1 
Data represent averages from multiple measurements. The standard error is less than 20% of the average value. 
Reaction conditions: (a) 50 mM Tris·HCl pH 8.0, 26 °C, 200 µM SAM, 1 µM S-adenosylhomocysteine nucleosidase, 
1 µM adenine deaminase. (b) 20 mM Tris·HCl pH 7.5, 150 mM NaCl, 25 °C, 100 µM EgtD in cell, 5 mM ligand in 
syringe. (c) EgtD solution contained 7mM SAH. 
In our approach, we aimed to compare the 1H-NMR shift of the two methyl groups of DMH free 
in solution with the respective shift(s) when bound to EgtD in presence and absence of SAH. 
For this purpose we synthesized Nα,Nα-[13C]dimethyl-L-histidine (13C-DMH). First, a spectrum 
of the unbound substrate was measured at the concentration and under the same buffer 
conditions which we would later use to conduct the measurements with the enzyme. After 
measuring the shifts of the unbound 13C-DMH (δH: 2.74 ppm, δC: 41.63 ppm), spectra were 
recorded at a substrate to enzyme ratio of 1:2.5 in order to bind most of the substrate (Figure 
38). Judging by the peak areas, at least 70 % of the substrate was bound to the active site, 
while the other 30 % remained free in solution.  
Under these conditions however, a distinct shift of each methyl group was detected, one 
moving into lower field along the proton axis and retaining its shift on the carbon axis (δH: 2.87 
ppm, δC: 41.59 ppm; referred to in the following discussion as Me1DMH), while the other shifted 
into lower field along the carbon axis, only moving downfield slightly along the proton axis (δH: 
2.81 ppm, δC: 45.04 ppm; referred to in the following discussion as Me2DMH). 
These results were very encouraging as they demonstrated a significant difference between 
free and EgtD-bound DMH. While in both cases the dimethylammonium nitrogen is a 
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stereogenic center and, hence, the two methyl groups are diastereotopic, only the bound DMH 
displays two distinguishable methyl resonances. This may be due to the more pronounced 
anisotropy of the chiral environment in the active site of the enzyme but could also be 
interpreted as a sufficient increase of the rotational barrier along the Cα-Nα axis to shift the 
rotation into the slow exchange regime. Furthermore, the shift of Me1DMH along the proton axis 
is consistent with C-H∙∙∙O bonding.44 The strong downfield shift of Me2DMH on the carbon scale 
indicates a different deshielding interaction with the protein. One possibility is that this position 
is being coordinated by a carbonyl group, as proposed in Section 2.1.5. By creating a partial 
positive charge on the methyl carbon, the nucleus is deshielded accounting for the observed 
shift of ΔC = 3.43 ppm. 
We then continued by adding a saturating amount of SAH to the mixture 
(substrate/enzyme/SAH 1:2.5:5) and recorded another spectrum. Under these conditions >95 
% of the substrate was bound, apparently “locked” into the active site by the addition of SAH. 
Most strikingly however, Me1DMH shifted further downfield (δH: 3.06 ppm, δC: 42.90 ppm), while 
Me2DMH remained more or less unchanged (δH: 2.73 ppm, δC: 44.61 ppm). Especially the shift 
of ΔH = 0.32 ppm of Me1DMH from its unbound to bound state suggests increased strengthening 
of the C-H∙∙∙O bonds. This trend is also reflected in the downfield shift of Me1DMH along the 
carbon-axis, possibly sensing the approach of the S-nucleophile and giving the methyl group 
a more electrophilic character. It thus seems likely that substrate binding becomes tighter and 
the hydrogen bonds stronger upon addition of SAH. Especially the former observation was to 
be expected, based on the increase in KD for DMH when the system is saturated with SAH. 















Figure 38 Top: HMQC-spectrum of 13C-DMH [62 µM]. Middle: HMQC-spectrum of 13C-DMH [62 µM] and EgtD [154 
µM]. Bottom: HMQC-spectrum of 13C-DMH [62 µM] and EgtD [154 µM] and SAH [300 µM]. Spectra were recorded 





2.3.4 Binding of MMH to EgtD 
A close examination of MMH binding produced corroborating evidence that SAH-binding 
increases occupation of the Me1 position. We have demonstrated this by conducting the same 
set of experiments as described above, replacing 13C-DMH with 13C-MMH. After determining 
the shifts in the unbound state (δH: 2.60 ppm, δC: 32.05 ppm referred to in the following 
discussion as MeMMH), we repeated the measurement in the presence of 2.5 eq of EgtD. When 
bound to the enzyme, the methyl group of the substrate exhibits a similar change in chemical 
shift (δH: 2.55 ppm, δC: 33.28 ppm) as Me2DMH does in the case of DMH. A slight downfield 
shift along the carbon axis, combined with little change – even a small upfield shift – along the 
proton axis. The downfield carbon shift suggests that this methyl group adopts the Me2-
position, coordinating to Gly161. 
After adding the same saturating concentration of SAH as previously, something rather 
remarkable occurred. We detected a distinct shift of MeMMH to low field along the hydrogen 
axis, with an additional small downfield shift along the carbon axis (δH: 2.79 ppm, δC: 34.46 
ppm). It seems as though MeMMH is pointing into the binding pocket Me2 when bound without 
co-substrate and moves into the position Me1 once SAH is added. 
For mechanistic implications, one needs to regard this process in reverse: after the methyl 
group is transferred from SAM onto histidine, producing MMH, SAH leaves the active site and 
the transferred methyl group on MMH rotates away from where the next methyl group will be 
bound when it enters the active site on the next equivalent of SAM (Figure 39). 
13C-MMH can thus be regarded as a molecular balance. Some more classical examples of 
molecular balances, where intramolecular interactions are examined,113 include the study of 
C-H∙∙∙O interactions by Ȫki et al.,114 or more recently the description of C-H∙∙∙π interactions.115 
In contrast to these examples we have introduced ours into an enzyme active site and can 




Figure 39 Methyl transfer from SAM onto histidine to form MMH, followed by rotation of the Nα-methyl group into 























Figure 40 Top: HMQC-spectrum of 13C-MMH [62 µM]. Middle: HMQC-spectrum of 13C-MMH [62 µM] and EgtD [154 
µM]. Bottom: HMQC-spectrum of 13C-MMH [62 µM] and EgtD [154 µM] and SAH [300 µM]. Spectra recorded in 50 





2.3.5 Binding of TMH to EgtD 
In order to obtain what we hoped would be the full picture of the active site after the final 
methylation step, we conducted an analogous set of experiments using 13C-TMH. In particular, 
we were interested in position Me3 and what effect coordination by Asn166 would have on the 
chemical shift of the respective methyl group. However, both upon addition of only enzyme 
and enzyme plus SAH, no differentiation between the three methyl groups could be recorded. 
Although we could see a difference between the unbound and the bound signal, the signal of 
the methyl groups could not be resolved into three distinct resonances. The rotational barrier 
along the Cα-Nα bond was too low to slow down the rotational frequency relative to that of the 
NMR frequency. In order to determine the energetic barrier of rotation it would be necessary 
to measure the samples at temperatures well below 0 °C. This in turn is not possible when 
working in an aqueous solvent system. 
Based upon the available crystal structure, it is safe to assume that position Me3 is indeed 
coordinated to Asn166, as shown in Figure 41. 
 
Figure 41 Active site of EgtD in complex with TMH (cyan), showing the coordination of all three methyl Nα-groups. 
The distances between the TMH-methyl groups and the side chain residues are as follows: Me1 3.8 Å (Thr163), 
















Figure 42 Top left: HMQC-spectrum of 13C-TMH [40 µM]. Middle: HMQC-spectrum of 13C-TMH [40 µM] and EgtD 
[100 µM]. Bottom: HMQC-spectrum of 13C-TMH [40 µM], EgtD [100 µM] and SAH [200 µM]. All spectra recorded in 




2.3.6 Binding of SAM to EgtD with α-Chlorohistidine 
To examine whether solvation of the transferrable methyl group forms the same C-H∙∙∙O bonds 
before and after methyl transfer we also investigated EgtD in complex with SAM and the non-
nucleophilic histidine analog αCl-L-histidine (αClHis). For this purpose 13C-labelled SAM was 
synthesized as described in Section 2.3.2 and measured in combination with the enzyme and 
a histidine analog, which did not possess a suitable acceptor and was known to bind to the 
enzyme with high affinity. For this purpose we chose αClHis (compound X in Figure 34), a 
derivative of histidine where the Nα is replaced by a chloride atom, which was shown to be a 
potent inhibitor of EgtD, competitive to histidine with a KI of 6.2 ± 1.5 µM.99 
An X-ray crystal structure for the EgtD:SAM:αClHis complex has been solved by Allegra Vit.116 
Alignment of this structure with the EgtD:SAH:DMH complex gives an RMSD of 0.245 Å (270 
atoms). Comparison of the two ternary complexes revealed some important changes within 
the active site, which are immediately apparent and are relevant to catalysis. Firstly, the 
distance between the methyl group on SAM and the Cl-atom of αClHis (Figure 43, left) is 0.3 
Å shorter than that of the methyl group on DMH and the thioether of SAH (Figure 43, right). 
The distance thus becomes slightly larger after methyl transfer. Secondly, the angles for C-
H∙∙∙O bonding are nearly 90° before and only 70° after methyl transfer relative to the S-CH3-
N/Cl axis (see also Table 2). According to this model, the methyl group is bound in a more 
strained conformation before transfer from SAM to the acceptor. 
   
Figure 43 Left: View of the binding pocket of the ternary complex EgtD:SAM:αClHis. The distances between the 
SAM-methyl group and the three side chain residues are 3.2 Å (Thr163), 3.6 Å (Phe47) and 3.8 Å (Tyr39). Right: 
View of the binding pocket of the ternary complex EgtD:SAH:DMH.97 The distances between the DMH-methyl group 
and the three side chain residues are 3.5 Å (Thr163), 3.9 Å (Phe47) and 3.6 Å (Tyr39). The solid black lines indicate 




Table 2 Angles for C-H∙∙∙O bonding relative to the S-CH3-N/Cl axis in the ternary structures EgtD:SAM:αClHis and 
EgtD:SAH:DMH. 
  EgtD:SAM:αClHis EgtD:SAH:DMH 
Residue Angle 
Tyr39 91° 69° 
Phe47 116° 55° 
Thr163 80° 79° 
Average 96° ± 18° 67° ± 12° 
 
SAM free in solution and in combination with 2.5 eq of EgtD shows no substantial shift of its 
labelled methyl group (δH: 2.84 ppm, δC: 23.28 ppm and δH: 2.84 ppm, δC: 23.31 ppm, 
respectively, referred to in the following discussion as MeSAM), allowing for the assumption that 
only a non-detectable fraction of SAM is bound to the enzyme when no histidine analog is 
present. This is in line with the KD of 270 ± 20 µM determined for SAM, which preferentially 
binds to the EgtD:His complex, as well as the findings that EgtD binds its substrates in a 
sequential order, first binding histidine and only then binding SAM.99 
Upon addition of αClHis a significant downfield shift of MeSAM on the hydrogen axis could be 
observed (δH: 3.02 ppm, δC: 29.66 ppm), which was however less (ΔH = 0.17 ppm) than that 
observed for Me1DMH (ΔH = 0.32 ppm). In comparison to the crystal structure with bound DMH, 
EgtD in complex with SAM and chlorohistidine reveals very similar distances between the 
methyl carbon in position Me1 and the coordinating residues (Table 3). 
Table 3 Distances between the transferred methyl group on the donor (SAM) and acceptor (DMH) and the three 
coordinating residues in position Me1. 
Substrate: SAM DMH 
Tyr39 3.8 Å 3.6 Å 
Phe47 3.6 Å 3.9 Å 
Thr163 3.2 Å 3.5 Å 
 
The strong downfield shift along the carbon axis of ΔC = 6.38 ppm is remarkable and the effect 
of significant deshielding and thus activation as an electrophile. It is however possible that the 
47 
 
nearby chlorine atom (3.1 Å from the methyl group of SAM) contributes to the deshielding 




















Figure 44 Top: HMQC-spectrum of 13C-SAM [70 µM]. Middle: HMQC-spectrum of 13C-SAM [39 µM] and EgtD [95 
µM].Bottom: HMQC-spectrum of 13C-SAM [39 µM], EgtD [95 µM] and αCl-L-His [190 µM]. All spectra recorded in 




2.3.7 Binding of SAM to EgtD with α-methylhistidine 
The binding studies shown in the previous section were repeated using a different histidine 
analog in order to rule out any substantial influence of the α-chloro group. To do so, the chloro 
substituent was replaced with a methyl group (59 and 60 respectively in Figure 34). The KI-
value of α-methyl D/L-histidine (αMeHis) is comparable to that of the chlorinated analog and 





Figure 45 HMQC-spectrum of 13C-SAM [39 µM], EgtD [95 µM] and αMe-DL-His [400 µM] All spectra recorded in 
50 mM phosphate buffer, pH 8 containing 50 mM NaCl and 5 % D2O. 
Interestingly, this experiment produced two signals for the bound substrate with slightly 
different shifts, which could arise from the fact that αMeHis is a racemic mixture due to the 
synthesis (see Section 2.6.2). It is reasonable to assume that the weaker signal (δH: 2.92 ppm, 
δC: 28.70 ppm) is SAM in complex with EgtD and αMe-D-His, while the stronger signal (δH: 
2.87 ppm, δC: 28.44 ppm) is in complex with αMe-L-His due to the different affinities for D- and 
L-histidine.99 The downfield shifts along the carbon coordinate (ΔC = 5.16 and 5.42 ppm) are 
comparable to the previously measured shift of ΔC = 6.38 ppm with the chlorinated substrate. 
Along the hydrogen coordinate the downfield shift is decreased for both signals. In conclusion, 
it appears that the binding of SAM and the interactions of the enzyme with the methyl group 
are not greatly influenced by the nature of the substitution in the α-position of the co-substrate. 
It also looks like EgtD can bind both the D- and L-form of 60 at a ratio of roughly 1:3, an 




2.3.8 Binding of DMW to Engineered EgtDM252V,E282A 
To examine whether solvation of the N-methyl group is influenced by the side chain of the 
substrate we also studied a variant of EgtD in complex with Nα,Nα-dimethyl tryptophane 
(DMW). 
By introducing two point mutations in the histidine binding pocket (M252V and E282A) one can 
change the substrate specificity of EgtD from histidine to tryptophan by a factor of almost 107. 
Comparing the wild type methylation of histidine with the mutant methylation of tryptophan 
reveals that kcat/KM remains unperturbed yet kcat drops by roughly six-fold, indicating that 
binding affinity remains the same but catalysis is slightly slower (see also Table 1). The mutant 
enzyme showed virtually no more activity for histidine and diminished activity for DMW over 
tryptophan (Table 4). Despite this dramatic change in structure and activity, the binding affinity 
for tryptophan rivals that of the wild type for histidine. There is however one major change in 
the activity, namely the significantly less efficient final methylation step from DMW to TMW, 
which is in stark contrast to the high efficiency of the last methylation step from DMH to TMH 
in the wild type. It thus seems reasonable to assume that the transition state is only weakly 
stabilized in the final methylation step of this variant. 
Table 4 Kinetic parameters of the engineered EgtDM252V,E282A for histidine, tryptophan and DMW.99 
  kcat [s-1] KM [µM] kcat/KM [M-1s-1] 
His - - 2 
Trp 0.11 20 5'500 
DMW 0.01 11 830 
Reaction conditions: 25 °C, 50 mM Tris·HCl pH 8.0, 50 mM NaCl, 200 µM MnII, 500 µM SAM, 10-500 µM tryptophan 
or DMW, 5 µM SAH nucleosidase, 10 µM adenine deaminase and 6.6 µM of EgtDM252V,E282A. 
In addition to the NMR experiments done on the wild type variant of EgtD, we hoped to gain 
some insights into the binding mode of tryptophan to the engineered EgtD with the point 
mutations M252V and E282A. We speculated that the 40-fold decrease in kcat observed for 
this variant (compared to EgtBwt:DMH) could be due to weaker solvation of the Nα-methyl 
group and a decrease in nucleophilicity of the amine. In order to test this hypothesis, we 
measured the chemical shifts of 13C-labelled DMW in complex with EgtDM252V,E282A with and 
without SAH as well as free in solution. 
The results are similar to those obtained from the analogous measurements with EgtD and 
DMH. The chemical shift (δH: 2.79 ppm, δC: 41.54 ppm) is only marginally different than that of 
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DMH, as could be expected. Upon binding of DMW to the enzyme, a resolution of the single 
signal into two distinct binding modes can be observed. A slight shift downfield along the 
hydrogen and almost no shift along the carbon axis hints towards one methyl group pointing 
into the characteristic C-H∙∙∙O hydrogen bond pocket Me1 (δH: 2.93 ppm, δC: 41.79 ppm; 
referred to in the following discussion as Me1DMW). As is the case with DMH, the second shift 
corresponds to the orientation Me2, with little shift along the hydrogen and a substantial shift 
along the carbon axis (δH: 2.85 ppm, δC: 44.47 ppm; referred to in the following discussion as 
Me2DMW). This downfield carbon shift of ΔC = 2.9 ppm is slightly less than what was measured 
for DMH, which was ΔC = 3.4 ppm. 
Once the system is saturated with SAH, Me1DMW moves downfield along both the hydrogen 
and carbon axes (δH: 3.07 ppm, δC: 43.49 ppm), again demonstrating that C-H∙∙∙O bonding is 
stronger in the presence of SAH. The shift along the hydrogen axis of ΔH = 0.28 ppm is nearly 
the same as the 0.32 ppm for DMH. The carbon shift was slightly more with ΔC = 1.95 ppm 
versus 1.27 for DMH. For the second binding position Me2DMW (δH: 2.79 ppm, δC: 44.05 ppm) 
we observed a shift which was slightly less than Me2DMH (ΔC = 2.5 and 3.0 ppm, respectively). 
These shifts are both roughly 0.5 ppm less than the equivalent shifts in the EgtD:DMH and 
EgtD:DMH:SAH complexes, as summarized in Table 5. 
Table 5 comparison of the shift along the carbon axis of the position Me2 for DMW and DMH in complex with EgtD 
and SAH. 
  [X] [EgtD:X] [EgtD:X:SAH] 
X δC (ppm) 
DMW 41.54 44.47 44.05 
DMH 41.63 45.04 44.61 
Δ 0.09 0.57 0.56 
 
While the reduction in reaction rate for this mutant versus the wild type enzyme does not seem 
to correlate with diminished C-H∙∙∙O bonding in position Me1, it could be explained by the 
weaker coordination to Gly161 in position Me2. If this interaction indeed increases the 












Figure 46 Top: HMQC-spectrum of 13C-DMW [55 µM]. Middle: HMQC-spectrum of 13C-DMW [55 µM] and 
EgtDM252V,E282A [138 µM]. Bottom: HMQC-spectrum of 13C-DMW [55 µM], EgtDM252V,E282A [138 µM] and SAH [276 




2.3.9 Binding of 15N-Labelled DMH 
As a final indication that the nucleophilicity of Nα is increased upon binding to EgtD, we 
attempted to show that electron density was transferred onto the amine. In order to measure 
this, we synthesized the DMH-variant 15N-DMH that contains a 15N-label in the appropriate 
position by the usual procedure of reductive amination. As starting material we used histidine 
completely labelled with 15N and 13C. Due to the low sensitivity of the 15N-nucleus, a pseudo 
3D-NMR experiment was necessary. By irradiating Hα and transferring the magnetization via 
Cα to Nα and then back to Hα via Cα we were able to generate a 1H/15N-HMQC spectrum of 15N-
DMH. The signal however was much weaker than in the preceding 1H/13C-HMQC experiments, 
due to the very small coupling constant between 13Cα and 15Nα of J = 4.5 Hz. This resulted in 
a long transfer delay time from Cα to Nα and back of around 50 ms, which was larger than the 
(15N)t2 relaxation time. 
While we were able to obtain a clear, albeit weak signal of the compound free in solution, the 
signal was lost once the substrate was bound to the enzyme both with and without SAH. It is 
possible that the signal was hidden under the water peak, in which case it would be impossible 
to detect under all conditions. If the signal was simply weaker than the signal to noise ratio, 
one could run a different magnetization-transfer experiment with an appropriate direct 
detection cryoprobe for 15N. In such an experiment only one chemical shift evolution from Hα 
to Cα to Nα would be necessary and the magnetization could be directly detected on Nα. This 
however, was not realizable with the instruments at our disposition. 
Quantum chemical computations, based on the X-ray structures of three EgtD-substrate 
complexes, provided some support for our hypothesis of enhanced nucleophilicity of Nα(His) 
upon binding. By calculating the effect of methyl group coordination by Gly161, Corminboeuf 
et al. were able to show that the positive charge of Nα in the unbound state was slightly higher 
than in the bound state. (Unpublished results kindly provided by Prof. Clémence Corminboeuf) 
This would mean that coordination by Gly161 does indeed increase the electron density on Nα, 
thus rendering it more nucleophilic. Since the nucleus would be more shielded, in the NMR 
spectrum one would expect an upfield shift away from the water peak. Additional NMR 
experiments with a cryoprobe which is more sensitive to 15N would certainly be necessary to 




2.3.10 Binding Isotope Effects of Asymmetrically 2H-Labelled DMH 
Another way to test our hypothesis of the presence of C-H∙∙∙O interactions was via a binding 
isotope effect. Since hydrogen bonds are sensitive to changes in distance,117 we reasoned that 
by labelling DMH with one –CH3 and one –CD3 methyl group we might be able to see an 
asymmetric distribution. We believed that position Me1, where C-H∙∙∙O bonds are formed, 
would preferentially bind the –CH3 group over the –CD3 group, since C-D bonds are slightly 
shorter than C-H bonds due to their lower zero point energy.118 We thus synthesized an 
asymmetrically labelled variant of DMH (X) from 13C-MMH by the usual reductive amination 
procedure using deuterated formaldehyde and NaCNBD3, as shown in Figure 47. 
  
Figure 47 Reagents and conditions for the synthesis of 63 from 58. 
Unfortunately, no asymmetric distribution in binding could be observed in our measurements. 
If there is indeed a preferential binding of the non-deuterated methyl group in the Me1 position, 
it is below the limit of detection. The error of peak integration was higher than the observable 
effect. 
The difference in binding energies between C-H∙∙∙O and C-D∙∙∙O should be expected to be 
quite low in any case. Even arguably stronger hydrogen bonds show only very small deuterium 
isotope effects. For example, in the system (H2O∙∙∙H/D∙∙∙O2H)+ the H-bonded complex was 
calculated to be favored over the D-bonded complex by only 0.5 kcal/mol, which is a difference 







2.3.11 Determination of the Geminal Angle of Methyl C-H Bonds 
By creating a stereogenic center on each methyl group, we hoped to be able to compare the 
germinal coupling constants between the two hydrogen atoms on each methyl group. In case 
of a decrease in the coupling constant upon substrate binding to the enzyme, one could deduce 
that the hydrogen atoms are being “pushed” into an SN2-like transition state where the C-N 
bond is being weakened and the hydrogen atoms are closer to perpendicular to the N-C∙∙∙O-
axis. We speculated that this effect would be especially pronounced in position Me2, where 
coordination to Gly161 would start to fill the σ*-orbital of the methyl carbon (Figure 48). 
Correlations between geminal H-H coupling constants and H-C-H bond angle have been 
determined on systems such as CH2DCN (mono-deuterioacetonitrile).120 
 
Figure 48 Possible increase in the geminal C-H angle upon binding of the substrate to EgtD. 
For our purpose a derivative of DMH was synthesized containing two 13C-methyl groups with 
two hydrogens and one deuterium each, thus creating methyl groups with diastereotopic 
hydrogens. 
 
Figure 49 Synthesis of Nα,Nα-bis(methyl-13C-d)-L-histidine (64) from L-histidine. 
The labelled methyl groups showed coupling constants of 144.2 Hz and 1.8 Hz, the first arising 
from the coupling to the 13C-atom, the smaller one could possibly represent an H-C-D 2J-
coupling as it is similar to that observed in the molecule DMF (1.9 Hz).121 Multiplication by the 
ratio of the gyromagnetic constants of hydrogen and deuterium (γH/γD = 6.55) gives a geminal 
H-C-H 2J-coupling value of 11.8 Hz, which is just under that determined for methane (12.4 ± 
0.6)122 and well under that determined for acetonitrile (16.9 ± 0.3).120 The coupling constants 
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in complex with the enzyme were unfortunately not of sufficient precision to be able to observe 




2.4 Mechanistic Implications 
The molecular toolbox of EgtD, which it uses to catalyze methyl transfer, can be divided into 
three parts: C-H∙∙∙O bonding, n→σ* interactions and acid-base catalysis. The last of these was 
characterized comprehensively by Laëtitia Misson in her dissertation,99 the former two were 
the focus of this work. In this last section, we would like to summarize our findings and what 
we have been able to learn with respect to the enzyme mechanism and its overall strategy. 
By a combination of NMR and crystallography, we have characterized some of the molecular 
strategies employed by EgtD for catalysis. On the one hand, we have added another example 
to the group of methyltransferases where C-H∙∙∙O bonding plays a role in the methyl transfer 
reaction from SAM to the acceptor.44,123,124 On the other hand we propose a unique method of 
nucleophilic activation by unusual attractive coordination of two carbonyl residues to the 
substrate(s).102 Binding via these unusual interactions has been shown both on the methyl 
donor as well as on different acceptors (MMH and DMH). 
2.4.1.1 C-H∙∙∙O Bonding 
The first binding site we could observe was Me1, between the sulfur of SAM/SAH and the 
nitrogen acceptor, featuring the C-H∙∙∙O bonding triangle formed by Phe47, Tyr39 and Thr163. 
Upon binding to this site, the chemical shift of one methyl group in DMH moves downfield 
slightly by 0.13 ppm. After addition of SAH an additional downfield shift is observed leading to 
a total shift of 0.32 ppm from the unbound to the bound state with SAH. The strength of the 
hydrogen bonds thus increases once the substrate is locked into the active site by SAH. In the 
binding of MMH this site is only occupied when SAH is present, leading to a downfield shift of 
0.19 ppm. When this binding site is occupied by the methyl group on SAM, the downfield shift 
is less pronounced. When αClHis is used as the co-substrate the shift is 0.17 ppm, when 
methylhistidine is used the shift is only 0.02-0.07 ppm. Coordination of the transferred methyl 
group by C-H∙∙∙O bonding is thus weaker when it is on the donor and stronger on the acceptor. 
However, the downfield shift of the methyl group on the carbon scale was much larger on SAM, 
both in complex with methylhistidine (5.4 ppm) and chlorohistidine (6.4 ppm), than on the 
acceptors MMH (2.4 ppm with SAH) or DMH (1.3 ppm with SAH). The electrophilic character 
of the methyl group is thus increased on the donor versus the acceptor, as expected. 
Analysis of the crystal structures of EgtD in complex with either SAM:αClHis or SAH:DMH 
provides a comparison of the binding before and after methyl transfer, respectively. In the first 
structure where C-H∙∙∙O bonds are formed with the methyl group on SAM, the angle of these 
bonds relative to the S-C axis is nearly perpendicular. In the second structure where C-H∙∙∙O 
bonds are formed with the methyl group on DMH, the angle becomes smaller. According to 
these models there would be more strain on the C-H bonds in the first structure, before methyl 
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transfer takes place. By these interactions it is conceivable that EgtD brings the substrate 
methyl-group closer to the geometry of the transition state and enhances its reactivity in this 
fashion. This in turn is observable as the strong downfield shift along the carbon axis, indicating 
increased electrophilicity of the carbon center. 
Compared with a similar system, the lysine methyl transferase SET7/9, the proton chemical 
shift we measured and hence the hydrogen bonding effect is weaker. The main difference 
between the C-H∙∙∙O bonding motives in EgtD and SET7/9 is that the former consists of two 
C-H∙∙∙O and one C-H∙∙∙π interaction, while the latter forms three C-H∙∙∙O bonds. In contrast to 
this enzyme however, EgtD catalyzes three methylation steps instead of only one. 
  
 
Figure 50 Active sites of EgtD (left, unpublished structure) and SET7/9 (right, PDB: 1N6A) showing the C-H∙∙∙O/π 
interactions between the methyl group of SAM (purple) with the respective residues (green). The indicated distances 
to the carbons of each methyl group on SAM are as follows. EgtD: Tyr39 (3.9 Å), Phe47 (3.6 Å), Thr163 (3.8 Å); 
SET7/9: Gly269 (3.7 Å), His293 (3.0 Å), Tyr335 (3.5 Å). 
Since the average distance to the coordinating residues is very similar (EgtD 3.8 ± 0.2 Å, 
SET7/9 3.4 ± 0.4 Å), this can hardly be used as an argument to justify this observation. The 
most obvious possibility for the weaker bonding in EgtD than in SET7/9 is the substitution of 
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one C-H∙∙∙O bond with a C-H∙∙∙π interaction. The latter are generally weaker with an enthalpy 
of 0.5-2 kcal/mol,125 while the former has been calculated to be as high as around 9 kcal/mol 
for strongly polarized systems.126 Testing this hypothesis would be a bit of a challenge, since 
introducing a point mutation replacing Phe47 with a potential C-H∙∙∙O bond acceptor could 
significantly reduce the catalytic efficiency of the enzyme. 
In any case, the main role of these interactions seems to be the coordination of the transition 
state (TS). In a recent study on human DNA methyltransferase 1 (DNTM1), Schramm et al. 
conducted a number of KIE measurements, which they combined with QM calculations to 
generate a model of the TS at subangstrom resolution.127 Their exhaustive analysis resulted 
in a picture of a relatively loose TS, in contrast to the compressed TS suggested by some50,52 
and disputed by others51,56 for COMT (see also Section 2.1.2). 
Similar KIE/computational studies to those of Schramm et al. have also been done recently on 
different histone KMTs. In a study on SET8, Linscott et al. suggest an early SN2 TS with a long 
N-C distance (2.35-2.40 Å) and a short C-S distance (2.00-2.05 Å), with the methyl hydrogens 
coordinated by noncanonical C-H∙∙∙O bonding with Cys270, Arg295, and Tyr336.128 In NSD2, 
a related histone KMT, Poulin et al. described the opposite case, with a late SN2 TS with a 
short N-C distance (2.02-2.10 Å) and a long C-S distance (2.50 Å).123 
Since there seems to be a more or less general consensus that enzymes catalyze reactions 
by stabilization of the transition state,129 it makes sense to discuss our own findings in the light 
of Hammond’s original postulate on transition state theory.130 According to this, when reactant 
and product are of equal energy, the transition state should be exactly in the middle of the 
energy diagram and its structure should be equally similar to both (ii in Figure 51). If the 
reactant is of higher energy, the structure of the transition state should be more similar to that 
of the reactant and is termed an early transition state (i in Figure 51). In the opposite case, 
where the product is higher in energy than the reactant, the transition state is more similar to 




Figure 51 Graphical representation on Hammond’s postulate on transition state theory. 
Because the methyl group on SAM is clearly more electrophilic – as we have shown in our 
NMR analysis – and reactive than on MMH or DMH, an early transition state should be favored. 
Hence, stabilization of this state might be a strategy for EgtD to facilitate methyl transfer. In 
this unobservable transition state we would expect C-H∙∙∙O bonding to be strongest due to the 
planar nature of the intermediate, where the H∙∙∙O distance would be at a minimum. However, 
as discussed above, this is a slightly oversimplified model and many more subtle effects may 
play a role in defining whether a TS is early or late and tight or loose. 
Hence, one option for elucidating the character of the EgtD TS would be to conduct the same 
combination of KIE determination with computational modelling. 
 
Figure 52 Transition state in the SN2-type methyl transfer from SAM onto histidine. 
This hypothesis could be tested with kinetic experiments using isotopically labelled SAM. 
When using SAM containing a methyl group with hydrogen substituted for deuterium or tritium 
one would expect an inverse secondary KIE for the methyl transfer step in the case that the 
TS is stabilized by equatorial C-H∙∙∙O bonds.131 Others may however argue that the only true 
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way of elucidating what exactly is the cause of the catalytic efficiency is by computational 
methods. 
2.4.1.2 Carbonyl Coordination 
The second binding site we could observe was Me2, where the methyl group is coordinated to 
the backbone carbonyl of Gly161. We propose that n→σ* interactions between the lone pair 
orbital of the carbonyl oxygen and the antibonding σ-orbital of the methyl carbon can be 
observed in the 13C-NMR shift of the methyl carbon coordinated to this position. Upon binding, 
the resulting deshielding of the methyl carbon is observable as a downfield shift of 2.4-3.4 ppm, 
depending on the substrate. After the first methylation of histidine, this is the position occupied 
by the Nα-methyl of MMH, making room for the next methyl group to enter the active site on 
the second equivalent of SAM.  
By demonstrating that the methyl carbon in the Me2 position becomes electron deficient upon 
coordination to the enzyme we can deduce that the adjacent Nα becomes more nucleophilic 
(see also Section 2.1.5). This may also be the reason for the drop in catalytic efficiency of the 
EgtD M252V E282A mutant, which catalyzes the (di-)methylation of tryptophan. In our NMR 
experiments with DMW we observed a smaller downfield shift of the methyl carbon in position 
Me2 than for DMH, both with and without SAH. Although the computational model of 
Corminboeuf et al. (see Section 2.3.9) supports our assumption, solidification of this 
hypothesis would warrant some sort of direct observation, for example on the NMR shift of Nα. 
The second carbonyl coordination position Me3 could not be observed in our NMR 
experiments. The methyl group of MMH preferentially coordinates to Me1 (with SAH) and Me2 
(without SAH) and both methyl groups in DMH are coordinated to Me1 and Me2 (with and 
without SAH). Only before the final methylation step is Me3 occupied by one of the DMH methyl 
groups and only during SAM-binding. While we were not able to observe this position in our 
NMR experiment with TMH, we can see coordination of the third methyl group to Asn166 in 
the crystal structure (Figure 41). 
The complete catalytic mechanism we propose is shown in Figure 53. In A, histidine, the first 
substrate, is bound and deprotonated by Asn166 in Me3 when SAM enters the active site in 
B. After methyl group transfer from SAM onto MMH in C, SAH leaves the active site and the 
methyl group on MMH rotates into Me2 in D. The substrate is once again deprotonated by 
Asn166 upon binding of the second SAM equivalent in E. The second transferred methyl group 
remains coordinated in Me2 in the presence (F) and absence (G) of SAH. Only after 
deprotonation of Nα and binding of the third equivalent of SAM does one methyl group occupy 
the Me3 position during methyl transfer (H). Evidence for all intermediate ground states is 





Figure 53 Proposed mechanism of the three methylation steps catalyzed by EgtD. Me1 is the binding site formed 
by the C-H∙∙∙O bonding triangle consisting of Tyr39, Phe47 and Thr163. Me2 is the binding site with coordination to 
the backbone carbonyl of Gly161. Me3 is the binding site with coordination to the sidechain carbonyl of Asn166, 





In conclusion, we have shown direct evidence for C-H∙∙∙O bonding, both on the methyl donor 
as well as on a selection of acceptors via NMR. These findings are in excellent agreement with 
the available crystal structures and in the case of MMH provide new insights into methyl group 
coordination in the catalytic mechanism. We propose that C-H∙∙∙O bonding may be a more 
widespread strategy of SAM-dependent methyltransferases to facilitate methyl group transfer 
than has previously been shown. We hope that our contribution will inspire research into similar 
systems, such as the glycine sarcosine N-methyltransferase discussed in Section 2.1.4.2. 
We have also shown that a second, novel type of interaction is at play during catalysis, namely 
the transfer of electron density from two carbonyl groups to Nα via n→σ* interactions with the 
adjacent methyl carbons. Although direct experimental evidence for increased electron density 
on the nitrogen of interest could not yet be obtained, computational models support our 
assumption. Furthermore, all the indirect evidence obtained from our experiments strongly 
backs our hypothesis. 
In contrast to the discussion surrounding the reasons for methyltransferase efficiency outlined 
in Section 2.1.2, where the transition state is the main focus, all our measurements represent 
snapshots of ground states. Further experiments would be warranted if the transition state 
were to be addressed more directly, either via kinetic isotope effects, QM/MM or a combination 
of the two. 
 




2.6.1 NMR Spectroscopy 
The 1H-13C HSQC experiments were performed using a sensitivity enhanced pulse sequence 
with watergate solvent suppression.132 Typically, 512 increments were performed in the indirect 
carbon dimension and 2048 data points were acquired in the proton dimension. The acquisition 
time was 141 ms in F2 and 11 ms in F1 dimensions, the total experiment time varied between 
40 min and 12 hours. Processing was performed using the Bruker Topspin 3.2 software and 
zero-filling to 1k data points was applied in F1. 
 
2.6.2 Synthesis 
Reductive amination using formaldehyde and NaCNBH3 – Procedure A: The starting material 
(1 eq) was dissolved in water (10 ml per mmol) and the pH was adjusted to 5.5 – 6 by addition 
of glacial AcOH. Formaldehyde (2-5 eq) was added and the solution was stirred at room 
temperature for 15 min before adding NaCNBH3 (2-3 eq), readjusting the pH if needed and 
stirring for 2-18 h. Conversion of starting material was checked by either 1H-NMR or IE-HPLC 
(using the method shown in Table 14 of Section 3.6.2.1) and if starting material was still 
detected, another portion of formaldehyde (1-2 eq) was added and the reaction was stirred for 
an additional 2 h. When the reaction was complete it was quenched by acidifying to pH 1 with 
concentrated HCl and stirred vigorously for 30 min. Unless noted otherwise, products were 
purified by procedure Xb. 
Purification by cation exchange chromatography – Procedure B: The crude sample was 
dissolved in water and the pH was adjusted to 1 by addition of  HCl (either concentrated or 1 
M, depending on sample size) and the volume was increased so that the total concentration 
of NaCl or other unwanted inorganic salts was <50 mM. The sample was loaded onto a flash 
column packed with Dowex® cation exchange resin (50WX-8) and the loaded resin was 
washed with several volumes of water. Product elution was carried out using 100 or 250 mM 
NH4OH and fractions containing product were identified by TLC (1-BuOH/AcOH/water 3:1:1), 
staining with ninhydrin. All fractions containing product were combined and dried either by 






Synthesis of Nα,Nα-di(methyl-13C)-L-histidine (55) 
 
Using procedure A and starting with L-histidine (225 mg, 1.45 mmol, 1 eq), 13C-formaldehyde 
(20 %, 1 ml, 7.26 mmol, 5 eq) and NaCNBH3 (273 mg, 4.35 mmol, 3 eq), this product was 
obtained as white solid (222 mg, 1.21 mmol, 84 %) after purification according to procedure B 
and lyophilization. 1H NMR (400 MHz, D2O) δ 7.63 (s, 1H), 6.94 (s, 1H), 3.71 (tt, 3JHH = 6.6 Hz, 
3JCH = 2.5 Hz, 1H), 3.17 – 3.07 (m, 2H), 2.74 (dd, 1JCH = 142.2, 3JCH = 4.1 Hz, 6H). HRMS m/z 
calcd. for C613CH14N3O2 [M+H+]: 186.1148, found: 186.1147 
 
Synthesis of Nα-benzyl-L-histidine (61) 
 
To a suspension of L-histidine (1.551 g, 10.00 mmol, 1 eq) in dry MeOH (25 ml) was added 
finely ground NaOH (420 mg, 10.50 mmol, 1.05 eq) and the solution was stirred at room 
temperature for 30 min, in which time the starting material dissolved. Benzyladehyde was 
added (3.55 ml, 34.99 mmol, 3.5 eq) and the clear solution was cooled to 0 °C before adding 
NaBH4 (945 mg, 24.99 mmol, 2.5 eq) and the solution was stirred for 2 h at 0 °C. The reaction 
was acidified to pH 1 with conc. HCl and the organic solvent was removed under reduced 
pressure. The residue was dissolved in water and the product was purified by cation exchange 
chromatography according to procedure B, obtaining the pure product (2.284 g, 9.31 mmol, 93 
%) as white solid after lyophilization. 1H NMR (400 MHz, MeOD) δ 8.92 (d, J = 1.4 Hz, 1H), 
7.63 – 7.58 (m, 3H), 7.48 – 7.45 (m, 3H), 4.48 (dd, J = 8.4, 5.2 Hz, 1H), 4.42 – 4.35 (m, 2H), 







Synthesis of Nα-benzyl-Nα-(methyl-13C)-L-histidine (62) 
 
Using procedure A and starting with 61 (200 mg, 0.82 mmol 1 eq), 13C-formaldehyde (20 %, 
225 µL, 1.63 mmol, 2 eq) and NaCNBH3 (102 mg, 1.63 mmol, 2 eq) this product was obtained 
as off-white solid (174 mg, 0.67 mmol, 82 %) after purification according to procedure B and 
lyophilization. 1H NMR (400 MHz, D2O) δ 7.77 (s, 1H), 7.48 – 7.41 (m, 2H), 7.02 (s, 1H), 4.25 
– 4.16 (m, 1H), 3.84 (td, J = 7.0, 6.9, 2.7 Hz, 0H), 3.28 – 3.18 (m, 1H), 2.69 (d, 1JCH = 142.0 
Hz, 3H). MS m/z calcd. for C1313CH18N3O2 [M+Na]+ 261.14, found 261.01. 
 
Synthesis of Nα-(methyl-13C)-L-histidine (58) 
 
To a solution of 62 (174 mg, 0.67 mmol, 82 %) in dry MeOH (2 ml) was added 10 % Pd/C (71 
mg, 0.07 mmol, 0.1 eq) an atmosphere of H2 (1 atm) was applied and the reaction mixture was 
stirred at room temperature overnight. After reaction control by 1H-NMR and completion of the 
reaction, the mixture was filtered over a pad of celite and evaporated to dryness. The product 
was obtained as an off white solid (100 mg, 0.59 mmol, 88 %) after purification by procedure 
B. 1H NMR (400 MHz, D2O) δ 8.67 (d, J = 1.4 Hz, 1H), 7.42 (d, J = 1.1 Hz, 1H), 4.22 (ddd, J = 
7.4, 5.4, 2.8 Hz, 1H), 3.53 – 3.47 (m, 1H), 3.45 – 3.39 (m, 1H), 2.79 (d, J = 144.2 Hz, 4H). 








Synthesis of Nα,Nα,Nα-tri(methyl-13C)-L-histidine (57) 
 
To a solution of 55 (120 mg, 0.65 mmol, 1 eq) in dry MeOH (3 ml) was added conc. NH4OH 
(40 µL, 0.65 mmol, 1 eq) and 13CH3I (58 µL, 0.92 mmol, 1.4 eq) and the solution was stirred at 
room temperature overnight. Analysis by IE-HPLC (Table 14, in Section 3.6.2.1) showed 14 
% of the starting material had not been converted, thus an additional portion of 13CH3I (16 µL, 
0.26 mmol, 0.4 eq) was added and the reaction mixture was stirred overnight. The solvent was 
removed under reduced pressure and the residue was dissolved in a minimal amount of warm 
MeOH. To this, Et2O was added and the crude product was allowed to precipitate in the fridge 
overnight. The solvent was decanted and the remaining solid was dried, dissolved in water 
and the product was purified by anion exchange chromatography, using Amberlite® IRA-410, 
where the product does not bind to the resin. After lyophilization of product-containing fractions 
(stained with ninhydrin), the pure product (99 mg, 0.50 mmol, 76 %) was obtained as colorless 
solid. 1H NMR (400 MHz, D2O) δ 7.68 (d, J = 1.2 Hz, 1H), 6.97 (d, J = 1.2 Hz, 1H), 3.88 (ddt, 
3JHH = 10.7, 3JHH = 4.4, 3JCH = 2.3 Hz, 1H), 3.25 (dt, 1JCH = 145.1, 3JCH = 3.4, 3JCH = 3.4 Hz, 3H), 
3.28 – 3.14 (m, 3H). HRMS m/z calcd. for C613C3H16N3O2 [M+H]+ 201.1338, found 201.1339. 
 
Synthesis of Nα,Nα-di(methyl-13C)-L-tryptophan (56) 
 
Using procedure A and starting with L-tryptophan (20 mg, 0.10 mmol, 1 eq), 13C-formaldehyde 
(20 %, 54 µL, 0.39 mmol, 4 eq) and NaCNBH3 (15 mg, 0.24 mmol, 2.5 eq), this product was 
obtained as white solid (29 mg, 0.10 mmol, quant.) after purification according to procedure B 
and lyophilization. 1H NMR (500 MHz, D2O) δ 7.72 (d, J = 7.9 Hz, 1H), 7.51 (d, J = 8.1 Hz, 1H), 
7.27 – 7.24 (m, 1H), 7.21 (s, 1H), 7.20 – 7.16 (m, 1H), 3.44 (dt, J = 14.0, 4.2, 4.2 Hz, 1H), 3.20 
– 3.16 (m, 1H), 3.10 – 3.06 (m, 1H), 2.43 (dd, J = 135.8, 4.8 Hz, 9H). HRMS m/z calcd. for 
C1113C2H17N2O2 [M+H]+ 235.1352, found 235.1349. 
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Synthesis of (S)-2-chloro-3-(1H-imidazol-4-yl)propanoic acid (X) 
 
To a stirred solution of L-histidine (200 mg, 1.29 mmol, 1 eq) in conc. HCl (3 ml) was slowly 
added a cold solution of NaNO2 (320 mg, 4.64 mmol, 3.6 eq) in water (1 ml) at 0 °C. The 
reaction mixture was stirred at 0 °C for 1 h and then at RT for 5 h. The solvent was removed 
by evaporation and the product was extracted from the white precipitate with 3 x acetone 
followed by evaporation of the organic solvent to give the HCl salt of the product (95 mg, 0.45 
mmol, 35 %) as clear oil.1H NMR (400 MHz, D2O) δ 8.62 (d, J = 1.5 Hz, 1H), 7.37 (s, 1H), 4.82 
(dd, J = 6.7, 5.6 Hz, 1H), 3.51 – 3.40 (m, 2H). HRMS m/z calcd. for C6H8ClN2O2 [M+H]+ 
175.0269, found 175.0269. 
 
Synthesis of S-adenosyl 13C methionine 
 
SAM was synthesized enzymatically using SAM synthetase metK, which was kindly provided 
by Alice Harnacke. The reaction was carried out in a total volume of 750 µL containing 100 
mM Tris buffer (pH 8), 10 mM 13C-Met, 13 mM ATP, 1 mM EDTA, 26 mM MgCl2, 50 mM KCl 
and 8 % β-mercaptoethanol. The reaction was initiated by adding 3 µM of purified metK, after 
which the reaction was shaken for 5 h. The reaction was monitored by IE-HPLC until no more 
consumption of ATP could be detected, at which point the reaction mixture was flash frozen 
and lyophilized. After resuspension and centrifugation, the supernatant was purified by RP-
HPLC and pure fractions were lyophilized to give the product as the triple TFA salt (2.5 mg, 
3.4 µmol, 34 %) as white powder. 1H NMR (500 MHz, D2O) δ 8.47 (d, J = 2.7 Hz, 2H), 6.19 (d, 
J = 4.0 Hz, 1H), 4.88 (dd, J = 5.5, 4.0 Hz, 1H), 4.64 (t, J = 5.7, 5.7 Hz, 1H), 4.60 – 4.57 (m, 
1H), 4.06 – 4.01 (m, 1H), 3.96 – 3.93 (m, 1H), 3.86 (t, J = 6.6, 6.6 Hz, 1H), 3.74 (s, 2H), 3.73 
– 3.67 (m, 1H), 3.52 – 3.45 (m, 1H), 3.02 (d, J = 146.6 Hz, 3H), 2.40 – 2.35 (m, 2H). HRMS 




Synthesis of 4-(chloromethyl)-1H-imidazole hydrochloride (65). 
 
To 4-(hydroxymethyl)imidazole (613 mg, 6.25 mmol, 1 eq.) was added thionyl chloride (2.2 ml, 
31,3 mmol, 5 eq.). The mixture was stirred for 1 day then the solvent was removed at the HV 
to obtain the title compound (950 mg, 6.2 mmol, 99%) as a beige solid. 1H NMR (400 MHz, 
DMSO-d6) δ 14.81 (bs, 2H), 9.16-9.10 (m, 1H), 7.88 – 7.64 (m, 1H), 4.88 (s, 2H). 
 
Synthesis of diethyl 2-((1H-imidazol-4-yl)methyl)-2-methylmalonate (66). 
 
To a stirred solution of diethyl methylmalonate (0.15 ml, 0.87 mmol, 1 eq.)  in DMF (3ml) was 
added sodium hydride (60% mineral oil dispersion, 60 mg, 1.5 mmol, 2.3 eq.) at 0°C. To this 
mixture was added 65 (100 mg, 0.65 mmol, 1.0 eq.) portion wise. The mixture turned yellow. 
Stirred for 24 h at room temperature. The reaction was diluted with ethylacetate (10 ml), 
washed with 1 M sodium hydroxide (3x 10 ml) and dried over sodium sulfate. The solvent was 
removed in vacuo and the crude was purified by column chromatography (DCM/MeOH 94:4) 
to yield the title compound as white solid (67 mg, 0.26 mmol, 40%). 1H NMR (400 MHz, DMSO-
d6) δ 11.80 (s, 1H), 7.49 (d, J = 1.2 Hz, 1H), 6.73 (s, 1H), 4.35 – 3.85 (m, 4H), 3.01 (s, 2H), 
1.25 (s, 3H), 1.16 (t, J = 7.1 Hz, 6H). ESI-MS m/z calcd. for C12H19N2O4 [M+H]+ 255.13, found 
255.0 
 
Synthesis of 3-(1H-imidazol-4-yl)-2-methylpropanoic acid (60). 
 
To a stirred solution of 66 (30 mg, 0.12 mmol, 1 eq.) in water (0.35 ml) was added concentrated 
HCl (0.35 ml). The mixture was heated to reflux and stirred for 48 hours. The solvent was 
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removed in vacuo to yield the title compound as colorless oil (22 mg, 0.12 mmol, 98%). 1H 
NMR (400 MHz, D2O) δ 8.59 (d, J = 1.4 Hz, 1H), 7.29 – 7.26 (m, 1H), 3.09 – 2.76 (m, 3H), 
1.25-1.15 (m, 3H). HRMS m/z calcd. for C7H11N2O2 [M+H]+ 155.0815, found 155.0816. 
 
Synthesis of Nα-dimethyl-L-histidine-13C6,15N3 (67) 
 
Using procedure A and starting with L-histidine-13C6,15N3 (10 mg, 0.05 mmol, 1 eq), 
formaldehyde (37 %, 17 µl, 0.23 mmol, 5 eq) and NaCNBH3 (7 mg, 0.11 mmol, 2.5 eq), this 
product was obtained as white solid (7 mg, 0.04 mmol, 82 %) after purification according to 
procedure B and lyophilization. 1H NMR (600 MHz, D2O) δ 7.72 (dtd, 1JCH = 209.6 Hz, 2JNH = 
9.5 Hz, 4JHH = 5.0 Hz, 1H),  7.02 (ddd, 1JCH = 190.9 Hz, 2JNH = 9.1 Hz, 4JHH = 5.0 Hz, 1H), 3.85 
(ddt, 1JCH =146.9, 2JNH = 5.6 Hz, 3JHH = 6.2 Hz, 1H), 3.24 (d, 1JCH = 131.2 Hz, 2H),  2.89 (d, 2JNH 
= 3.1 Hz, 6H). MS m/z calcd. for C213C6H915N3O2 [M+H+]: 188.08, found: 188.09. 
 
Synthesis of Nα-(methyl-d3)-Nα-(methyl-13C)-L-histidine (63) 
 
Using procedure A and starting with 58 (46 mg, 0.27 mmol, 1 eq), d2-formaldehyde (20 %, 119 
µL, 0.81 mmol, 3 eq) and NaCNBD3 (34 mg, 0.54 mmol, 2 eq) adjusting to pH 5 with d4-acetic 
acid, this product was obtained as white solid (30 mg, 0.16 mmol, 59 %) after purification 
according to procedure B and lyophilization. 1H NMR (400 MHz, D2O) δ 7.64 (s, 1H), 6.93 (s, 
1H), 3.68 – 3.57 (m, 1H), 3.17 – 3.01 (m, 2H), 2.66 (d, J = 140.7 Hz, 3H). MS m/z calcd. for 






Synthesis of Nα,Nα-di(methyl-13C-2H)-L-histidine (64) 
 
 
Using procedure Xa and starting with L-histidine (50 mg, 0.32 mmol, 1 eq), 13C-formaldehyde 
(20 %, 222 µL, 1.61 mmol, 5 eq) and NaCNBD3 (61 mg, 0.97 mmol, 3 eq) in D2O (1 ml), this 
product was obtained as white solid (55 mg, 0.29 mmol, 91 %) after purification according to 
procedure X and lyophilization. 1H NMR (400 MHz, D2O) δ 8.67 (d, J = 1.4 Hz, 1H), 7.43 (d, J 
= 1.3 Hz, 1H), 4.16 (tt, J = 6.6, 2.5 Hz, 1H), 3.57 – 3.47 (m, 1H), 3.48 – 3.35 (m, 1H), 2.98 
(ddnb-t, 1JCH = 144.2 Hz, 3JCH = 4.0 Hz, 2JHD = 5.0 Hz, 4H) HRMS m/z calcd. for 
C613C2H122H2N3O2 [M+H]+ 188.1273, found 188.1271. 
 
2.6.3 Protein Production 
EgtDwt and EgtDE282A,M252V were produced and kindly provided by Laëtitia Misson. All enzymes 
were expressed in E. coli BL21 cells and purified using Ni2+ NTA agarose beads (Qiagen) 
following standard procedures.99  
 






m/z (EgtD WT): calc.: 36989.6 Da, measured: 36990.0 Da 
Ɛ280(EgtD) = 36440 M-1cm-1 
 
 








m/z (EgtDE282A,M252V): calc.: 36899.5 Da, measured: 36899.1 Da 
Ɛ280(EgtDE282A,M252V) = 36440 M-1cm-1 
 
MetK was produced and kindly provided by Alice Harnacke. The enzyme was expressed in E. 
coli BL21 cells and purified using Ni2+ NTA agarose beads (Qiagen) following standard 
procedures.133  
 
Figure 54 SDS-PAGE picture of MetK after Ni-NTA affinity chromatography M - Molecular weight marker;  A – MetK. 
 









m/z (MetK): calc.: 44114.9 Da, measured: 44291.7 Da (The mass difference of 177 Da 
corresponds to Nα-6-phosphogluconoylation of the His-tag)134 





3 Probing the Bifurcation Mechanism in the Non-
Heme Iron Enzyme EgtB 
Abstract 
The mycobacterial sulfoxide synthase EgtB belongs to the family of mononuclear non-heme 
iron (NHI) oxygenases and catalyzes C-S bond formation in the second step of ergothioneine 
biosynthesis between hercynine (TMH) and γGC. Introduction of a single point mutation on the 
proposed catalytic base (Y377F) effectively converts EgtB from a sulfoxide synthase to a thiol 
dioxygenase, consuming γGC and oxygen at the same rate as the wild type reaction. 
Astoundingly, this efficiency rivals that of naturally occurring cysteine dioxygenases (CDO), 
which share no evolutionary background with sulfoxide synthases. The precise role of Tyr377 
is currently subject to debate. Specifically, it is not clear at which point in the catalytic cycle it 
helps to direct the reactivity towards the sulfoxide synthase pathway in the wild type reaction. 
Herein we show that substitution of TMH by 2-amino Nα-dimethyl-L-histidine (2A-DMH) 
effectively suppresses dioxygenase activity in both the wild type and the mutant variant of 
EgtB. X-Ray crystal structures of 2A-DMH in complex with both variants of EgtB demonstrate 
that the added amino-function provides a functional substitute for the phenol group of Tyr377. 
In combination with kinetic data from this and previous studies these findings provide strong 







3.1.1 Non-Heme Iron Enzymes 
Non-heme iron (NHI) enzymes constitute an important class of biocatalysts that capitalize on 
the power of molecular oxygen to catalyze four-electron oxidation of their substrates.135 While 
some rely on cofactors, such as α-ketoglutarate, others have no need for any apparent 
cosubstrates.136 One important subset of NHI enzymes acts on substrates containing a thiol 
group, which is coordinated to the iron center during catalysis. This group include isopenicillin 
N synthase, cysteine dioxygenase (A in Figure 55) and the sulfoxide synthases involved in the 
biosynthesis of the thiohistidine antioxidants ovothiol and ergothioneine, OvoA and EgtB 
respectively (B and C in Figure 55).17,137,138 While IPNS has been discussed extensively in the 
introduction, the latter two classes of enzymes will be examined in greater detail in the 
following. 
 






3.1.2 Cysteine Dioxygenase 
Oxidation of cysteine to cysteine sulfinic acid (CSA) is the first step in the biochemical pathway 
used to oxidize cysteine to either taurine or sulfate as shown in Figure 56.137 In the first 
pathway, desulfurization of cysteine produces inorganic sulfate and pyruvate, which is 
metabolized in the citric acid cycle. The initial dioxygenation is carried out by cysteine 
dioxygenase (CDO), an enzyme which has stirred much interest due to the association 
between elevated cysteine levels and Parkinson’s as well as Alzheimer’s disease among other 
pathological conditions.139 As mentioned above, this enzyme is an NHI oxygenase with iron 
coordinated in a 3-His facial triad, which incorporates both atoms of oxygen into its product.140 
An additional, interesting structural feature of eukaryotic CDO is the presence of a tyrosine-
cysteine crosslink, analogous to that found in galactose oxidase.141 
 
Figure 56 Pathways for cysteine oxidation leading either to sulfate via 3-sulfinyl pyruvate and pyruvate/sulfite or to 
taurine via hypotaurine.137 CSD: Cysteine sulfonate dioxygenase. 
In the proposed mechanism shown in Figure 57 cysteine binds to the iron center first (A), 
followed by oxygen (B), a binding order consistent with findings from EPR studies with nitrous 
oxide and cyanide used as mimics for oxygen.142,143 The radical cation resonance form of the 
thiolate (C) is then attacked by the superoxo-species forming a four-membered ring between 
the sulfur, iron and both oxygen atoms (D). Although this intermediate has not been directly 
detected thus far, DFT calculations support its existence.144 Heterogeneous cleavage of the 





Figure 57 Proposed catalytic mechanism for the dioxygenation of cysteine by CDO.140 
 
3.1.3 Sulfoxide Synthases OvoA and EgtB 
As described in more detail in Section 1.4.1, ergothioneine and ovothiol are both thiohistidines 
with antioxidant properties.138 The key step in both their biosynthetic pathways is the formation 
of a C-S bond between a histidinyl and a cysteinyl moiety. The enzymes catalyzing this step 
are OvoA for ovothiol and EgtB for ergothioneine and both are FeII- and O2-dependent 
sulfoxide synthases.  
Kinetic studies by Mashabela et al.145 and Song et al.104 showed that OvoA displays remarkable 
substrate promiscuity. Interestingly, when OvoA is supplied with Nα-mono-, di- and trimethyl 
histidine, C-S bond formation on the C-2 instead of the C-5 position of the imidazole ring 
becomes increasingly dominant. This in turn is essentially the same reaction that is catalyzed 
by EgtB. Although no X-ray crystal structure has been solved as of yet for OvoA, kinetic studies 
along with the obvious similarities to EgtB allow for the assumption that the two catalytic 
mechanisms follow the same pathway. 
The X-ray crystal structure for EgtB from Mycobacterium thermoresistibile has been solved in 
its apo form and with TMH, binding iron as well as in complex with manganese and the 
substrates γGC and DMH.146 The iron center was revealed to be coordinated by a 3-His facial 
triad, bearing strong resemblance to the iron coordination sphere of CDO, even though the two 
enzymes are not evolutionarily related (see also Figure 79 in Section 3.4). As is the case in 
CDO, the three other positions of the hexagonal coordination sphere of the iron center are 
occupied by the substrates for catalysis. In contrast to CDO however, where the iron 
coordinates the thiolate and the α-amine of cysteine along with one water molecule, in EgtB 
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two positions are occupied by Nτ of TMH and the thiolate of γGC along with one water. In each 
case the water molecule is thought to serve as a placeholder for oxygen, which is bound upon 
initiation of catalysis. As is the case for OvoA, in the course of said catalysis three main events 
take place: C-S bond formation, C-H bond cleavage and oxygen atom transfer from activated 
oxygen to sulfur. Although different opinions on the sequence of these steps exist, there is a 
consensus that an FeIII-superoxo species is involved in the catalytic cycle.41,146–148 There is 
however some considerable disagreement concerning the reactivity of the superoxo species 
during catalysis.148 
One proposed mechanism, based on structural and kinetic analysis done in our laboratory is 
shown in Figure 58. After binding of TMH (A) followed by γGC and oxygen, an FeIII-superoxo 
species is formed (B). A thiyl radical is generated after donating one electron to oxygen, 
generating a peroxide anion which is stabilized after protonation by Tyr377 (C). The thiyl radical 
then attacks the imidazole ring (D) in a manner resembling a thiol-ene type reaction and 
forming an iminyl radical.145 As of yet it remains unclear at which point the distal oxygen atom 
of the peroxide is transferred to the sulfur (shown here in step E). It should be noted that the 
current data is consistent with both an early148 and late146,149 peroxidation step. Lastly, 
deprotonation of the C-2 hydrogen by the phenolate of Tyr377 (F) yields the final product (G). 
 
Figure 58 Proposed mechanism for the sulfoxidation of TMH by EgtB.146 
In order to examine the role of Tyr377, a variant carrying the single point mutation Y377F was 
produced. This mutant still consumed γGC, but only generated traces of the usual sulfoxide 
product, and instead catalyzed the dioxygenation of γGC as the main product. By removal of 
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this crucial active site hydroxyl group EgtB could effectively be converted into a CDO with a 
kinetic efficiency that rivals naturally occurring CDOs.150 These findings are consistent with the 
idea that the role of Tyr377 is to protonate the FeIII-superoxo species and prevent early 
sulfoxidation of γGC by EgtB. This however is in stark contrast to DFT-calculations by Wei et 
al. who propose that sulfoxidation in fact occurs before C-S bond formation.148 As shown in 
Figure 59 the authors argue that the FeIII-superoxo species reacts to sulfoxidized γGC, 
generating an FeIV-oxo ferryl species which in turn is protonated by Tyr377 and induces C-S 
bond formation. The following C-H bond cleavage step, where Tyr377 abstracts the C-2 
hydrogen of the imidazoyl ring was calculated to be the rate limiting step of the reaction. 
Although the calculated activation energy is in agreement with data from published kinetic 
studies, some difficulties with this explanation arise upon closer inspection. 
 
Figure 59 Alternative mechanisms for EgtB where C-S bond formation either takes place before (B) or after (B’) 
sulfoxidation.148 
More recent experiments in our laboratory have shown that C-H bond cleavage is not the rate 
limiting step, as no KIE was observed using C-2 deuterated TMH.149 It should be noted that 
this is also not the rate limiting step in the synthesis of ovothiol by OvoA, where the analogous 
experiment with C-5 deuterated histidine did not yield an observable KIE.41 Furthermore, when 
using C-2 deuterium-labelled substrate on EgtBY377F, no redistribution of products was 
observed.151 If indeed this step was isotope-sensitive one would expect that the enzyme would 
generate more γGC dioxide relative to sulfoxide. In order to illustrate this argument, it is 
necessary to consider the proposed energy profile of the reaction as calculated by Wei et al.148 
According to this proposal, with C-H bond cleavage as the rate limiting step, the point of 
bifurcation between the sulfoxide synthase and cysteine dioxygenation pathway must lie 
somewhere before this step. If hydrogen is replaced by deuterium, the energy barrier for C-H 
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bond cleavage would be raised, even if no KIE is observable. In this case, the dioxygenation 
pathway would have to be slightly favored over the same pathway with a non-deuterated 
substrate and thus lead to a redistribution of products. This however is not supported by our 
kinetic data.151 
 
Figure 60 Qualitative representation of the energy profile calculated by Wei et al.148 showing the three key steps of 
C-O and C-S bond formation, as well as the proposed rate limiting step of C-H bond cleavage. The full mechanism 





3.2 Aim of this Chapter 
One of the main controversies in the catalytic mechanism of EgtB is the role of Tyr377, which 
functions as a catalytic acid/base. While it seems clear that it promotes sulfoxidation it is 
conceivable that it also actively suppresses dioxygenation of γGC. The question hence arises 
of how to disentangle sulfoxide synthase and γGC-dioxygenase activity. Since both the wild 
type and the Y377F variant of EgtB are hardly active as dioxygenases in the absence of TMH, 
an alternative co-ligand or activator was necessary. We chose to synthesize TMH-analogues 
with a substitution on the C-2 position, which cannot form a sulfoxide product and allow for 
analysis of the dioxygenation pathway in isolation. Comparison of kinetic and structural data 
of the enzyme in complex with these probes provided insights into the factors governing the 






3.3 Results and Discussion 
3.3.1 Design and Synthesis of Histidine Analogues 
Since formation of the C-S bond takes place on the C-2 position of the imidazole ring of 
histidine, a series of histidine analogues was synthesized with a modification in this position. 
In order to increase their affinities to EgtB, the Nα-dimethylated variants were synthesized since 
the binding affinity for DMH is similar to that of TMH.146 
     
Figure 61 Structures of Nα,Nα-dimethyl histidine (DMH, 68), 2-amino Nα,Nα-dimethyl histidine (2A-DMH, 69) and 2-
methyl Nα,Nα-dimethyl histidine (2M-DMH, 70) 
 
3.3.2 Synthesis of 2-Amino L-Histidine (2A-His) 
Synthesis of 2-amino L-histidine (71) was carried out according to published procedures,152,153 
with a few slight modifications.154 Starting from appropriately protected histidine (72), the 
desired nitrogen was inserted in the 2-position of the imidazole ring in a diazonium reaction in 
the form of diazo-4-methylbenzoate. Reduction of the resulting diazonium compound 73 was 
carried out by hydrogenation at 70 bar using PtO2 as the catalyst, yielding an unstable 
intermediate which could be stabilized by Ts-protection of Nτ.154 This approach had the 
additional advantage that 74 could be purified by flash chromatography, since subsequent 
deprotection essentially yielded the final product 71 in one step. The pure final product was 




Figure 62 Reagents and conditions for the synthesis of X: a) methyl 4-aminobenzoate, NaNO2, HCl, Na2B4O7, 
NaOH, 0 °C, 1 h, 72 %; b) PtO2, AcOH, H2, 144 h; c) TsCl, Et3N, MeCN, 2 h, 12 %; d) 1 M NaOH, 2.5 h, 94 %. 
 
3.3.3 Synthesis of 2-Amino Nα,Nα-Dimethyl L-Histidine (2A-DMH) 
Originally it was attempted to convert 2-amino histidine to 2-amino Nα,Nα-dimethyl L-histidine 
by reductive amination using formaldehyde and NaCNBH3.103 This approach however proved 
to be unsuccessful and a number of unwanted side-reactions took place. We therefore 
designed an alternative synthesis involving direct insertion of the nitrogen into the desired 2-
position of the imidazole ring in the form of an azide, which could subsequently be reduced to 
the final amine 69. 
 
Figure 63 Reagents and conditions for the synthesis of X: (a) formaldehyde, NaCNBH3, AcOH, water, 16 h, 99 %; 
(b) Trt-Cl, Et3N, DCM, reflux, 18 h, 57 %; (c) tert-butyl 2,2,2-trichloroacetimidate, AcOH, DCM, 144 h, 66 %; (d) i) 
LDA, ii) TsN3, THF, -78 °C, 1 h, 45 %; (e) i) TFA/TES/DCM, ii) H2, 10 % Pd/C, water, 6 h, 91 %. 
Starting with L-histidine, dimethylation of the primary amine was achieved by reductive 
amination using formaldehyde and NaCNBH3, yielding 68 in nearly quantitative yield. After 
protection of the Nτ-position by triphenylmethyl (75)155 and the carboxylate by t-Bu (76),156 the 
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azide functionality could be inserted (77). This was achieved by deprotonating and lithiating 
the 2-position of the imidazole ring using LDA followed by addition of TsN3, an electrophilic 
azide donor.157 Removal of both protecting groups was carried out in one step using 
TFA/TES/DCM,158 during which a part of the azide was reduced to the amine (69 see Section 
3.6.1). Complete reduction of the azide to the desired amine was then performed with H2 and 
Pd/C.159 The pure final product was obtained in a total yield of 15 % over 5 steps. 
 
3.3.4  Synthesis of 2-Methyl D/L-Histidine (2M-His) and 2-Methyl Nα,Nα-Dimethyl D/L-
Histidine (2M-DMH) 
For the histidine derivative containing a methyl group in the 2-position of its imidazole ring a 
different synthetic approach was chosen, based on work done by Madsen et al. and Hirohato 
et al.106,160 The sole disadvantage to this approach was that the final product was formed as a 
racemic mixture of the D- and L-forms as can be seen in Figure 64. 
 
Figure 64 Reagents and conditions for the synthesis of 83 and 70: (a) DMAS-Cl, Et3N, 1,2-dichloroethane, 16 h, 
98 %; (b) i) n-BuLi, DMF, ii) HCl, THF -78 °C – RT, 3 h, 61 %; (c) NaBH4, EtOH, 4 h, 45 %; (d) i) SOCl2, 16 h, 91 
%; (e) NaH, diethyl acetamidomalonate, EtOH, 0 °C – RT, 2 h, 72 %; (f) 6 M HCl, 100 °C, 19 h, 97 %; (g) 
formaldehyde, NaCNBH3, AcOH, water, 16 h, 69 %. 
The first step involved protection of the Nτ position of 2-methylimidazole with N,N-
dimethylsulfamoyl chloride (DMS-Cl) in 1,2-dichloroethane, using Et3N as base (78). The next 
step consisted of insertion of the aldehyde functionality in the 4-position of the imidazole ring 
with subsequent deprotection of Nτ with concentrated acid at temperatures between -78 °C 
and room temperature (79). Aldehyde insertion was achieved by deprotonating the 4-position 
with n-BuLi, followed by nucleophilic attack on DMF. By acidifying the reaction (pH 1 with conc. 
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HCl), release of dimethylamine as well as deprotection of Nτ was accomplished, leading to the 
desired product. Reduction of the aldehyde (79) to the alcohol (80) was carried out using 
NaBH4 in EtOH.  The following chlorination of the alcohol was achieved by reacting 80 neatly 
in SOCl2 to give 81 in high yield as the HCl salt. For the SN2 reaction which followed to form 
82, diethyl acetamidomalonate had to be deprotonated by a strong base in order to generate 
the nucleophile. Although the literature suggested using Na in EtOH, NaH in ethanol was used 
instead, due to its easier handling. Subsequent deprotection of the amino acid function as well 
as decarboxylation was achieved by refluxing in 6 M HCl overnight. Non-reflux conditions did 
not show any conversion after 1 hour. The product 2-methyl D/L-histidine 83 was obtained as 
the di-HCl salt as light brown oil, which crystallized in the fridge overnight. Finally, the Nα-
dimethylated product 70 was synthesized by reductive amination as described in the previous 
section. The pure final product was obtained in a total yield of 12 % over 7 steps. 
 
3.3.5 Michaelis-Menten Parameters of L- and D-DMH 
Due to the fact that 2M-DMH was synthesized as a racemic mixture, it was necessary to assess 
the preference of EgtB for the L- over the D-form. A good approximation could be given by 
comparing the kinetic parameters of L-DMH with D-DMH. 
Table 6 Michaelis-Menten parameters of EgtBTh1 for L- and D-DMH. The values for kcat are given in s-1, KM in µM 
and kcat/KM in M-1s-1. 
  kcat [s-1] KM [µM] kcat/KM [M-1s-1] 
L-DMH 2.3 ± 0.1 85 ± 5 26'600 
D-DMH 0.9 ± 0.1 1'300 ± 150 700 
Reaction conditions were: (12.5-1000) µM L- or D-DMH respectively, 1 mM γGC, 0.06 µM EgtBTh1, 2 mM TCEP, 
0.4 µM FeSO4, 2 mM ascorbate, 100 mM NaCl in 100 mM phosphate pH 8. 
The binding for the D-form is hence almost 15-fold lower than for the L-form, meaning that in 
a racemic mixture roughly 93 % of the bound substrate is in the L-form. Extrapolating these 
findings for the racemic 2M-DMH, we will discuss binding affinities and other data as that of 





3.3.6 2A-DMH and 2M-DMH as Inhibitors of Sulfoxide Synthase Activity in EgtBwt and 
EgtBTh2 
With the two modified DMH variants in hand we sought out to test their respective potentials 
as inhibitors of sulfoxide synthase activity in two variants of EgtB. The first originates from M. 
thermoresistibile, uses γGC as the thiol-substrate and is termed EgtBwt. The second variant is 
from Candidatus chloracidobacterium thermophilum B, uses cysteine as the thiol-substrate 
and is termed EgtBTh2. Using an HPLC-based assay to determine the kinetics, conversion of 
DMH to DMH-sulfoxide was measured in the presence and absence of 1 mM of each 
respective inhibitor and 0.1 mM DMH. The methyl variant 2M-DMH showed no significant 
inhibition in either enzyme, meaning that it binds to the active site at least five-fold worse than 
DMH. On the other hand 2A-DMH showed strong inhibition of product formation by a factor of 
over 30 in EgtBwt, meaning that this variant is bound at least as well as DMH. 
Table 7 Rates of sulfoxide synthase activity of EgtBwt and EgtBTh2 for 0.1mM DMH with and without 1 mM 2A-DMH 
or 2M-DMH 
Enzyme EgtBwt EgtBTh2 
Substrate Rate (s-1) Activity (%) Rate (s-1) Activity (%) 
DMH 1.23 100 0.037 100 
w/ 2M-DMH 1.19 97 0.035 94 
w/ 2A-DMH 0.04 3 0.030 82 
Reaction conditions were: 0.1 mM DMH, 1 mM γGC, 0-1 mM 2A-DMH or 2M-DMH, 0.06 µM EgtBwt(left) or 1.5 µM 
EgtBTh2(right), 2 mM TCEP, 4 µM FeSO4, 2 mM ascorbate, 100 mM NaCl in 100 mM phosphate pH 8. 
These preliminary results prompted us to further investigate the details of sulfoxide inhibition 
by 2A-DMH in EgtBwt. 
 
3.3.7 2A-DMH is a Competitive Inhibitor to DMH for Sulfoxide Synthase Activity in 
EgtBwt 
After determining the Michaelis-Menten parameters for DMH the measurements were 
repeated with a fixed concentration of DMH (0.1 mM) and increasing concentrations of inhibitor 
(12.5 µM – 1 mM). While the KM increased substantially upon addition of inhibitor, the values 
for kcat remain unaffected, indicating competitive inhibition. Plotting 1/V against 1/S 
(Lineweaver-Burk plot)161 leads to the typical form one would expect for competitive inhibition, 
where the linear fits of the inverse substrate concentration (1/S) relative to the inverse velocity 




Figure 65 Left: Michaelis-Menten parameters for sulfoxide formation between DMH and γGC, catalyzed by EgtBwt 
with different concentrations of inhibitor. Right: Lineweaver-Burk plot of the same data. Reaction conditions were: 
0.1 mM DMH, 1 mM γGC, (12.5-1000) µM 2A-DMH, 0.06 µM EgtBwt, 2 mM TCEP, 0.4 µM FeSO4, 2 mM ascorbate, 
100 mM NaCl in 100 mM phosphate pH 8. 
Using the apparent KM-values obtained from these measurements and equation (i), a KI of 14 




    (i) 
The same reaction was then repeated at a fixed concentration of the substrate DMH (0.2 mM) 
and a varying concentration of γGC (12.5 µM – 1 mM). At all concentrations a decrease in KM 
as well as kcat could be observed as can be seen in Figure 66. 
 
Figure 66 Left: Michaelis-Menten parameters for sulfoxide formation between DMH and γGC, catalyzed by EgtBTh1 
with different concentrations of inhibitor 2A-DMH. Right: Lineweaver-Burk plot of the same data. Reaction conditions 
were: 0.2 mM DMH, (12.5-1000) µM γGC, (25-100) µM 2A-DMH, 0.06 µM EgtBwt, 2 mM TCEP, 0.4 µM FeSO4, 2 
mM ascorbate, 100 mM NaCl in 100 mM phosphate pH 8. 
When the data is plotted in a Lineweaver-Burk plot, the data cannot be fitted linearly. Dixon 
and Webb describe two possible cases for a substrate analog A’ that binds to an enzyme E in 











































































the same site as the natural substrate A (Figure 67).162 Furthermore, the binding of A’ does not 
disturb the binding of the second substrate B. In case of a sequential binding order (i in Figure 
67), binding of A’ leads to a dead-end complex EA’B when the second substrate B is bound. 
In this case, plotting 1/[B] versus 1/V leads to a non-linear curve. In an alternative case (ii in 
Figure 67), where the binding order is non-sequential, a linear correlation between 1/[B] and 
1/V is predicted. 
 
Figure 67 Alternative schemes for sequential and non-sequential binding orders, as proposed by Dixon and 
Webb.162 
Thus, the observed non-linear correlation of 1/[B] (where B is γGC) versus 1/V suggests a 





3.3.8 Dioxygenase Activity of EgtBY377F with DMH, 2A-DMH and 2M-DMH 
As detailed previously a single point mutation of tyrosine to phenylalanine (Y377F) in the active 
site of EgtB results in a complete shift in product specificity from the usual sulfoxide to the 
sulfinic acid of γGC. We sought out to compare the effects of a modification in the 2-position 
of the imidazole ring on the activator in this reaction. Before determining the dioxygenase 
activity of the mutant variant EgtBY377F in complex with 2A-DMH and 2M-DMH, we analyzed 
the reaction by 1H-NMR to ensure that no unexpected products were formed. When EgtBwt is 
reacted with DMH, all γGC is incorporated into the sulfoxide product (Figure 68), and the 
dioxygenase pathway is too slow to form detectable levels of γGC-sulfinic acid. If instead DMH 
is incubated with EgtBY377F, barely any sulfoxide is formed (<2 %) and the γGC is instead 
dioxygenated (Figure 69). 
     
Figure 68 Aromatic region of the reaction mixtures containing EgtBwt with DMH and EgtBY377F with DMH, 2A-DMH 
or 2M-DMH (top to bottom). Reaction conditions: 0.3 µM EgtBwt or EgtBY377F, 1 mM DMH, 2A-DMH or 2M-DMH, 0.8 
mM γGC, 4 µM FeSO4, 2 mM ascorbate, 2 mM TCEP, 100 mM NaCl in 100 mM phosphate buffer at pH 8 in a total 
volume of 2000 µL. Reactions were quenched by freezing the samples at -80 °C, followed by lyophilization, 
resuspension in 500 µL D2O after which the spectra were recorded. 
When EgtBY377F is incubated with either 2A-DMH or 2M-DMH, no sulfoxidation product is 
observed judging by the aromatic region of the 1H-NMR spectra (Figure 68). The enzyme is 
however still active and instead converts γGC to the dioxygenation product (Figure 69), albeit 




Figure 69 Aliphatic region of the reaction mixtures containing EgtBwt with DMH and EgtBY377F with DMH, 2A-DMH 
or 2M-DMH (top to bottom). Reaction conditions: 0.3 µM EgtBwt or EgtBY377F, 1 mM DMH, 2A-DMH or 2M-DMH, 0.8 
mM γGC, 4 µM FeSO4, 2 mM ascorbate, 2 mM TCEP, 100 mM NaCl in 100 mM phosphate buffer at pH 8 in a total 
volume of 2000 µL. Reactions were quenched by freezing the samples at -80 °C, followed by lyophilization, 
resuspension in 500 µL D2O after which the spectra were recorded. 
Since sulfoxidation takes place to a negligible extent in the EgtBY377F:DMH system and is not 
a factor in complex with either 2A-DMH or 2M-DMH, the rate at which γGC is consumed can 
be assumed as the rate of γGC-sulfinic acid formation. Hence, the consumption of γGC was 
measured instead of the formation of product. Since neither γGC nor γGC-sulfinic acid is 
detectable at low concentrations, the former was derivatized with a chromophore. In our case 
we chose to use 4-BMC allowing us to detect the substrate at concentrations as low as 10 µM 
(Figure 70). 
 
Figure 70 Reaction between γGC and 4-BMC. 
Production of sulfinic acid was hence extrapolated from the decrease in substrate as a function 
of time. In all the described cases DMH, 2A-DMH and 2M-DMH act more like an activator than 
a substrate in the classical sense since they are not consumed in the course of the reaction. 
First, the binding affinities of all compounds were determined at a low concentration of γGC 
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(0.1 mM), where the binding affinity is not influenced by saturating conditions of the second 
substrate. Since EgtB was shown to follow an ordered substrate binding mode, with γGC as 
the second substrate bound to the Egtb:TMH complex, the concentration of γGC affects the 
observed KM of TMH.151 
Table 8 Michaelis-Menten parameters of EgtBY377F for DMH, 2A-DMH and 2M-DMH at [γGC] = 0.1 mM. 
  kcat,app [s-1] KA,app [µM] kcat/KM [M-1s-1] 
DMH 0.4 ± 0.1 20 ± 1 21'000 
2A-DMH 0.2 ± 0.1 50 ± 5 4'600 
2M-DMH 0.03 ± 0.1 1'500 ± 300 20 
Reaction conditions were: (12.5 – 1000) µM DMH, (25 – 2000) µM 2A-DMH, (25 – 5000) µM 2M-DMH , 0.5 µM 
(DMH and 2A-DMH) or 2.5 µM (2M-DMH) EgtBY377F, 0.1 mM γGC, 4 µM FeSO4, 2 mM ascorbate, 2 mM TCEP, 100 
mM NaCl in 100 mM phosphate buffer at pH 8. 
Interestingly, under the chosen conditions DMH and 2A-DMH catalyze the reaction at a similar 
kcat and also bind within the same order of magnitude (herein we refer to the affinity of the 
activator as KA). On the other hand the binding affinity and kcat for 2M-DMH are strongly 
reduced. Binding affinities of γGC were determined next at saturating conditions (at least 3 x 
KA,app) of the respective DMH variant. Under these conditions reliable values for kcat could be 
calculated since the enzyme was saturated with both substrates. 
Table 9 Michaelis-Menten parameters of EgtBY377F for γGC at saturating concentrations of DMH, 2A-DMH and 2M-
DMH. 
  kcat,γGC [s-1] KM,γGC [µM] kcat/KM [M-1s-1] 
DMH 1.4 ± 0.2 185 ± 45 7'400 
2A-DMH 0.08 ± 0.01 36 ± 9 2'200 
2M-DMH 0.11 ± 0.1 290 ± 45 380 
Reaction conditions were: DMH (1 mM), 2A-DMH (1 mM) or 2M-DMH (7.5 mM), 0.5 µM (DMH and 2A-DMH) or 2.5 
µM (2M-DMH) EgtBY377F, 12.5 – 500 µM γGC, 4 µM FeSO4, 2 mM ascorbate, 2 mM TCEP, 100 mM NaCl in 100 
mM phosphate buffer at pH 8. 
Under these conditions the difference becomes more apparent between the native and the 
unnatural substrates. Specifically, Vmax of the enzyme with 2A-DMH as co-ligand is roughly the 
same as for 2M-DMH, which is almost 15-fold lower than for DMH. The binding affinity of the 
system for γGC seems to increase for 2A-DMH compared to both other ligands. Apparently 
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the presence of either an amino- or a methyl-group in the 2-position of the imidazole ring 
similarly disrupt the oxidation of γGC. 
Additionally, the reaction was investigated for possible pH-dependence, measuring the rate at 
fully saturated conditions. While the reaction with DMH is most efficient at pH 8.0-8.5, no 




Figure 71 Comparison of the rates of γGC-dioxygenation by EgtBY377F with DMH (top), 2A-DMH (bottom left) and 
2M-DMH (bottom right) in the pH range 7.0-9.0. Reaction conditions: DMH (1 mM), 2A-DMH (1 mM) or 2M-DMH (5 
mM), 0.5 µM (DMH) or 1 µM (2A-DMH) or 2.5 µM (2M-DMH) EgtBTh1Y377F, 1 mM γGC, 4 µM FeSO4, 2 mM 
ascorbate, 2 mM TCEP, 100 mM NaCl in 100 mM phosphate buffer (pH 7.0-8.0) or Tris buffer (pH 8.5-9.0). 
 
3.3.9 Dioxygenase Activity of EgtBTh1 with 2A-DMH and 2M-DMH 
Next we tested whether binding of the unnatural substrates to the wild type enzyme would 
force the system to proceed along the dioxygenation pathway. By performing analogous 
experiments as described in Section 3.3.8, we concluded that no sulfoxide product was 
formed in the reaction and that instead the enzyme was producing γGC-sulfinic acid. 


















































Figure 72 Aromatic (top) and aliphatic region (bottom) of the reaction mixtures containing EgtBwt with DMH and 
EgtBY377F as well as EgtBwt with 2A-DMH or 2M-DMH (top to bottom). Reaction conditions: 0.3 µM EgtBwt or 
EgtBY377F, 1 mM DMH, 2A-DMH or 2M-DMH, 0.8 mM γGC, 4 µM FeSO4, 2 mM ascorbate, 2 mM TCEP, 100 mM 
NaCl in 100 mM phosphate buffer at pH 8 in a total volume of 2000 µL. Reactions were quenched by freezing the 
samples at -80 °C, followed by lyophilization, resuspension in 500 µL D2O after which the spectra were recorded. 
Only traces of the dioxygenation product could be observed and the same kinetic assay as 
described in Section 3.3.8 was employed in order to monitor consumption of γGC. Again, the 





Table 10 Michaelis-Menten parameters of EgtBTh1 for 2A-DMH and 2M-DMH at 0.1 mM γGC. The values for kcat 
are given in s-1, KM in µM and kcat/KM in M-1s-1. 
  kcat,app [s-1] KA,app [µM] kcat/KM [M-1s-1] 
2A-DMH 0.014 ± 0.001 30 ± 10 400 
2M-DMH 0.014 ± 0.002 1'100 ± 300 10 
Reaction conditions were: 12.5-500 µM 2A-DMH or 25-1000 µM 2M-DMH, 0.1 mM γGC, 2.4 µM EgtBwt, 4 µM 
FeSO4, 2 mM ascorbate, 2 mM TCEP, 100 mM NaCl in 100 mM phosphate buffer at pH 8. 
The measured binding affinity of EgtBwt for 2A-DMH (30 + 10 µM) is in the same range as the 
KI of 14 ± 2 µM we had previously determined in our inhibition experiments of the sulfoxide 
synthase activity of the enzyme. Binding of 2M-DMH is nearly 20 times less favorable, which 
is also in line with our previous findings of its poor inhibition of sulfoxide synthesis. 
In a second series of experiments the same parameters were determined for the dioxygenase 
activity of EgtBwt, first determining the values for 2A-DMH and 2M-DMH at a non-saturating 
concentration of γGC (0.1 mM). After measuring the parameters for γGC at saturated 
conditions of 2A-DMH (1 mM) however, it turned out that 0.1 mM was well over the KM of γGC 
in this system. The main point of these measurements though was to determine Vmax, which is 
another 10-fold lower than the mutant with the same co-ligand. 
Table 11 Michaelis-Menten parameters of EgtBTh1 for γGC at saturated concentrations of 2A-DMH and 2M-DMH. 
The values for kcat are given in s-1, KM in µM and kcat/KM in M-1s-1. 
  kcat,γGC [s-1] KM,γGC [µM] kcat/KM [M-1s-1] 
2A-DMH 0.012 ± 0.001 10 ± 5 1'200 
2M-DMH 0.07 ± 0.01 350 ± 50 200 
Reaction conditions were: 1 mM 2A-DMH or 5 mM 2M-DMH, 0.1 mM γGC, 2.4 µM EgtBTh1, 4 µM FeSO4, 2 mM 
ascorbate, 2 mM TCEP, 100 mM NaCl in 100 mM phosphate buffer at pH 8. 
As can be seen in Table 11, γGC possesses a greatly inflated KM when in complex with 2M-
DMH rather than 2A-DMH, which is in agreement with what we had previously measured when 
comparing the two as inhibitors of the sulfoxide synthesis. Interestingly however, Vmax is six 
times higher for the methylated derivative than its amine counterpart. This indicates that the 
additional protons supplied by the protonated amino-group (the pKA of 2-amino imidazole is 
8.46163) perturb the reaction more severely than the added steric bulk of the methyl group. 
94 
 
These effects are seemingly not as relevant in the Y377F mutant, where the two 
aforementioned compounds display similar Vmax values once the system is saturated. Again 
however, the methylated version is bound significantly worse than the amino variant. The 
overall catalytic efficiency of the system containing 2A-DMH is roughly five to six-fold higher 
for both the wild type and the mutant. Albeit at this point it should once again be noted that 
since 2M-DMH was measured as a racemic mixture, the KM values can effectively be halved 
since the L-form is bound 15-times more efficiently than its enantiomer, as was shown with the 
example of L- versus D-DMH in Section 3.3.5. 
As a further point, it should be noted that no spike in consumption of TCEP or ascorbate, the 
antioxidants present in all reaction mixtures, was detected in any of the assays. This indicates 
that, although 2A-DMH and 2M-DMH bind to EgtB and elicit dioxygenase activity, no 
detectable excess of activated oxygen species is formed by the enzyme. Specifically, no 
dehydroascorbate could be observed in the 1H-NMR spectra of the reaction mixtures 
containing any combination of wild type or mutant enzyme and either activator (Figure 73 and 
Figure 74). If dehydroascorbate was formed during the reaction, one would expect to see the 
following signals in the displayed range: δ 4.59 (m), 4.28 (dd, J = 10.34 Hz, J = 5.34 Hz), 4.28 
(dd, J = 10.34 Hz, J = 2.59 Hz).164 
 
Figure 73 1H-NMR (500 MHz) spectra of 2M-DMH and 2A-DMH after incubation with EgtBwt. Reaction conditions 
were: 0.3 µM EgtBwt, 1 mM 2A-DMH or 2M-DMH, 0.8 mM γGC, 4 µM FeSO4, 2 mM ascorbate, 2 mM TCEP, 100 
mM NaCl in 100 mM phosphate buffer at pH 8 in a total volume of 2 mL. Reactions were quenched by freezing the 





Figure 74 1H-NMR (500 MHz) spectra of 2M-DMH and 2A-DMH after incubation with EgtBY377F. Reaction conditions 
were: 0.3 µM EgtBwt, 1 mM 2A-DMH or 2M-DMH, 0.8 mM γGC, 4 µM FeSO4, 0.2 mM ascorbate, 2 mM TCEP, 100 
mM NaCl in 100 mM phosphate buffer at pH 8 in a total volume of 2 mL. Reactions were quenched by freezing the 
samples at -80 °C, followed by lyophilization, resuspension in 500 µL D2O after which the spectra were recorded. 
Since TCEP also reacts with 4-BMC, it is possible to monitor TCEP-oxidation as a function of 
time in the same assay described in Section 3.3.8. 
Table 12 Consumption of TCEP during the γGC-dioxygenation reaction as observed in a decrease in absorption at 
310 nm (mAU/min). 
  EgtBwt EgtBY377F 
DMH 1.6 ± 1.7   
2A-DMH 2.2 ± 2.4 0.4 ± 0.2 
2M-DMH 0.3 ± 0.5 1.3 ± 0.6 
 
No significant deviation from the normal consumption of TCEP, could be detected either (see 
Table 12). It must be considered however, that these measurements did not deliver precise, 
quantitative values, but rather offer a qualitative analysis of this aspect. In order to more 
accurately quantify a possible increase in the rate of oxygen activation, measurements at 




3.3.10 Crystal Structures 
The kinetic data described thus far suggests that 2A-DMH is a competitive inhibitor towards 
DMH and binds in the same pocket as the latter. Furthermore, in the EgtBwt:2A-DMH complex, 
dioxygenation activity is suppressed compared to the same enzyme in complex with 2M-DMH. 
We surmised that 2A-DMH with its acidic protons may engage in hydrogen bonding to the FeII-
superoxo species, lowering the reactivity of this species much like Tyr377 does in the 
mechanism proposed in Figure 58. To examine the structural basis of this idea, we crystallized 
the EgtB:2A-DMH complex for both the wild type and the Y377F mutant. Crystal structures of 
EgtBY377F in complex with DMH or 2M-DMH were solved as well. Each structure was solved 
as the quaternary complexes EgtB:DMH:γGC with manganese as a substituent for iron. 
Crystals were grown and their structures solved by Peer Lukat at the Helmholtz Centre for 
Infection Research in Braunschweig, using conditions described in Section 3.6.2.7. All crystal 
structures were consistent with those reported previously for EgtBwt,146 belonging to the same 
space group and superimposing with an RMSDs < 0.150 Å (380 atoms). Due to anisotropies 
of the EgtBY377F:2M-DMH crystal and because of low occupancy, the electron density of 2M-
DMH is incomplete. Given the low stability of the EgtB:2M-DMH complex this result is not 
surprising (Table 8).  
The basic topology of the active site remains unchanged in all five quaternary complexes, with 
the metal center (manganese), γGC and the key active site residues (His51, Gln55, His 134, 
His 138, Tyr380) in identical positions. In each structure the histidine ligand is bound to the 
metal center by Nτ-coordination, while Nπ forms a water-mediated H-bridge to the backbone 
carbonyl of Tyr380. In this binding mode the C-2 position of all three histidine ligands point 
towards residue 377. In EgtBY377F the C-2 amino group makes van der Waals contact with the 
phenyl ring of Phe377 (3.3 Å). In EgtBwt the same group is within hydrogen bonding distance 
to the phenol function of Tyr377 (2.9 Å), dislocating the latter by 0.7 Å from its usual position 





Figure 75 Top: Active site of EgtBwt in complex with γGC and DMH (A) or 2A-DMH (B). Middle: Active site of 
EgtBY377F in complex with γGC and DMH (C) or 2A-DMH (D). Bottom: Active site of EgtBY377F in complex with γGC 







Besides the dislocation of the crucial tyrosine residue, a second major difference is apparent 
upon binding of 2A-DMH and 2M-DMH: the aquo ligand in the last coordination site of the 
metal center is not present in either structure. In all other crystal structures of EgtB (PDB: 
4X8B, 4X8D, 4X8E) this ligand is present with an occupancy approaching 100 %, while in the 
two structures containing 2A-DMH and the structure containing 2M-DMH it is found in less than 
10 % of the protein chains.165 This observation is rather puzzling as the N-O distance of 2.7 Å 
is within the van der Waals cutoff distance of 3.7 Å for an N-H∙∙∙O hydrogen bond.166 In addition, 
the C2-N∙∙∙O angle of 107° (the O-H∙∙∙O angle in tetrahedral coordinated water is 109°)167 
would also allow H-bonding to take place with the expected aquo ligand as shown in the model 
in Figure 76 (left). Furthermore, there is no structural indication that the 2-amino group directly 
competes for the sixth coordination position or for steric clashes being the reason for its 
absence. A crystal structure of the binuclear metalloenzyme Human Arginase I in complex with 
2-amino histidine can be used as a point of reference (PDB: 3MFW). Herein, the 2-amino group 
of interest hydrogen bonds with the oxygen anion of a sulfate (2.5 A) and forms an N-O-S 
angle of 103° as shown in Figure 76 (right).168 
  
Figure 76 Left: Aligned structures of the complexes EgtBwt:2A-DMH:γGC (cyan) and EgtBwt:DMH:γGC (green, 
PDB: 4X8D).146 The angle and distance between the 2-amino group and the aquo-ligand missing in the first structure 
are displayed in black. Right: Coordination of the 2-amino group of 2-amino L-histidine to the oxygen anion of a 
sulfate molecule in the substrate binding pocket of the binuclear manganese metalloenzyme human arginase I 
(PDB: 3MFW).168 
As steric clash does not seem to be responsible for the displacement of the aquo ligand, it 
seems more plausible that protonation thereof by the 2-amino group of the co-ligand 
destabilizes coordination to the metal. This theory is in line with our finding that 2A-DMH 
essentially quenches dioxygenase activity in the wild type enzyme, even though it binds to the 
active site with similar affinity as the native substrate DMH. 
It is also possible that 2A-DMH weakens the affinity of the enzyme for O2 by stabilizing the 
metal-bound aquo ligand. In this case however we would expect this position to be more highly 
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occupied in the crystal structure, which is not the case. Every other structure of EgtB in the 
absence or presence of either DMH or TMH (PDB: 4X8B, 4X8D, 4X8E) contain a fully occupied 
aquo ligand. In addition, it has been shown that upon lowering of the pH from 8.0 to 6.0, the 
kcat of the dioxygenase activity of EgtBY377F remains basically unchanged (kcat,pH8.0 = 1.2 s-1; 
kcat,pH6.0 = 0.9 s-1). Under the same conditions, the sulfoxide synthase activity of the mutant 
increases by 3.5-fold (kcat,pH8.0 = 0.9 x 10-4 s-1; kcat,pH6.0 = 3.2 x 10-3 s-1) while the same activity 
of the wild type increases by only 1.4-fold (kcat,pH8.0 = 1.2 s-1; kcat,pH6.0 = 0.85 s-1). If indeed the 
protonation state of the aquo-ligand was the factor decreasing the affinity for O2, one would 
expect to see a considerable drop in activity at lower pH, leading us to conclude that active 
site acidity does not lead to decreased oxygen-binding. 
 
Hydrogen-Bonding Network 
In both crystal structures containing 2A-DMH, the 2-amino group hydrogen bonds to a 
crystallographic water (a in Figure 77) at distances of 3.1 Å (EgtBwt; H2O_160) and 3.0 Å 
(EgtBY377F; H2O_112). This water is conserved in all other crystal structures of EgtB, except in 
the EgtBY377F:2M-DMH complex. In the first structure (EgtBwt:2A-DMH, A in Figure 77), the 2-
amino function makes direct contact to a and the phenol of Tyr377, which also seems to 
compete for the water ligand. Furthermore, H2O_112 makes contact to the backbone carbonyl 
of Arg380, as well as the bridging water (b in Figure 77, H2O_61) between the backbone 
carbonyl of Tyr380 and Nπ. When bound to the mutant variant in EgtBY377F:2A-DMH (B in 
Figure 77), the same basic coordination to the water a (H2O_160) is observed, albeit without 
the interaction with the missing phenol group. Instead, the water is in contact with an additional 
molecule of water (c in Figure 77, H2O_107) above the coordination plane. This type of 
tetrahedral coordination in turn is found in both crystal structures with the native ligand DMH. 
In the EgtBwt:DMH complex (C in Figure 77), the water molecule a (H2O_729) is coordinated 
by the phenolic group of Tyr377, the backbone carbonyl of Arg380, the bridging water b 
(H2O_719) between the backbone carbonyl of Tyr380 and Nπ and the water above this 
coordination plane c (H2O_766). Finally, in the complex with the mutant EgtBY377F:DMH (D in 
Figure 77), the missing contact with the phenol group is replaced by recruitment of a different 
water (d in Figure 77, H2O_198), which in turn is in direct contact to the manganese-
coordinated water (e in Figure 77, H2O_304). In summary, the 2-amino group of 2A-DMH 
neatly fits in to the hydrogen-bonding network of the enzyme active site, which could be an 
explanation for its high affinity for both the native and the mutant variant. Not only does it make 
direct contact with Tyr377 in the wild type, but it seems to emulate some important aspects of 
this missing residue in the mutant. As noted above, in the EgtBY377F:2M-DMH complex (D in 
Figure 77) this key water molecule is not present and the imidazole ring is only stabilized by 
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the bridging water b (H2O_117) between the backbone carbonyl of Tyr380 and Nπ. 
Displacement of water a by the 2-methyl group is quite likely energetically unfavorable, a fact 
which may provide one explanation for the decreased affinity of this ligand. 
 
Figure 77 Hydrogen bonding system in the active site of EgtBwt and EgtBY377F with either DMH or 2A-DMH. The 
interactions of some key water residues are shown in black, for details on the H-bonding network see text. 
Based upon literature pKA values for imidazole (7.0),169 2-methyl imidazole (7.9)170 and 
2-amino imidazole (8.5),163 we expect the pKA values of 2M-DMH and 2A-DMH to be 1 and 1.5 
units higher than histidine.171 Based upon the high binding affinity of 2A-DMH, which is 
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comparable to that of DMH, in contrast to the weak affinity for the 2-methyl variant, it is evident 
that the electronic properties of the imidazole ring do not dictate binding strength. Instead it 
seems more likely that the increased hydrophobic steric bulk of the 2-methyl group accounts 
for the decreased affinity of 2M-DMH, which cannot be compensated for by H-bonding, as is 
the case for 2A-DMH. 
Since the 2-amino group in 2A-DMH has higher pKA than its methyl counterpart or DMH, we 
can assume that it is a stronger nucleophile and thus a stronger donor ligand. We hypothesized 
that binding of both more electron-rich variants may decrease oxygen activation by the metal 
center. To test this, we investigated the viability of analogous compounds (2-amino L-histidine 
and 2-methyl D/L-histidine) as substrates for the related sulfoxide synthase OvoA. 
 
3.3.11 Expanded Substrate Scope of OvoA 
The sulfoxide synthase OvoA is a distant relative to EgtB and additionally contains a second, 
SAM-dependent methyltransferase domain. It thus catalyzes the first and last step of ovothiol 
biosynthesis (see also Section 3.1.3 and Section 1.4.1). Different homology models of OvoA 
suggest that it contains a similar active site to that of EgtB.135,148 Furthermore, as mentioned in 
Section 3.1.3, OvoA accepts a range of modified or truncated substrate analogues, among 
others 2-fluoro L-histidine with a turnover rate similar to the native substrate L-histidine. 
 
Figure 78 Top: Conversion of C2-modified histidine derivatives to the corresponding sulfoxide by OvoA. 
Since OvoA catalyzes C-S bond formation between the cysteine and the C-5 position of 
histidine, this enzyme provides an opportunity to test whether the electronic properties of the 
histidine analogues affect oxygen activation. Although the affinity of the enzyme for both 
substrates was quite low, the reaction rates were remarkably similar for both substrates and 
only marginally lower than for the native substrate as shown in Table 13. As was the case in 
the rather electron-poor substrate 2-fluoro L-histidine, the electronic structure and pKA of the 
histidine-substrate does not seem to influence the catalytic efficiency of OvoA. Due to the 
similarities between OvoA and EgtB, we can extrapolate that this is indeed not a factor in the 
sulfoxide synthase activity of either enzyme. 
102 
 
Table 13 Rates of conversion of C2-modified histidine derivatives to the corresponding sulfoxide by OvoA. 
  kcat,app [s-1] KM,app [µM] kcat/KM [M-1s-1] 
2A-His 0.33 ± 0.02 2'000 ± 200 170 
2M-His 0.83 ± 0.07 5'300 ± 900 160 
His 1.4 ± 0.1  200 ± 10  7'000 
Reaction conditions were: 10 mM cysteine (2A-His) or 1 mM cysteine (2M-His), 1 µM OvoA (2A-His) or 1 µM OvoA 





One of the greatest challenges for enzymes is how to channel their reactivity in order to control 
product specificity. They must be able to efficiently promote the forward reaction with minimal 
contributions toward alternate, unproductive pathways. Enzymes which catalyze energetically 
challenging reactions rely on reactive intermediates to achieve this feat, much like synthetic 
chemists rely on harsh conditions or highly reactive catalysts to drive forward similar 
transformations. The reactions catalyzed by NHI enzymes are notoriously tricky to control, as this 
class makes use of species so reactive, that the enzyme must prevent them from reacting with 
the active site residues themselves. Within the protein core of a given enzyme, first and second 
order coordination spheres around the reactive site are key for keeping enzymes selective and 
productive. Naturally, as enzymes have evolved their unique strategies over millennia, the rational 
design of enzyme catalysts for single or multistep reactions remains extremely challenging.172,173 
Derailing enzymes from their “natural” pathway is one way to gain understandings of their precise 
mechanism of action. This has been done successfully in the past by either modifying the enzyme 
itself by site-directed mutagenesis, modifying the enzyme substrate(s) or a combination of the 
two.7,174 Careful analysis of the products formed and comparison of the reaction rates offers a 
deeper understanding even of more complex, multistep reactions. 
In our case, we have chosen to study a thiol dioxygenase pathway in the NHI enzyme EgtB, which 
becomes dominant over the natural reactivity after introduction of a single point-mutation in the 
active site.150 Similarly, in the related sulfoxide synthase OvoA it has been shown that the same 
reactivity is achieved when the enzyme is incubated with non-physiological substrates.37,175 By 
pairing both the wild type and the mutant variant of EgtB with substrates that allow for only the 
dioxygenation pathway to take place, we have been able to shed light onto the factors governing 
the enzymes selectivity. This in turn gives us additional information on what intermediates are 
formed during the reaction and in which sequence. 
Major structural differences between sulfoxide synthases and cysteine dioxygenases, as shown 
in Figure 79, point towards two diverse evolutionary backgrounds. On the one hand, CDO 
assumes the characteristic β-barrel fold of the cupin superfamily, which is typical for NHI 
enzymes.140 In contrast, EgtB consists of two domains, with the active site located at the interface 
between the two. A first, N-terminal four-helical bundle forms the DinB_2 domain, which is 
reminiscent of Zn-dependent glutathione S-transferases.149 The second, C-terminal domain 
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adopts a less ordered fold, which is closely related to the copper dependent formylglycine 
generating enzyme (FGE) and is thus termed the FGE-like domain.176,177 
 
Figure 79 X-Ray crystal structures of EgtB from M. thermoresistibile (left, PDB: 4X8E)146 and CDO from Mus musculus 
(right, PDB: 2ATF).140 Showing the 3-His facial triad coordinating the respective metals in the active site (EgtB: Fe in 
brown; CDO: Ni in red). In the EgtB structure the DinB_2 domain is shown in cyan, while the FGE-like domain is shown 
in blue. 
Regardless of these differences in evolutionary origin, EgtB and CDO display some remarkable 
commonalities. Both active sites harbor a 3-histidine facial triad coordinating FeII, leaving the other 
three sites open for substrate binding. Both enzymes catalyze four-electron oxidation reactions 
where at least one atom of the molecular oxygen used is inserted into the product.135 Neither 
enzyme is in need of an auxiliary reducing agent or co-substrate in order to perform catalysis. And 
finally, as mentioned above, the sulfoxide synthase OvoA can also catalyze dioxygenation of 
cysteine under appropriate conditions.37,175 All these factors, along with the fact that EgtB can 
effectively be turned into a thiol dioxygenase by the point mutation Y377F, support the assumption 
that sulfoxide synthesis and thiol dioxygenation share one or multiple reactive intermediates and 
apply similar strategies for catalysis. In recent years, controversy has arisen over the precise role 






3.4.1 The Sulfoxide Synthase Pathway of EgtB 
In previous studies it was shown that by mutating Tyr377 to Phe, sulfoxide synthase activity was 
reduced by a factor of 1000 from 8.5 x 10-1 s-1 to 0.9 x 10-4 s-1. When the pH was lowered from 8.0 
to 6.0, the same activity was increased by a factor of 3.5 to 3.2 x 10-3 s-1. Furthermore this activity 
displayed a kinetic solvent isotope effect (KSIE) of 1.9 ± 0.1, showing that there is involvement of 
exchangeable protons in the rate limiting step. This is in contrast to both the sulfoxide synthase 
activity of EgtBwt and the dioxygenase activity of EgtBY377F, both of which showed KSIEs near unity 
(1.2 ± 0.2 and 0.9 ± 0.1 respectively).150 These findings suggest that the role of Tyr377 is to 
regulate the reactivity of the FeIII superoxo species by protonation. In absence of this crucial 
protonation step, dioxygenation is favored over sulfoxide synthesis. This would be analogous to 
the protonation of superoxide to the peroxyl radical, changing its reactivity from a reductant to an 
oxidant.178 
The question arises, whether the role of Tyr377 is to support sulfoxide synthase activity or to 
quench possible dioxygenation of the thiol substrate. To this end we investigated the enzyme in 
combination with substrates that allow only for the dioxygenation route to take place. By adding 
additional protons into the active site, essentially rendering the catalytic center more acidic, 
dioxygenase activity was suppressed.  
The crystal structure of the EgtB:DMH:γGC complex reveals that the C-2 hydrogen points towards 
the phenol group of Tyr377, indicating that a polar group such as an amine would be well-tolerated. 
Indeed, kinetic and structural data showed that 2A-DMH is an excellent ligand for both EgtBwt and 
EgtBY377F with an affinity that rivals the natural ligand DMH. The orientation of the amino group in 
the active site is such that it is conceivable that protons from the amine could be transferred to the 
FeIII superoxo species, leading to reduced dioxygenation of γGC (B → B’ in Figure 80). As 2-
aminoimidazoles have a pKA of 8.5,163 one would expect 2A-DMH to be fully protonated under 
assay conditions (pH 8.0). Due to the fact that the C-2 position of this compound can hardly form 
a C-S bond – the intermediates would be highly unstable (C → D in Figure 80) – the only route for 
the enzyme to take in this case is that towards dioxygenation. As the related compound 2-
aminobenzimidazole is characterized by a low oxidation potential of Eox = 0.6 V,179 the redox 
potential of 2A-DMH is also likely to be quite low. It thus seems plausible that 2A-DMH could 
alternatively act as an H-atom donor in a hydrogen atom transfer (HAT) instead of a protonation 
step (A → A’ in Figure 80). In a recent computational study by Faponle et al,180 Tyr377 was 
considered as a proton and electron donor to reduce the FeIII superoxo species. The resulting 
tyrosyl radical is then reduced concomitantly to C-S bond formation. This proton-coupled electron 
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transfer pathway would prevent the FeIII superoxo species from reacting with the thiol and 
producing the unwanted dioxygenation product. If this is the case, it is conceivable that 2A-DMH 
could act as a substitute for Tyr377 in this role. The observation that no spike in ascorbate or 
TCEP consumption is observed during the reaction suggests that any reactive species formed are 
quenched within the enzyme. 
 
Figure 80 Conceivable intermediates in the complex EgtBwt:2A-DMH. 
In the mutant variant EgtBY377F, dioxygenation is reduced by a factor of 13 and 17 when adding 
either an amino or methyl group in the C-2 position of DMH. In the wild type enzyme, dioxygenation 
takes place at a 6-fold lower rate with the 2-amino than the 2-methyl variant. If this was a purely 
steric effect, one would expect the rates to be similar, or possibly even lower for 2M-DMH as a 
methyl group is slightly larger than an amino group.181 In summary, EgtBwt and EgtBY377F in 
complex with 2A-DMH are roughly 20 and 100 fold less active thiol dioxygenases compared to the 
system EgtBY377F:DMH. The complexes of EgtBwt and EgtBY377F with 2M-DMH are roughly 10 and 
20 fold less active thiol dioxygenases compared to the system EgtBY377F:DMH. Based on the 
observation that no dioxygenation product can be detected in the EgtBwt:DMH complex, it can be 
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assumed that this process is at least as inefficient in the EgtBwt:2A-DMH and EgtBwt:2M-DMH 
system. 
3.4.2 The Thiol Dioxygenase Pathway of EgtB 
The consensus mechanism for thiol dioxygenation involves a highly reactive FeIV oxoferryl 
species.137,182,183 Based on the crystal structures of EgtB in complex with 2A-DMH, one would 
expect the N-H bond of the 2-amino group to point directly towards this strong oxidant. 
Furthermore, given the large difference in redox potentials between 2-aminoimidazoles and 
oxoferryls,184,185 this hydrogen atom transfer would most likely have to be irreversible. If the N-H 
bond is cleaved it must then be reverted in a subsequent step as no decay of 2A-DMH is observed 
during the reaction. It is also possible that sulfur oxygenation is faster than N-H bond cleavage or 
that no oxoferryl species is formed during thiol dioxygenation.186 The observation that the 2-amino 
group of 2A-DMH slows the reaction down 6-fold more than the 2-methyl group of 2M-DMH, 
demonstrates that a polar group is more detrimental to the reactivity of the oxoferryl species than 
a hydrophobic group. One possible explanation for this can be illustrated when comparing the two 
resonance structures of the oxoferryl complex after the first oxidation of the thiolate, shown in 
Figure 81. In the structure A, the thiolate has donated one electron to the oxo-ligand, giving the 
latter a more anionic character. This anionic group could then be stabilized by protonation by the 
2-amino group, which in turn is stabilized by Tyr377 (B). Product formation (C) would be 
significantly slowed down by such a hydrogen bonding network, for which the crystal structure of 
the EgtBwt:2A-DMH complex provides suitable evidence. 
If on the other hand, as shown in structure A’, electron density remains on the sulfoxide, the oxo-
ligand would have more radical character. As described above, in that case a HAT could take 
place (B’), which could lead to oxygenation of the 2-amino group (C’). No such hydroxyamino 
product or decomposition-products thereof187 were observed in any of our assays however, 





Figure 81 Alternative electron distribution in the oxoferryl species leading to γGC-dioxygenation. The top structure (A) 
positions higher electron density on the oxo-ligand, giving it a more anionic character amenable to proton transfer (B). 
This would lead to a reduction in activity of dioxygenation (C), which is in agreement with our kinetic data. The bottom 
structure (A’), describes an oxo-ligand with more radical character, which could engage in hydrogen atom transfer with 
2A-DMH (B’). This however could lead to the N-hydroxylated product (C’), which was not observed in our assays and 
which are inherently instable and labile to attack by nucleophiles.187  
 
3.4.3 Alternative Model for Timing of Proton Transfer 
As discussed briefly in Section 3.1.3 and shown in Figure 82, a computational study by Wei et al. 
using DFT calculations came to the conclusion that C-S bond formation occurs after irreversible 
O-atom transfer to the thiol.148 According to this model, in both the dioxygenation and the sulfoxide 
synthase pathway this step (A and B) results in an FeIV=O intermediate (C, displayed here as the 
RSO•-FeIII=O species instead of RSO--FeIV=O) which is protonated by Tyr377 to prevent the 
second oxygen atom being transferred to sulfur. Tyr377 then deprotonates Nπ of the imidazole 
ring via two active site water molecules. Next, C-S bond formation occurs between the oxygenated 
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thiol and C-2 of the imidazole ring (E), followed by water-assisted deprotonation of the C-2 position 
by Tyr377 (F) and protonation of the imidazole ring (G). 
This suggestion is in contrast to the model proposed by Goncharenko et al.146,149,150 where the 
oxoferryl species is only formed in the dioxygenation pathway, which becomes dominant in the 
mutant enzyme EgtBY377F. 
In this model, the 2-amino group of 2A-DMH would likely reduce the reactivity of the FeIV oxoferryl 
species and reduce dioxygenation of γGC. As mentioned above, the 2-amino group is in a position 
amenable to either proton or hydrogen atom transfer to the oxoferryl species and this step would 
almost certainly be irreversible due to the difference in reduction potential. 
 
 






3.4.4 Promiscuity of OvoA 
Although the binding affinity of OvoA for both 2A-His and 2M-His is quite low, the enzyme is able 
to catalyze C-S bond formation on each substrate with a remarkably high turnover rate once 
saturation is reached. This finding underlines the assumption that the electronic structure of the 
imidazole ring does not play a large role in oxygen activation. In addition, these results further 
demonstrate the wide potential substrate scope of OvoA and may open new semisynthetic routes 





We have characterized two complementary probes for the reactivity of EgtBs two possible reactive 
pathways; 2A-DMH and 2M-DMH. The first inserts a hydrophilic and slightly acidic group towards 
the iron-bound oxygen necessary for catalysis, while the second introduces hydrophobic steric 
bulk into the active site. Crystallographic data provides a plausible explanation for the high affinity 
of EgtB for 2A-DMH and the low affinity for 2M-DMH. The neat incorporation into the hydrogen-
bonding system of the former and the opposite for the latter not only explain the discrepancy in 
affinities, but also offer an explanation for their difference in reactivity in the wild type enzyme. 
While 2A-DMH could conceivably stabilize the system by its incorporation into the hydrogen 
bonding network, 2M-DMH does exactly the opposite, disrupting the geometry around the iron 
center with its hydrophobic steric bulk. Control experiments on the pH-sensitivity of these probes 
in combination with the viability of their non-methylated analogs as substrates for OvoA show that 
it is not the electronic structure of the imidazole substrate that reduces activity. To test whether 
oxygen binding is influenced, kinetic measurements at different oxygen concentrations will be 
necessary 
Regarding the reactivity of the crucial active site residue Tyr377, these studies have raised some 
interesting points. In the mechanistic proposal by Goncharenko et al.146,149,150 an FeIII superoxo 
complex is formed and the role of this residue is to provide a proton to this species, slowing down 
oxygen transfer to sulfur. According to this model, bifurcation of the two possible pathways – 
sulfoxidation or dioxygenation – takes place early on in the catalytic cycle. In the alternative 
proposal by Wei et al.148 the first step in the catalytic cycle is the same for both pathways and 
involves formation of an FeIV oxoferryl species. Herein, the role of Tyr377 is to protonate the oxo-
ligand and prevent it from reacting with the sulfoxide and forming the dioxygenase product. 
Regulation of which pathway is chosen by the enzyme is thus achieved at a later stage in the 
catalytic cycle. 
In the EgtBwt:2A-DMH complex where only the dioxygenation pathway is available, the second 
oxygen transfer step is slowed down by acidic protons supplied by the co-ligand. This speaks for 
less radical character on the oxygen atom, since the anionic oxygen can hydrogen bond with the 
2-amino group, which is further stabilized by interactions with the phenolic group of Tyr377. This 
observation applies to both models, albeit at different points in the catalytic cycle. 
The low binding affinity of 2M-DMH additionally supports the hypothesis that deprotonation and 
re-aromatization of the imidazole ring after C-S bond formation do not precede sulfoxidation. This 
finding is in agreement with both proposed mechanisms and with kinetic data from our laboratory, 
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indicating that sulfoxidation and rearomatization is likely a concerted step. The lack of stabilization 
for a non-polar functional group in the C-2 position underlines that the thioether intermediate would 
be bound with a low affinity. In turn, a low binding affinity for an intermediate would not be in the 
interest of the enzyme as it only aims to release the fully synthesized product after completion of 
the transformation. Again, this is in agreement with both suggestions for the catalytic cycle 
although it does not address the question of when sulfoxidation takes place precisely. 
We expect that our kinetic and structural contributions will help to further drive the discussion on 




3.6 EgtB - Experimental 
3.6.1 Synthesis 
Synthesis of methyl L-histidinate 
  
To a suspension of L-histidine (10.00 g, 64.45 mmol, 1 eq) in MeOH (100 ml) was carefully added 
SOCl2 (7 ml, 96.67 mmol, 1.5 eq) at 0 °C, upon which the solution became clear. The solution was 
stirred at 0 °C for 30 min and then allowed to warm up to ambient temperature. The solution was 
refluxed for 24 h, after which no more starting material was detected by UPLC-MS. The solvent 
was evaporated to give the pure product (15.60 g, 64.44 mmol, 99 %) in quantitative yield as 
slightly off white powder as the 2 x HCl salt. 1H NMR (400 MHz, MeOD) δ 8.94 (d, J = 1.4 Hz, 1H), 
7.53 (s, 1H), 4.47 – 4.43 (m, 1H), 3.86 (s, 3H), 3.49 – 3.35 (m, 2H). MS m/z calcd. for C7H12N3O2 
[M+H+]: 170.1, found: 170.1  
 
Synthesis of methyl (2,2,2-trifluoroacetyl)-L-histidinate (72) 
  
To trifluoracetic anhydride (27 ml, 193.35 mmol, 3 eq) cooled to 0 °C was added methyl L-
histidinate (15.60 g, 64.44 mmol, 1 eq). The light brown suspension was allowed to warm up to 
room temperature and stirred for 17 h. Since some starting material was still not completely 
dissolved, dry MeOH (15 ml) was added and the reaction was stirred for an additional 5 h. The 
solvent was evaporated, to give the pure product (18.86 g, 55.78 mmol, 87 %) as off white solid 
as the 2 x HCl salt. 1H NMR (400 MHz, MeOD) δ 8.84 (s, 1H), 7.35 (s, 1H), 4.90 (m, 1H), 3.79 (s, 




Synthesis of methyl (S,E)-4-((4-(3-methoxy-3-oxo-2-(2,2,2-trifluoroacetamido)propyl)-1H-
imidazol-2-yl)diazenyl)benzoate (73) 
 
A solution of NaNO2 (4.98 g, 58.57 mmol, 1.05 eq) in water (10 ml) was slowly added to an ice-
cold solution of Methyl-4-aminobenzoate (8.432 g, 55.78 mmol, 1 eq) in water (150 ml) and conc. 
HCl (20 ml), whilst stirring vigorously at 0 °C for 1 h. During this time, a solution of 72 (18.86 g, 
55.78 mmol, 1 eq) in water (500 ml) was brought to pH 7 by portion wise addition of solid sodium 
tetraborate and then to pH 8 by addition of 1 M NaOH. The solution of diazonium salt was gradually 
added to the aforementioned solution. The pH of the solution was maintained at 7-8 by adding 1 
N sodium hydroxide. The dark orange suspension was stirred at 0 °C for 30 min. The dark red 
precipitated crude product was removed by centrifugation, dissolved in methanol, dried over 
Na2SO4 and concentrated to dryness in vacuo. The crude product was purified in 3 batches by 
absorbing the product onto silica and purifying by flash chromatography on silica gel (DCM/MeOH, 
98.5:1.5), to give the pure product (17.25 g, 40.38 mmol, 72 %) as orange solid. 1H NMR (400 
MHz, MeOD) δ 8.17 (d, J = 8.6 Hz, 1H), 7.98 (d, J = 8.6 Hz, 1H), 7.18 (s, 1H), 4.89 (m, 1H), 3.94 
(s, 3H), 3.78 (s, 3H), 3.36 (m, 1H), 3.17 (m, 1H). MS m/z calcd. for C17H17F3N5O5 [M+H]+ 428.1, 
found 428.1 
 
Synthesis of methyl (S)-3-(2-amino-1-tosyl-1H-imidazol-4-yl)-2-(2,2,2-trifluoroacetamido) 
propanoate (74) 
  
To a solution/suspension of PE2.7.A (1 g, 2.34 mmol, 1 eq) in AcOH (10 ml), was added Pt2O 
(266 mg, 1.17 mmol, 0.5 eq), an initial hydrogen pressure of 70 bar was applied in an autoclave 
and the dark red solution/suspension was stirred at ambient temperature. Since analysis by UPLC-
MS showed that reaction was not yet complete, additional portions of PtO2 (86 mg, 0.35 mmol, 
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0.15 eq) were added followed by reloading with 70 bar H2 after 40 and 64 h. After another 18 h 
reaction time, the colorless reaction mixture was filtered and evaporated to dryness. The residue 
was treated with water and washed with 4 x EtOAc, the aqueous layer was lyophilized and the 
product, which was confirmed by UPLC-MS and 1H-NMR, was used in the next step without further 
purification. The intermediate product (950 mg, 1.70 mmol, ~50 % pure, 1 eq)  was dissolved in 
MeCN (10 ml) and Et3N (1.18 ml, 8.48 mmol, 5 eq) at 0 °C and was added TsCl (1.616 g, 8.48 
mmol, 5 eq) in MeCN (5 ml) and the solution was stirred for 30 min. The reaction was allowed to 
warm up to room temperature and stirred for an additional 18 h. The solvent was evaporated under 
reduced pressure, the residue was treated with water and the aqueous layer was extracted with 3 
x DCM. The combined organic layers were washed with sat. NaHCO3 and brine, dried over 
Na2SO4 and evaporated to dryness to yield the crude product as brown oil. The crude product was 
purified by column chromatography (cHex/EtOAc 1:1) to give the product (123 mg, 0.28 mmol, 12 
%) as orange oil. Intermediate: 1H NMR (400 MHz, MeOD) δ 8.84 (s, 1H), 7.35 (s, 1H), 4.90 (m, 
1H), 3.79 (s, 3H), 3.42 (m, 1H), 3.19 (m, 1H). MS m/z calcd. for C9H11F3N3O3 [M+H]+ 266.1, found 
266.1 Product: 1H NMR (400 MHz, MeOD) δ 7.83 (d, J = 8.4 Hz, 2H), 7.42 (d, J = 9.2 Hz, 2H), 
6.72 (s, 1H), 4.67 (dd, J = 9.6, 4.8 Hz, 1H), 3.67 (s, 3H), 2.94 – 2.89 (m, 1H), 2.81 – 2.74 (m, 1H), 
2.43 (s, 3H). MS m/z calcd. for C16H18F3N4O5S [M+H]+ 435.1, found 435.2  
 
Synthesis of (S)-2-amino-3-(2-amino-1H-imidazol-4-yl)propanoic acid (71) 
  
PE2.12.C (123 mg, 0.28 mmol, 1 eq) was dissolved in 1 M NaOH (1 ml) and the orange solution 
was stirred at room temperature for 2.5 h (start 09:40). The reaction mixture was cooled to 0 °C 
and brought to pH 2 using 1 M HCl (ca. 1 ml). Organic impurities were extracted with 3 x DCM 
and the aqueous layer was evaporated to dryness. The crude product was purified by procedure 
B (see Section 2.6.2) to give the product (45 mg, 0.26 mmol, 93 %) as green solid after 
lyophilization. 1H NMR (400 MHz, D2O) δ 6.69 (s, 1H), 4.08 – 4.05 (m, 1H), 3.17 – 3.12 (m, 2H). 




Synthesis of Nα,Nα-dimethyl-L-histidine (68) 
 
Using procedure A (see Section 2.6.2) and starting with L-histidine (2 g, 12.9 mmol, 1 eq), 
formaldehyde (37 % w/w, 4.8 ml, 64.5 mmol, 5 eq) and NaCNBH3 (1.46 g, 38.7 mmol, 3 eq), the 
product 55 was obtained as white solid (2.103 g, 11.5 mmol, 89 %) after purification according to 
procedure B (see Section 2.6.2) and lyophilization. 1H NMR (400 MHz, D2O) δ 7.66 (s, 1H), 6.95 
(s, 1H), 3.63 (dd, J = 7.8, 6.0 Hz, 1H), 3.15 – 3.03 (m, 4H), 2.67 (s, 9H). MS m/z calcd. for C8H14N3O2 
[M+H+]: 184.11, found: 184.07 
 
Synthesis of Nα,Nα-dimethyl-Nτ-trityl-L-histidine (75) 
  
To a suspension of 68 (600 mg, 3.27 mmol, 1 eq) in DCM (40 ml) was added Et3N (2.28 ml, 16.37 
mmol, 5 eq) and the solution was stirred at reflux for 45 min before adding trityl-Cl (1.826 g, 6.55 
mmol, 2 eq) and refluxing overnight. The reaction mixture was treated with water and extracted 
with 3 x DCM, the organic phases were combined, dried over Na2SO4 and evaporated to dryness 
to give the crude product as sticky white solid purified by flash chromatography (DCM/MeOH 9:1) 
to give the pure product (790 mg, 1.86 mmol, 57 %) as slightly off white solid. 1H NMR (400 MHz, 
MeOD) δ 7.42 – 7-36 (m, 10H), 7.18 – 7.15 (m, 6H) 6.92 (s, 1H), 3.81 – 3.78 (m, 1H), 3.31 – 3.22 
(m, 1H), 3.15 – 3.10 (m, 1H), 2.88 (s, 6H). MS m/z calcd. for C7H12N3O2 [M+H]+: 426.22, found: 






Synthesis of tert-butyl Nα,Nα-dimethyl-Nτ-trityl-L-histidinate (76) 
  
To a solution of 75 (780 mg, 1.83 mmol, 1 eq) in dry DCM (20 ml) was added tert-butyl 2,2,2-
trichloroacetimidate (0.656 ml, 3.67 mmol, 2 eq) and acetic acid (0.105 ml, 1.83 mmol, 1 eq) at 
room temperature. The solution was stirred at reflux for 72 h, adding additional tert-butyl 2,2,2-
trichloroacetimidate (0.328 ml, 1.84 mmol, 1 eq) in portions of one equivalent until no more starting 
material could be detected by TLC. The reaction mixture was treated with water and extracted 
with 3 x DCM, the organic phases were combined, dried over Na2SO4 and evaporated to dryness. 
The crude product was purified by flash chromatography (DCM + 5 % MeOH), to give the pure 
product (582 mg, 1.21 mmol, 66 %) as colorless oil. 1H NMR (400 MHz, MeOD) δ 7.38 – 7.36 (m, 
11H), 7.13 – 7.11 (m, 7H), 6.71 (s, 1H), 3.41 (dd, J = 10.4, 4.8 Hz, 1H), 3.00 – 2.94 (m, 1H), 2.81 
– 2.76 (m, 1H), 2.37 (s, 6H), 1.35 (s, 9H). MS m/z calcd. for C7H12N3O2 [M+H]+: 482.28, found: 
482.13.12; [M+Na]+: 504.26, found: 504.12 
 
Synthesis of tert-butyl (S)-3-(2-azido-1-trityl-1H-imidazol-4-yl)-2-(dimethylamino) 
propanoate (77) 
 
To a solution of 76 (562 mg, 1.17 mmol, 1 eq) in dry THF (12 ml) und Ar, cooled to -78 °C was 
added 2 M LDA (2.33 ml, 4.67 mmol, 4 eq) and the orange solution was stirred at -78 °C for 30 
min. 10 % TsN3 in toluene (9.66 ml, 4.90 mmol, 4.2 eq) was added and the red solution was 
allowed to warm up to room temperature and stirred for 1 h. The reaction was quenched by adding 
1 M NH4Cl (12 ml). The aqueous layer was extracted with 3 x EtOAc, the organic layers were 
combined, dried over NaSO4 and evaporated to dryness. The crude product was purified by flash 
column chromatography (EtOAc/cHex 1:1) obtaining the pure product (272 mg, 0.52 mmol, 45 %) 
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as slightly yellow solid. 1H NMR (400 MHz, CDCl3) δ 7.33 – 7.28 (m, 8H), 7.12 – 7.07 (m, 6H), 
3.40 (dd, J = 10.5, 4.6 Hz, 1H), 2.94 (dd, J = 14.2, 10.5 Hz, 1H), 2.69 (dd, J = 14.5, 4.3 Hz, 1H), 
2.36 (s, 6H), 1.38 (s, 9H). MS m/z calcd. for C7H12N3O2 [M+H]+: 523.28, found: 523.12; [M+Na]+: 
545.26, found: 545.13 
 
Synthesis of (S)-3-(2-azido-1H-imidazol-4-yl)-2-(dimethylamino)propanoic acid (69) 
 
To a solution of 77 (272 mg, 0.52 mmol) in DCM (4.3 ml) was added TFA (2.1 ml) and TES (1.7 
ml) and the orange solution was stirred overnight at room temperature. The solvent was 
evaporated and then co-evaporated 3 x with toluene, treated with water, washed with 3 x DCM 
and the aqueous layer was lyophilized to give the intermediate product as a slightly orange oil. 
Both the azide and the reduced amine were detected by ESI-MS and 1H-NMR at a ratio of 55:45 
respectively. The intermediate was dissolved in water (10 ml), 10 % Pd/C (49 mg, 0.05 mmol, 0.1 
eq) was added and H2 (1 atm) was applied by first bubbling through the solution for 5 min and 
then continued stirring for 6 h at room temperature. The Pd/C was removed by filtration through a 
pad of celite, and the filtrate was lyophilized. To the product was added 1 M HCl (3 ml) and 
evaporated to dryness (3 x), then treated with water and purified according to procedure B (see 
Section 2.6.2) and lyophilized to give the product (113 mg, 0.42 mmol, 91 %) as slightly orange 
solid. Azide: 1H NMR (400 MHz, D2O) δ 6.85 (s, 1H), 4.32 (t, J = 6.1, 6.1 Hz, 1H), 3.36 – 3.31 (m, 
1H), 3.26 – 3.20 (m, 1H), 3.03 (s, 6H). MS m/z calcd. for azide C8H13N6O2 [M+H]+: 225.11, found: 
224.95 Amine: 1H NMR (400 MHz, D2O) δ 6.74 (s, 1H), 4.18 (dd, J = 8.7, 5.2 Hz, 1H), 3.36 – 3.31 
(m, 1H), 3.26 – 3.20 (m, 1H), 2.98 (s, 6H). MS m/z calcd. for amine C8H15N4O2 [M+H]+: 199.12, 
found: 198.94 Final Product: 1H NMR (400 MHz, D2O) δ 6.74 (s, 1H), 4.15 (dd, J = 8.7, 5.2 Hz, 
1H), 3.36 – 3.31 (m, 1H), 3.26 – 3.20 (m, 1H), 2.99 (s, 6H). 13C NMR (101 MHz, D2O) δ 169.82, 






Synthesis of N,N,2-trimethyl-1H-imidazole-1-sulfonamide (78) 
  
To a suspension of 2-methylimidazole (500 mg, 6.1 mmol, 1 eq) in 1,2-dichloroethane (6 ml) was 
added N,N-dimethylaminosulfonyl chloride (1.34 ml, 12.2 mmol, 2 eq) and Et3N (0.98 ml, 7.0 
mmol, 1.15 eq) and the turbid solution was stirred at room temperature for 17 h. The white 
precipitate was filtered off, the filter cake was washed with 1,2-dichloroethane and the filtrate was 
washed with saturated aqueous Na2CO3, dried over Na2SO4 and concentrated. The crude product 
was purified by flash chromatography (DCM to elute unreacted DMAS-Cl, then DCM/MeOH 4:1 
to elute product) to give the pure product (1.135 g, 6.0 mmol, 98 %) as pale yellow oil. 1H NMR 
(400 MHz, CDCl3) δ 7.23 (d, J = 1.7 Hz, 1H), 6.96 (d, J = 1.7 Hz, 1H), 2.92 (s, 6H), 2.66 (s, 3H). 
MS m/z calcd. for C6H12N3O2S [M+H]+: 190.1, found: 190.1 
 
Synthesis of 2-methyl-1H-imidazole-4-carbaldehyde (79) 
  
A solution of 78 (1.135 g, 6 mmol, 1 eq) in dry THF (40 ml) was cooled to -78 °C. 1.6 M n-BuLi in 
hexanes (4.5 ml, 7.2 mmol, 1.2 eq) was slowly added and the yellow solution was stirred at -78 
°C for 30 min before adding DMF (3 ml, 39 mmol, 6.5 eq) and stirring for additional 1 h at -78 °C. 
The reaction mixture was allowed to gradually heat up to room temperature over the course of 1 
h and then stirred for 30 min at room temperature. The pH was adjusted to 1 with concentrated 
HCl (aq) and the reaction mixture was stirred at room temperature for 2 h. The reaction mixture 
was poured into a saturated solution of NaHCO3, insuring the pH was adjusted to 8, and the THF 
was evaporated. The residue was extracted with 3 x EtOAc, the combined organic phases were 
dried over Na2SO4 and evaporated to give the crude product (400 mg, 3.6 mmol, 61 %) as yellow 
crystals. 1H NMR (400 MHz, DMSO) δ 12.73 (d, J = 149.9 Hz, 1H), 9.60 (s, 1H), 7.87 (s, 1H), 2.32 




Synthesis of (2-methyl-1H-imidazol-4-yl)methanol (80) 
  
To a solution of 79 (400 mg, 3.63 mmol, 1 eq) in EtOH (20 ml) was added NaBH4 (137 mg, 3.63 
mmol, 1 eq) and the yellow solution was stirred at room temperature for 4 h. Brine (10 ml) was 
added resulting in a white suspension. The solvent was evaporated and the crude material was 
suspended in MeCN and filtered. The filtrate was evaporated to give the pure product (182 mg, 
1.62 mmol, 45 %) as white crystals. 1H NMR (400 MHz, DMSO) δ 6.66 (s, 1H), 4.29 (s, 2H), 2.21 
(s, 3H). MS m/z calcd. for C5H9N2O [M+H]+: 113.1, found: 113.2 
 
Synthesis of 4-(chloromethyl)-2-methyl-1H-imidazole (81) 
  
80 (182 mg, 1.62 mmol, 45 %) was dissolved in 1 ml SOCl2 and stirred overnight at room 
temperature. The solvent was evaporated to give the pure product (246 mg, 1.47 mmol, 91 %) as 
yellow oil. 1H NMR (400 MHz, DMSO) δ 14.55 (d, J = 139.4 Hz, 1H), 7.59 (s, 1H), 4.84 (s, 2H), 
2.57 (s, 3H). MS m/z calcd. for C5H8ClN2 [M+H]+: 131.0, found: 131.1 
 
Synthesis of diethyl 2-acetamido-2-((2-methyl-1H-imidazol-4-yl)methyl)malonate (82) 
  
To a solution of NaH (135 mg, 3.39 mmol, 2.3 eq, 60 % in mineral oil) in dry ethanol (5 ml), was 
slowly added a solution of diethyl acetamidomalonate (416 mg, 1.91 mmol, 1.3 eq) in dry ethanol 
(5 ml) at 0 °C under N2. To this clear solution was slowly added 81 (246 mg, 1.47 mmol, 1 eq) in 
dry ethanol (5 ml) and the now slightly beige solution was stirred at 0 °C for 30 min and then at 
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room temperature for 90 min. The solution was filtered and the filtrate was evaporated to dryness 
to give the crude product as oily brown solid. After purification by flash chromatography 
(DCM/MeOH 95:5), the product (330 mg, 1.96 mmol, 72 %) was obtained as a yellow oil. 1H NMR 
(400 MHz, DMSO) δ 11.51 (br s, 1H), 8.01 (s, 1H), 6.56 (s, 1H), 4.12 (t, J = 7.08 Hz 4H), 3.27 (s, 
2H), 2.17 (s, 3H), 1.90 (s, 3H), 1.15 (t, J = 7.11 Hz, 3H). MS m/z calcd. for C14H22N3O5 [M+H]+: 
312.2, found: 312.2 
 
Synthesis of 2-amino-3-(2-methyl-1H-imidazol-4-yl)propanoic acid (83) 
  
To a suspension of 82 (330 mg, 1.06 mmol) in water (3 ml) was added conc. HCl (3 ml) and the 
clear yellow solution was heated to 100 °C and stirred under reflux for 19 h. The solvent was 
evaporated to dryness to give the product (250 mg, 1.03 mmol, 97 %) as light brown oil, which 
crystalized in the fridge. 1H NMR (400 MHz, DMSO) δ 14.66 (br s, 1H), 14.29 (br s, 1H), 8.66 (br 
s, 3H), 7.33 (s, 1H), 4.31 (s, 1H), 3.27 – 3.15 (m, 2H), 2.54 (s, 3H). 13C NMR (500 MHz, DMSO) 
δ 169.57 (s), 143.82 (s), 126.05 (s), 117.10 (s), 50.97 (s), 25.23 (s), 11.07 (s). MS m/z calcd. for 
C7H12N3O2 [M+H]+: 170.1, found: 170.2 
 
Synthesis of 2-(dimethylamino)-3-(2-methyl-1H-imidazol-4-yl)propanoic acid (70) 
 
Using procedure A (see Section 2.6.2) and starting with 83 (50 mg, 0.296 mmol, 1 eq), 
formaldehyde (37 % in water, 88 µL, 1.18 mmol, 4 eq) and NaCNBH3 (93 mg, 1.48 mmol, 5 eq), 
this product was obtained as white solid (40 mg, 0.203 mmol, 69 %) after purification according to 
procedure B (see Section 2.6.2) and lyophilization. 1H NMR (400 MHz, D2O) δ 7.21 (s, 1H), 3.89 
(dd, J = 9.4, 4.7 Hz, 1H), 3.44 – 3.39 (m, 1H), 3.29 – 3.22 (m, 1H), 2.97 (s, 6H), 2.60 (s, 3H). 13C 
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NMR (101 MHz, D2O) δ 172.69, 145.52, 130.80, 116.00, 70.10, 41.48, 25.62, 12.07. MS m/z calcd. 





3.6.2 Enzyme Kinetics 
3.6.2.1 Determination of Sulfoxide Formation 
All reaction rates were determined by HPLC-based assays, using a cation exchange HPLC (IE-
HPLC) to track product formation and a standard method (Table 14). 
EgtB: Reactions containing 100 mM phosphate buffer (pH 8.0), 100 mM NaCl, 0.0125-1 mM γGC, 
4 μM FeSO4, 2 mM tri-(2-carboxyethyl) phosphine (TCEP), 2 mM ascorbate and 0.0125-7.5 mM 
DMH/2A-DMH/2M-DMH in a final volume of 250 μL were incubated at 26 ℃. 40 μL of reaction 
mixture were quenched by adding to 20 μL 1 M phosphoric acid at different time intervals (4-6 
samples) and analyzed by cation exchange HPLC to monitor the sulfoxide formation. Enzyme 
concentrations ranged from 0.06-2.5 μM, depending on the substrate. 
OvoA: Reactions containing 50 mM phosphate buffer (pH 8.0), 20 mM NaCl, 10 μM FeSO4, 2 
mM tri-(2-carboxyethyl) phosphine (TCEP), 1 mM ascorbate and 10 mM Cysteine for 
aminohistidine or 1 mM Cysteine for methylhistidine and histidine in a final volume of 250 μL were 
incubated at 26 ℃. 40 μL of reaction mixture were quenched by adding to 20 μL 1 M phosphoric 
acid at different time points (at least 4 samples) and analyzed by IE-HPLC to monitor the sulfoxide 
formation. Enzyme concentration of the aminohistidine reaction was 1 μM and the enzyme 
concentration of the methylhistidine and histidine reaction was 0.5 μM. 
Table 14 Standard method for HPLC analysis of EgtB reaction products and starting materials; Solvent A: 20 mM 
phosphate pH 2.0; Solvent B: 20 mM phosphate pH 2.0 with 1 M NaCl. 






















3.6.2.2 Determination of Dioxygenase Activity via Thiol Consumption 
Consumption of γGC or cysteine was followed using an HPLC-based assay on a reversed phase 
(RP) HPLC and a standard method (Table 15). 
Since the thiol itself is not detectable at sufficiently low concentrations, it was derivatized with 4-
bromo-7-methoxycoumarine (4-BMC) before analysis by RP-HPLC (as shown in Figure 70). The 
standard conditions were: 0.5-2.5 µM EgtBwt or EgtBY377F, 0.1 mM γGC, 4 µM FeSO4, 2 mM 
ascorbate, 2 mM TCEP, 100 mM NaCl in 100 mM phosphate buffer at pH 8. Reactions were 
quenched by adding 40 µL of the reaction mixtures to 10 µL 30 mM 4-BMC in DMSO and 40 µL 
MeCN and incubating in the dark for 30 min. Each sample was diluted with 90 µL 0.1 % TFA and 
centrifuged (16’000 RPM, 15 min) before injecting 20 µL into the HPLC using the standard method. 
Table 15 Standard method for HPLC analysis of EgtB reaction products and starting materials; Solvent A: water + 1 % 
MeCN + 0.1 % TFA; Solvent B: MeCN + 0.1 % TFA. 






















3.6.2.3 Inhibition of Sulfoxide Synthase Activity in EgtBwt and EgtBTh2 by 2A-DMH and 2M-DMH 
 
Figure 83 Inhibition kinetics of 2A-DMH and 2M-DMH with EgtBwt (left) and EgtBTh2 (right). Reaction conditions were: 
0.1 mM DMH, 1 mM γGC or cysteine, 0-1 mM 2A-DMH or 2M-DMH, 0.06 µM EgtBwt(left) or 1.5 µM EgtBTh2(right), 2 mM 
TCEP, 4 µM FeSO4, 2 mM ascorbate, 100 mM NaCl in 100 mM phosphate pH 8. 
 
3.6.2.4 Michealis-Menten Curves: L-DMH and D-DMH as Substrates for Sulfoxide Synthase 
 
Figure 84 Michaelis-Menten parameters for sulfoxide formation between L-DMH and D-DMH and γGC, catalyzed by 
EgtBTh1. Conditions: 12.5-1000 µM L-DMH or D-DMH, 1 mM γGC, 0.06 µM EgtBwt, 2 mM TCEP, 0.4 µM FeSO4, 2 mM 
ascorbate, 100 mM NaCl in 100 mM phosphate pH 8, final volume: 250 µL. The reaction mixture was incubated at 26 
°C and at least 4 aliquots of 40 µL were quenched by addition of 20 µL 1 M phosphoric acid at intervals in a timeframe 
of 1-16 min. These were then analyzed by HPLC using the standard method. 
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3.6.2.5 Michealis-Menten Curves: Dioxygenase Activity of EgtBY377F 
 
[γGC] = 0.1 mM     [DMH] = 1 mM 
 
[γGC] = 0.1 mM     [2A-DMH] = 1 mM 
 




Figure 85 Left: Michaelis-Menten parameters of EgtBY377F for DMH (top), 2A-DMH (middle) and 2M-DMH (bottom) at 
[γGC] = 0.1 mM. Conditions were: (12.5 – 1000) µM DMH, (25 – 2000) µM 2A-DMH, (25 – 5000) µM 2M-DMH    0.5 µM 
(DMH and 2A-DMH) or 2.5 µM (2M-DMH) EgtBY377F, 0.1 mM γGC, 4 µM FeSO4, 2 mM ascorbate, 2 mM TCEP, 100 
mM NaCl in 100 mM phosphate buffer at pH 8. Right: Michaelis Menten Parameters of γGC at saturated conditions of 
DMH (top), 2A-DMH (middle) and 2M-DMH (bottom) Conditions were: 0.5 µM (top) and 2.5 µM (bottom) EgtBY377F, 12.5 
– 500 µM γGC, 4 µM FeSO4, 2 mM ascorbate, 2 mM TCEP, 100 mM NaCl in 100 mM phosphate buffer at pH 8. 
Reactions were quenched by adding 40 µL of the reaction mixtures to 10 µL 30 mM 4-BMC in DMSO and 40 µL MeCN 
and incubating for 30 min. Each sample was diluted with 90 µL 0.1 % TFA and centrifuged (16’000 RPM, 15 min) before 
injecting 20 µL into the HPLC.  
3.6.2.6 Michealis-Menten Curves: Dioxygenase Activity of EgtBwt 
 
[γGC] = 0.1 mM     [2A-DMH] = 1 mM 
 
[γGC] = 0.1 mM     [2M-DMH] = 5 mM 
 
Figure 86 Top left: Michaelis Menten Parameters of 2A-DMH at [γGC] = 0.1 mM. Top right: Michaelis Menten 
Parameters of γGC at [2A-DMH] = 1 mM. Bottom left: Michaelis Menten Parameters of 2M-DMH at [γGC] = 0.1 mM. 
Bottom right: Michaelis Menten Parameters of γGC at [2M-DMH] = 5 mM. Reaction conditions were: 2.4 µM EgtBwt, 4 





KM = (1.1 ± 0.3) 10
-3 M
kcat = 0.014 ± 0.002 s
-1












µM FeSO4, 2 mM ascorbate, 2 mM TCEP, 100 mM NaCl in 100 mM phosphate buffer at pH 8. Reactions were quenched 
by adding 40 µL of the reaction mixtures to 10 µL 30 mM 4-BMC in DMSO and 40 µL MeCN and incubating for 30 min. 
Each sample was diluted with 90 µL 0.1 % TFA and centrifuged (16’000 RPM, 15 min) before injecting 20 µL into the 
HPLC. 
3.6.2.7 Crystal Structures 
Crystals were grown and their structures solved by Dr. Peer Lukat at the Helmholtz Centre for 
Infection Research in Braunschweig, using conditions described in the experimental section. All 
crystals belong to the space group P43212 with cell constants a,b = 135 and c = 141 A. The crystal 
packing and conformation of all chains were essentially identical to those reported for EgtBwt.146 
The structures superimpose with RMSDs < 0.150 Å (380 atoms), for a full table of all RMSD 
values, see Table 16. The resolution of the structures for EgtBY377F in complex with DMH (2.2 Å), 
ADMH (2.5 Å) and MDMH (2.5 Å), and also EgtBwt in complex with 2ADMH (2.4 Å) is high. The 
electron densities of the complexes with DMH and 2ADMH allowed precise placement of the 
unnatural ligand in the active site. Due to anisotropies of the EgtBY377F:2M-DMH crystal and 
because of low occupancy, the electron density of 2M-DMH is incomplete. Given the low stability 




Analysis of the crystal structures (distances, angles, RMSDs etc.), as well as generation of all 
images thereof was done using PyMol software. 
Table 16 RMSD values in Å for the EgtBwt and EgtBY377F complexes with DMH, 2A-DMH and 2M-DMH as well as 
γGC and Mn.  
Crystal Structure EgtB:DMH:γGC EgtB apo EgtB:TMH 
PDB code 4X8D 4X8B 4X8E 
 RMSD (Atoms) RMSD (Atoms) RMSD (Atoms) 
EgtBwt:2A-DMH 0.133 (383) 0.114 (392) 0.128 (393) 
EgtBY377F:2A-DMH 0.130 (386) 0.104 (383) 0.116 (382) 
EgtBY377F:2M-DMH 0.150 (380) 0.143 (380) 0.149 (370) 






3.6.3 Protein Production 
EgtBwt, EgtBTh2 and EgtBY377F were produced and kindly provided by Kristina Goncharenko. All 
enzymes were expressed in E. coli BL21 cells and purified using Ni2+ NTA agarose beads (Qiagen) 
following standard procedures.149 
 
Figure 87 SDS-PAGE pictures of EgtBwt after Ni-NTA affinity chromatography. M – Molecular weight marker; A – EgtBwt 
without addition of a reducing agent; B - EgtBwt with addition of DTT;  








m/z (EgtBwt): calc.: 51343 Da, measured: 51374 Da (mass difference of 31 Da due to oxidation) 
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Ɛ280(EgtBwt) = 111630 M-1cm-1 
 
 
Figure 88 SDS-page picture of EgtB variants after Ni-NTA affinity chromatography. M - Molecular weight marker;  A - 
EgtBTh2; B - EgtBY377F.  








m/z (EgtBTh2): calc.: 51131 Da, measured: 51130 Da. 












m/z (EgtBY377F): calc.: 51327 Da, measured: 51358 Da (mass difference of 32 Da due to oxidation) 








4 Enantioselectively Deuterated Peptide Substrates as 
Probes for the Formylglycine Generating Enzyme 
Abstract 
The formylglycine generating enzyme (FGE) catalyzes the oxidation of a cysteine to the unique 
aldehyde-containing amino acid formylglycine (fGly), a key functional residue in the active site of 
sulfatases. With the help of a copper cofactor, this enzyme harnesses the reactive potential of 
molecular oxygen in order to achieve C-H bond activation. In light of the electrophilic nature of 
aldehydes, FGE has become a staple workhorse for biorthogonal conjugation reactions between 
engineered proteins and a wide array of substrates. In order to investigate the catalytic mechanism 
and the active site geometry of the enzyme-substrate complex, we have synthesized a series of 
isotopologue peptide substrates, carrying either hydrogen or deuterium as shown in the example 
below. With these in hand, we have established that there is a significant, temperature-
independent kinetic isotope effect (KIE) on C-H bond cleavage with contributions from primary 
and secondary KIEs. On the one hand this has confirmed that C-H bond cleavage is the rate 
determining step in the catalytic cycle, on the other hand the stereoselectivity of the reaction has 
provided valuable insights into the geometry of this step. This in turn has helped us to construct a 
novel model of the active site of this unique enzyme with all substrates bound, as well as to 







4.1.1 Formylglycine Generating Enzyme 
Sulfated biomolecules are a large and diverse class of compounds and come in a variety of flavors 
in all living organisms. Ranging from small molecules such as steroid sulfates in humans188 to 
large polymers like sulfated polysaccharides in marine algae189 to signaling oligosaccharides in 
symbiotic bacteria,190 sulfated molecules are truly omnipresent in nature. Sulfatases, along with 
sulfotransferases, are the key enzymes in sulfate metabolism. Their role is to cleave sulfate groups 
and can achieve this either by a hydrolytic or an oxidative mechanism.191 The largest subgroup of 
sulfatases uses the former method and contain a key functional residue in the active site called 
formylglycine (fGly).192 This unusual amino acid derivative is introduced in post-translational 
modification in the endoplasmatic reticulum (ER) in eukaryotes or in the cytosol of bacteria by the 
formylglycine generating enzyme (FGE).193 It is most often generated from a highly conserved 
cysteine residue in the active site of sulfatases.194 In certain prokaryotic sulfatases it can also be 
formed from a serine instead of a cysteine.195,196 In all cases, an N-terminal [C/S]XPXR motif is 
recognized by FGE and the thiol or alcohol of the cysteine or serine is oxidized to an aldehyde. In 




Figure 89 Top: Schematic view of the generation of formylglycine from cysteine by FGE. Bottom: Hydrolytic cleavage 
of a sulfate ester catalyzed by the fGly residue in sulfatases. 
Mutations in the gene encoding FGE (SUMF1) was shown to be the basis for a severe pathological 
condition termed multiple sulfatase deficiency (MSD).198,199 This rare orphan disease with a patient 
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population of only one in one million individuals200 can come in different degrees of severity and 
the onset is usually at a very young age and often fatal.201 Differences in the mutation pattern 
determine the residual activity of fGly and the resulting clinical phenotype.202 
 
4.1.2 Bioconjugation Applications 
Since aldehydes are not a part of the array of functional groups present in the 20 canonical amino 
acid side chains, FGE has become an attractive tool with which to insert such a unique residue 
into recombinant proteins.203 Aldehydes are excellent electrophiles and are able to undergo 
condensation reactions with aminooxy and hydrazide reagents, forming the corresponding oxime 
and hydrazones respectively, allowing for very specific labelling of any protein containing them. 
This has been exploited by a number of research groups, aiming to introduce a bioorthogonal 
functional handle onto a protein of interest. One of the most proficient groups in this field is that of 
Bertozzi et al. After reporting the synthesis of a formylglycine building block suitable for Fmoc-
based solid phase peptide synthesis (SPPS),204 they went on to show that especially membrane-
associated and secreted proteins are viable targets for aldehyde tagging, since eukaryotic FGE is 
localized in the ER.205,206 Glycosylation of different proteins was also achieved using FGE-
mediated fGly introduction into the engineered CXPXR sequence. Two examples are the human 
growth hormone (hGH) and one of the two distinct fragments of IgG, named the crystallizable 
fragment (Fc). The latter is a homodimeric glycoprotein, each monomer of which consists of two 
constant immunoglobulin domains from the C-terminal half of one heavy chain.207 Introduction of 
the fGly-residue in these proteins was followed by oxime formation with aminooxy glycans, 
producing site-specifically glycosylated protein variants. These approaches represent alternatives 
to the natural glycosylation pathways.208,209 Other research groups have introduced fGly into 
recombinant proteins to immobilize them on surfaces,210 create conjugates between DNA and 
proteins,211 or in order to attach fluorescent tags.212 In our own laboratory we have fixated proteins 




Figure 90 Several strategies for bioconjugations utilizing an aldehyde handle introduced onto a target protein (grey 
sphere) by FGE; i) condensation of the fGly aldehyde with an aminooxy or hydrazide reagent, forming an oxime- or 
hydrazine-linkage respectively; ii) immobilization of a target protein on a functionalized surface; iii) Pictet-Spengler type 
condensation reaction with the newest generation of ligands developed by Redwood Bioscience. 
Due to the keen interest of the pharmaceutical industry for antibody-drug conjugates (ADC),214 
antibodies are especially attractive targets for fGly introduction and subsequent labelling.215 
However, since oximes and hydrazones are prone to hydrolysis at physiological pH, a more stable 
chemical linkage was developed based on the Pictet-Spengler reaction of aldehydes with 
tryptamine nucleophiles.216 The newest generation of these reagents217 has been used to create 
ADCs with cytotoxic payloads located in different areas of the respective antibody, resulting in 
different in vivo efficacies and pharmacokinetic behaviors in rhodents.218 This technology, 
marketed under the name SMARTag™, has recently been acquired by the pharmaceutical 
company Catalent Biologics and is currently being employed in pre-clinical trials.219 
 
4.1.3 FGE Mechanism 
FGE-catalyzed C-H bond cleavage was recognized early on as being oxygen-dependent.176 The 
question of how the enzyme is able to activate oxygen to a reactive state however remained a 
mystery. Reactive forms of oxygen utilized by enzymes can either be formed by exciting or 
activating oxygen from the unreactive triplet to the singlet state or by reduction by an electron-
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donor. Originally, FGE was characterized as an enzyme without the need for any apparent 
inorganic or organic cofactors, besides a thiol reducing agent.177,220 Only small traces of copper 
(0.09 mol/mol FGE) were detected and supplementation with additional CuII inhibited FGE 
activity.176 In the meantime, our research group and others have established that copper is 
necessary for full activity and that CuI is the active species.221–223 Most recently X-ray crystal 
structures of FGE from Thermomonospora curvata in complex with AgI or CdII were solved in our 
laboratory, for the first time presenting structural evidence of copper binding in the active site.224 
Based upon our results and the current literature we propose the catalytic mechanism depicted in 
Figure 91. 
 
Figure 91 Proposed catalytic mechanism of cysteine oxidation by FGE 
The resting state of the enzyme (A) binds CuI and loses one molecule of water upon substrate 
binding, forming an electron rich complex (B). Next, oxygen is bound leading to a reactive CuII 
superoxo complex (C) followed by hydrogen abstraction and electron transfer to the CuII center 
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forming CuI and a thioaldehyde of the substrate (D). This highly instable intermediate hydrolyzes 
spontaneously to the corresponding fGly-containing peptide, leaving the active site to decay into 
an inactive oxidized form (E), which is reduced by two electrons from an external source back to 
the reactive resting state (A). 
In addition to the discussed FGE type, which relies on oxygen-dependent hydrogen abstraction, 
a second class exists using a 5’-deoxyadenosyl (5’-dA) radical generated from SAM by a redox-
active iron-sulfur cluster in the active site to cleave the C-H bond. These anaerobic sulfatase 
maturating enzymes (anSME) can catalyze the oxidation of both cysteine and serine residues 
under anaerobic conditions.225,226 Using a suitable peptide substrate carrying a deuterium label on 
Cβ of the target cysteine residue, Berteau et al. established that hydrogen abstraction is the rate-
limiting step (RLS) with a kinetic isotope effect (KIE) of kH/kD = 5.6 and that the 5’-dA radical is the 
abstracting species (Figure 92).227 
 
Figure 92 Oxidation of a cysteine-containing peptide by the 5’-dA radical produced by anSME. 
By showing that anSME can also convert threonyl peptides to the corresponding ketone products, 
it was deduced that the pro-S-hydrogen is abstracted in the native substrates, as allo-threonine 
containing peptides were oxidized at much lower efficiency.228 
 
4.1.4 Kinetic Isotope Effects 
Among the various tools enzymologists use to elucidate catalytic mechanisms, kinetic isotope 
effects are extremely useful, since they not only give information on the nature of a systems RLS, 
but also of structural features and binding order.229 Especially when bonds are cleaved, the 
difference in zero-point energies (ZPE) between two isotopic species can account for significant 
differences in rates. In the case of hydrogen and deuterium, primary KIEs are classically in the 
range of 2-10,230 in extreme cases where hydrogen-tunneling is involved even over 80.231 
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Secondary KIEs are much lower, usually in the range of 0.7-1.4, and are observed during 
rehybridization of bonds e.g. sp3 → sp2.232 These secondary KIEs are associated with changes in 
the vibrational frequencies of the bonds in the donor and acceptor. Changes from high to low 
frequency will give rise to a normal KIE (>1), while the opposite results in inverse KIEs (<1) as 
shown in Figure 93. When hydrogen is abstracted from a methylene group and both hydrogens 
are substituted for deuterium, a primary and a secondary isotope effect are observed, which are 
multipicative.233 
 
Figure 93 A: Rehybridization of C-H vs C-D bonds, where the vibrational frequencies of the product are higher than in 
the starting material (e.g. sp3 → sp2). In this case the activation energy for the C-H bond will be higher than for the C-D 
bond and the KIE will be inverse. B: Rehybridization of C-H vs C-D bonds, where the vibrational frequencies of the 
product are lower than in the starting material (e.g. sp2 → sp3). In this case the activation energy for the C-D bond will 
be higher than for the C-H bond and the KIE will be normal. 
As shown in Figure 94 the observable overall rate of a chemical reaction is determined by the step 
with the energetically highest transition state, which is the rate limiting step (RLS). It follows that 
a KIE is directly observable if the isotope sensitive step is rate limiting. For this to be the case it 
must either occur on the initial RLS or render a different step in the reaction profile rate limiting.  If 
the isotope effect does not increase, or is lower than the RLS itself it, will be obscured by the RLS 
but may still contribute to the overall rate.234 In such cases, deconvolution of KIEs becomes vastly 




Figure 94 Hypothetical example of an observable KIE on a rate limiting C-H bond cleavage step. 
The reaction catalyzed by FGE represents an ideal system to investigate by KIEs. Since C-H bond 
cleavage typically is not an easy task to accomplish in energetic terms, a KIE on this step is quite 
likely. Furthermore, since C-H bond cleavage takes place on a methylene group there is the 
possibility of observing a primary, secondary or cumulative KIE depending on the employed 
substrate. Indeed, preliminary measurements in our laboratory on FGE with a peptide substrate 
containing Cβ-dideuterated D/L-cysteine revealed a cumulative KIE, establishing that C-H bond 
cleavage is the RLS in fGly-formation.236 This prompted us to design compounds and experiments, 
which would enable us to differentiate between the primary and secondary KIEs and give us more 





4.2 Aim of this Chapter 
By synthesizing a peptide containing enantioselectively Cβ-deuterated cysteine, we aimed to 
establish the primary KIE and determine the precise geometry of hydrogen abstraction. 
Comparison with a cysteine derivative carrying two deuterium in the Cβ-position would allow us to 
resolve the cumulative KIE and thus calculate possible contributions from a secondary KIE, which 
one can expect to be significant since rehybridization of the carbon center takes place. 
Distinguishing additional factors such as temperature-dependence of the KIE and the fidelity of 
hydrogen abstraction could provide further hints towards the stability of the active site. Finally, 
measurement of the KIE in several mutant variants of FGE would give us insights into whether the 





4.3 Results and Discussion 
4.3.1 Synthesis of Enantioselectively Deuterated Cysteine 
Enantioselectively deuterated cysteine was synthesized following published protocols, which start 
from L-cysteine and result in a deuterium label in the pro-R position.237–239 If this hydrogen is 
abstracted by FGE a primary KIE should be observed, if instead the pro-S hydrogen is abstracted 
a secondary KIE would be observed instead. 
 
Figure 95 Reagents and conditions for the synthesis of the enantioselectively deuterated substrate and incorporation 
into the peptide substrate. (a) Pivalaldehyde, Et3N, pentane, 50 °C, 24 h, 99 %; (b) methyl chloroformate, K2CO3, 
acetone, 60 °C, 18 h, 99 %; (c) H2O2, AcOH,  12 h, 89 %; (d) TBDMS-triflate, Et3N, 72 h, 50 %; (e) D2, 10 % Pd/C, d4-
AcOD, 144 h, 96 %; (f) 6 M HCl, 110 °C, 72 h, 63 %; (g) Trt-OH, TFA, 2 h, 55 %; (h) Fmoc-OSu, Et3N, MeCN, H2O, 3 
h, 75 %; (i) SPPS: Rink Amide Resin, HCTU, DIPEA, DMF, 4 %. 
Starting with L-cysteine, a cyclization is carried out with pivaldehyde, introducing the tert-butyl 
group in nearly quantitative yield. The product 84 is formed as a mix of diastereomers, which is 
cleanly converted into the desired conformation upon acylation of the amine by methyl 
chloroformate, again in nearly quantitative yield.240 Formation of the single product 85 with the tert-
butyl group in the proper conformation occurs via a ring opening mechanism,241 as has also been 
143 
 
reported in penicillin derivatives242 and similar compounds.243 The configuration of 85 was 
confirmed by NOEs in the 1H-NMR spectrum shown in Figure 107 in Section 4.6.1. 
Sulfoxidation to 86 was then performed with hydrogen peroxide in high yield and 
stereoselectivity.244 The following Pummerer rearrangement245,246 to 87 was carried out using 
TBDMS triflate247 at a medium yield of 50 %. At this point hydrogenation was performed using 
deuterium gas and palladium on activated carbon as catalyst. Deuterated acetic acid was used as 
the solvent, since non-deuterated solvent resulted in deuterium-hydrogen exchange between 
liquid and gas-phase and incorporation of unwanted hydrogen into the product 88. Under 
optimized conditions <5 % hydrogen was incorporated into the product as can be seen in Figure 
96. Very long reaction times were necessary for this reaction to run to completion. Subsequent 
opening of the thiazolidine ring and deprotection of the amine and carboxylic acid was carried out 
in one step under harsh conditions of 6 M HCl and reflux over three days to give the desired 
labelled cysteine 89 as a free amino acid in satisfying yield of 63 %. Introduction of protecting 
groups suitable for SPPS – Trt on the thiol and Fmoc on the amine to give 90 – constituted the 
final steps of this synthesis before introduction into the peptide. 
       
Figure 96 1H-NMR spectrum of Xe. Conditions: D2, AcOD (top); D2, AcOH (middle); H2, AcOH (bottom). 
The peptide sequence (Abz-SALCSPTRA-CONH2) was chosen based on the recognition sequence of 
a sulfatase from Mycobacterium smegmatis248 and included an N-terminal anthranillic acid (Abz) 
group as a chromophore. Synthesis was carried out using standard Fmoc solid phase peptide 










Besides the enantioselectively deuterated peptide, three additional peptides were synthesized for 
kinetic experiments. In the case of Pep3 and Pep4, commercially available D/L-cysteine and D/L-
[3,3-2H2]-cysteine respectively were protected in the same manner as 89 before incorporation into 
the respective peptides. 
 
Figure 97 The relevant cysteine residue in the model peptides Pep1-4, where R = SerAlaLeuAbz-NH2 and R’ = 
SerProThrArgAla-CONH2. 
The enantiomeric purity of Pep1 (100 % L-Cys) and Pep2 (96 % L-Cys) was determined by RP-
HPLC, as the peptides containing racemic D/L-cysteine could be separated. Incorporation of an 
N-terminal anthranillic acid (Abz) group as a chromophore insured that the starting materials as 
well as the product of the reaction were detectable at concentrations below 1 µM by HPLC (see 
also next section). 
 
Figure 98 RP-HPLC traces for Pep1-Pep4 at 320 nm, the peak at tR = 15 min is the peptide containing L-Cys, the peak 
at tR = 16 min contains D-Cys. 




















4.3.2 HPLC Based Activity Assay 
Recombinant production of FGE was carried out in E. coli cell cultures and the protein was purified 
by Ni-NTA affinity chromatography. The mass of the enzyme was confirmed by HRMS and its 
homogeneity assessed by SDS-PAGE.249 The FGE used in all the following assays was from 
Thermomonospora curvata, unless otherwise indicated and was kindly produced and provided by 
Matthias Knop. This FGE was chosen due to its thermostability, which can be advantageous in 
terms of production and isolation yield as well as increased resistance towards thermal stress. 
Additionally, the fact that it shares 58 % sequence identity with the human variant,250 allows for 
comparison between the two. For all kinetic measurements we employed an HPLC based activity 
assay where the aldehyde of fGly formed from cysteine reacts with the ortho-amine of the N-
terminal Abz group, forming a Schiff base under acidic conditions. This was doubly beneficial, 
since the Schiff base a) has a larger extinction coefficient due to the extended π-system and can 
thus be detected at lower concentrations and b) facilitates peak separation thanks to its cyclic 
structure. 
 
Figure 99 Structures of substrate, product and observed Schiff base in the kinetic assay. R = SerProThrArgAla-CONH2 
Assays were run in 50 mM phosphate buffer containing DTT as reducing agent and 1 equivalent 
of copper relative to the enzyme. Samples were taken at different time points quenched in 7.5 M 
urea, containing 2 % TFA and directly subjected to analysis by HPLC. From the peak area we 
could calculate the concentration of product and plot it as a function of time, the slope of this linear 







4.3.3 C-H Bond Cleavage by FGE Displays a KIE with Large Contribution from a 
Secondary KIE 
With our array of differently deuterated peptides we sought out to determine the primary and 
cumulative KIEs by comparing Pep1 with Pep2 and Pep3 with Pep4 respectively. Dividing the 
cumulative by the primary KIE gives an estimate for the secondary KIE.251 Using the kinetic assay 
described above, all four peptides were incubated with FGE, the rates of the respective reactions 
were measured and the respective KIEs calculated. 
Table 17 A: Initial rates of conversion of Pep1-Pep4 by FGE. B: Calculated KIEs from the measured rates, the 
secondary KIE was calculated by dividing the cumulative by the primary KIE. 
A Substrate rate [s-1]  B KIE 
 Pep1 (2.4 ± 0.3) x 10-3   Prim. Cum. Sec. 
 Pep2 (0.7 ± 0.1) x 10-3   3.4 ± 0.2 5.6 ± 0.2 1.7 ± 0.2 
 Pep3 (2.4 ± 0.2) x 10-3    
  




Reaction conditions: 50 μM Pep1-4, 2 mM DTT, 50 mM EDTA, 50 mM NaCl, 50 mM phosphate pH 8, 0.5 μM FGE 
(previously activated with 1 eq CuSO4) at 30 °C. 
Comparison of the reaction rates of Pep1 and Pep2 resulted in a primary KIE of kH/kD = 3.4 ± 0.2, 
demonstrating that HR is the abstracted hydrogen.222 The cumulative KIE was in turn calculated 
from the reaction rates of Pep3 and Pep4, resulting in a larger effect of kH/kD = 5.6 ± 0.2. Such a 
large difference between the primary KIE and the cumulative KIE indicate considerable 
contributions to the latter from α-secondary KIEs in the rate limiting step. From our calculation we 
determined a large secondary KIE of 1.7 ± 0.2, which is above the semiclassical limit of 1.44.232,252 
A secondary effect of this magnitude is unusual, but the fact that it is a normal and not inverse KIE 
is compatible with rehybridization from sp3 → sp2.230 Although inflated secondary isotope effects 
have been linked to H-tunneling in enzymatic reactions, in these cases one also expects a primary 






4.3.4 The KIE is an Effect on kcat and not KM 
To determine whether hydrogen abstraction is fully or only partially rate limiting one can test if the 
KIE is observed on kcat or kcat/KM. If C-H bond cleavage is only partially rate-limiting and takes 
place before the RLS, a small isotope effect is observable on kcat/KM, but not on kcat. At conditions 
where the enzyme is saturated with substrate, an early C-H bond cleavage step would be less 
significant.254 We measured the initial rates of the reaction at varying concentrations of Pep1 and 
Pep2 and calculated the respective KIEs, which remained unchanged at each concentration.  
 
Figure 100 Michaelis-Menten parameters for the Pep1 (top left) and Pep2 (top right). Concentration dependence of 
KIE (bottom), Reaction conditions: 25 - 1000 μM Pep1 or Pep2, 4 mM DTT, 50 mM EDTA, 50 mM NaCl, 50 mM 
phosphate pH 8, 0.5 μM FGEwt (previously activated with 1 eq CuSO4) at 30 °C. 
The KIE is observable on kcat as well as kcat/KM with an average of kH/kD = 3.7 ± 0.2, meaning that 
C-H bond cleavage is fully rate limiting. On KM itself no effect is seen as one would expect, since 
the isotopic labelling should not have an observable effect on substrate binding. 
 














kcat = 0.08 ± 0.01 s
-1
KM = (250 ± 50) x 10
-1 M
kcat /KM = 330 ± 110 s
-1M-1













kcat = 0.02 ± 0.01 s
-1
KM = (230 ± 60) x 10
-6 M
kcat /KM = 90 ± 40 s
-1M-1


























4.3.5 The KIE Remains Unchanged in a Series of Mutant FGE Variants 
Several mutant variants of FGE have been produced in our laboratory and we strove to show 
whether the increase or decrease in their respective rates is associated with a shift of the RLS. In 
case a different step than hydrogen abstraction, such as substrate-binding, becomes rate limiting 
one would expect the observed KIE to be reduced or even invisible. To address this question three 
mutants were tested with Pep1 and Pep2 in order to determine and compare the primary KIE to 
the wild type. In the first mutant, termed FGE4C, all four non-active site cysteines are mutated to 
alanine or serine residues (C187A, C231A, C284S and C298A). In the presence of copper this 
first variant is roughly twice as active as the wild type, without copper it is even 10-fold more 
active.222 The precise reason for this increase in activity has not been conclusively elucidated as 
of yet, but it has been shown that the point mutation C187A is largely the cause, resulting in an 
elevated kcat and a reduced KM.249 The second mutation targeted an active site serine residue 
(S266A) in the immediate vicinity of the two active-site cysteines (C269 and C274). This led to a 
60-fold decrease in activity, since Ser266 is thought to be involved in oxygen binding and 
activation (see Section 4.1.3 and Figure 91). The last variant contained the mutation W84R, 
where a tryptophan residue involved in substrate binding is substituted by an arginine. This mutant 
was produced as part of an effort to create an orthogonal enzyme/substrate pair by inverting ionic 
bonds, allowing stepwise labelling of one protein with two different probes.255 Its activity is reduced 
by roughly 10-fold compared to the wild type enzyme. 
 
Figure 101 Left: Reaction rates measured on different mutants in comparison with the wild type enzyme with the 
substrates Pep1 and Pep2. Right: calculated primary KIEs for different mutants in comparison with the wild type 
enzyme. Reaction conditions: 50 μM Pep1 or Pep2, 4 mM DTT, 50 mM EDTA, 50 mM NaCl, 50 mM phosphate pH 8, 



















































While the values for the initial rate constants vary greatly between the different mutants, the KIEs 
are all within the same range of 3.4 ± 0.3. Hydrogen abstraction remains rate determining in each 
variant, allowing for the conclusion that the increase (FGE4C) or decrease (FGES266A and FGEW84R) 
is not associated with a different step becoming rate limiting, such as substrate binding or oxygen 
activation. 
 
4.3.6 The KIE is Temperature Independent 
In order to investigate a possible temperature dependence of either KIE, we determined the rate 
of conversion for each peptide substrate at different temperatures between 0 °C and 55 °C. 
  
Figure 102 Temperature dependence of reaction rate (left) and kinetic isotope effect (right), Conditions: 50 μM Pep1-
4, 2 mM DTT, 50 mM EDTA, 50 mM NaCl, 50 mM phosphate pH 8, 0.5 μM wtFGE (previously activated with 1 eq 
CuSO4). 
The rate of the reaction reaches a maximum at 45 °C before decreasing again approaching the 
highest temperature measured at 55 °C. Higher temperatures were not measured as the melting 
temperature of FGE was determined to be at 68 °C. Primary, cumulative and secondary KIEs 
remained constant over the full temperature range, displaying remarkable stability of the enzyme 
even at elevated temperatures. On average the primary KIE is 3.3 ± 0.5 and the cumulative is 5.0 























































4.3.7 Temperature Dependence of Selectivity 
After establishing that hydrogen abstraction remains the RLS even at elevated temperatures, we 
aimed to test whether the selectivity of the enzyme was unperturbed. If the active site becomes 
less compact at temperatures close to the melting point, one would expect that the enzyme might 
start to abstract the pro-S-hydrogen instead of the usual pro-R-hydrogen (see Figure 103). This 
in turn would lead to an observable difference in mass, which can be quantified by comparing the 
relative peak intensities of the mass spectra since it is safe to assume that the ionizability of the 
deuterated and non-deuterated product are identical.256 It is however noteworthy that racemization 
takes place on Cα of the formylglycine residue after cyclization and formation of the Schiff base 
at pH 2 (see Figure 99). 
Reaction mixtures containing either Pep1 or Pep2 were incubated at different temperatures with 
FGEwt overnight, after which the reaction mixtures were desalted by HPLC and product-containing 
fractions lyophilized before recording ESI-MS spectra. Up until 45 °C, where the reaction rate 
reaches a maximum, no difference in the hydrogen abstraction pattern could be detected when 
compared to control reactions at 15 °C and 30 °C. At temperatures of 50 °C and 55 °C however, 
a clear increase of the mass peak corresponding to pro-S-hydrogen abstraction was observable. 
After comparison of peak intensities, a ratio of almost 1:1 was calculated for the two intensities. 
This means that after subtracting the base value for the m/z = 988 peak (obtained from Pep1 at 
30 °C), in 14 % and 32 % of Pep2 the pro-S-hydrogen was abstracted at 50 °C and 55 °C 
respectively. The enzyme active site thus becomes increasingly instable at temperatures above 
50 °C. Although the KIE remains unchanged even at 55 °C, binding of the substrate becomes less 
tight, allowing for abstraction of the pro-S-hydrogen. 
 
 











Figure 103 Top left: Two possible hydrogen abstractions from Pep2 (a and b) with the corresponding products, which 
are formed in the reaction and their masses after cyclization. Top right:  ESI-MS spectra of Pep1 at 30 °C and Pep2 
at 45-55 °C, the range in which the hydrogen abstraction from the latter peptide becomes less selective. Bottom left: 
ratio of the mass peaks m/z = 988 to 989 in the measured temperature range using Pep1 at 30 °C as a standard. 
Bottom right: relative intensity of the respective mass peaks of Pep2 at increasing temperature, using Pep1 at 30 °C 
as a standard. Reaction conditions were identical to those described above, apart from letting the reactions run to 
completion overnight, followed by desalting using a short RP-HPLC method and subsequent lyophilization. 
These results underline that the large contribution from α-secondary KIEs is not inflated due to the 
enzyme cleaving the C-HS bond instead of the energetically less favorable C-D bond in Pep1. If 
this had been the case the observed primary KIE would have been significantly reduced and the 




4.4 Mechanistic Implications 
4.4.1 Geometry of the FGE Active Site 
As mentioned in Section 4.1.3, FGE was initially characterized as a cofactor-free enzyme and to 
date all solved crystal structures seemed to support this hypothesis.177,220,257 Subsequently 
however, it was shown by biochemical methods that this is not the case and FGE is indeed copper-
dependent.221–223 Most recently, our laboratory has been able to solve crystal structures of FGE 
from Thermomonospora curvata in complex with AgI and CdII (PDB: 5NXL and 5NYY respectively), 
both d10 systems mimicking copper in different coordination spheres.224 The AgI-complex shows 





















































nearly linear coordination between Cys269-AgI-Cys274 and most likely represents the resting 
state of the enzyme. On the other hand the CdII-complex displays tetrahedral coordination 
between Cys269, Cys274, a water molecule and an acetate molecule, giving a picture closer to 
the substrate binding mode. In particular, the metal-coordinating oxygen of the acetate ligand is 
in the exact same position as the substrate sulfur atom, when superpositioned with the crystal 
structure of human FGE bound with a short substrate analog (PDB 2AIJ).220 Replacement of the 
abovementioned, metal-coordinated water molecule by oxygen places the latter in the direct 
vicinity of the pro-R hydrogen on Cβ of the peptide substrate, which is consistent with the 
determined KIEs. 
 
Figure 104 Model of the active site of FGEcurvata (PDB: 5NYY)224 as the CuII-superoxo-complex, with the peptide 
substrate analog (yellow) modelled based on the crystal structure of FGEhuman (PDB 2AIJ). The proposed copper-center 
is coordinated by Cys269 and Cys274, the sulfur atom of the peptide substrate and activated oxygen (red). The latter 
is further coordinated by Ser266 and Trp228. 
4.4.2 Possibility of a Single Electron Transfer Step in the Catalytic Mechanism of FGE 
In galactose oxidase, a member of the radical copper oxidase family, a redox-cofactor consisting 
of CuII and tyrosylcysteine (TyrCys272) catalyzes the oxidation of galactose and other primary 
alcohols to the corresponding aldehydes as shown in Figure 105.251,258 The substrate alcohol binds 
to the active site copper (A), where after proton transfer to the catalytic base Tyr495 (B) a single 
electron transfer (SET) step from the substrate to the metal center (C) and a hydrogen atom 
transfer from Cβ of the substrate to the TyrCys cofactor (D) are thought to take place. Initial 
experiments by Whittaker et al. identified a large cumulative KIE of 22.5, which was proposed to 
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arise from a combination of factors.259 If the abovementioned SET were to exhibit an equilibrium 
isotope effect, a fractionation factor of 0.8 per deuterium would suffice to correct the primary KIE 
to a value of 7-10. In subsequent studies primary, secondary and cumulative KIEs were 
determined with appropriately labelled substrates, resulting in observed secondary KIEs (1.19-
1.44) ranging towards the upper limit of what theory would predict.251 While it was speculated that 
these values may be indicative of H-tunneling, it was also considered that the cause could lie in a 
partially rate-limiting SET during substrate oxidation. Since oxidation of an alcohol to an alkoxyl 
free radical also affects the vibrational frequencies of the adjacent methylene group, an equilibrium 
deuterium isotope effect on electron transfer would contribute to the overall reaction when the 
methylene hydrogens are substituted for deuterium. Analysis of the data led to the calculation of 
a fractionation factor of 0.78-0.80 and the conclusion that equilibrium isotope effects may be 
involved in the overall observed effects, although conclusive evidence on this aspect of catalysis 




Figure 105 Catalytic mechanism for the oxidation of a primary alcohol to an aldehyde by galactose oxidase, as proposed 
by Whittaker et al. After proton transfer (PT) from the substrate alcohol to Tyr495 (A to B), an unfavorable single-electron 
transfer (SET) redox equilibrium generates an alkoxyl complex (C). The aldehyde is then formed after hydrogen atom 
transfer (HAT) to the phenoxyl free radical, which is the rate limiting step (D).251 The oxidation state of copper is restored 
by one equivalent of dioxygen which reoxidizes the non-radical TyrCys species. In the crystal structure which this model 
is based on (PDB 1GOG), the copper center is additionally coordinated by two histidine residues (H496 and H581), 
which are omitted for clarity.141 
This explanation for an inflated observed secondary KIE however, raises an interesting point 
concerning our proposed mechanism for FGE. As we too observed an unusually large secondary 
KIE, it could be that the observed cumulative KIE can be attributed to the primary KIE combined 
with an isotope fractionation factor (1/β) of 0.8 per deuterium on a prior unfavorable single electron 
transfer step. A correction by a factor of this magnitude results in a lower secondary KIE of 1.1 ± 
0.2, which is much closer to what would be expected for bond rehybridization. This is however 
only a rough estimate, a precise value for β can only be calculated from the observed secondary 
isotope effect, something we did not measure directly. If this is indeed the case, the mechanism 
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shown in Figure 91 (Section 4.1.3) would need to be corrected (Figure 106) to account for an SET 
redox equilibrium as may also be the case in galactose oxidase. 
 
Figure 106 Accomodation of a possible single-electron transfer step in the mechanism of FGE. The blue pathway 
involves direct abstraction of HR by the superoxide radical, leading directly from C to D. The red pathway involves a 
single electron transfer from the sulfur to the copper center (C’), which would result in an equilibrium deuterium isotope 
effect on this step contributing to the observed KIEs. 
Incorporation of such an SET would make sense from an energetic standpoint, as the CuII-
superoxo species is a rather weak hydrogen-abstracting species.260 Weakening of the C-H bond 
by transferring one electron onto it might thus be a strategy of FGE to activate the substrate in 
addition to activating oxygen. In order to test this hypothesis one could envisage incorporating Cβ-
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dideuterated cysteine into the enzyme itself. The presence of deuterium in this position of Cys269 
and Cys274 would destabilize a putative radical on the substrate cysteine, as the radical would 
be expected to be delocalized over all three copper-bound thiolates, which in turn would lead to 





The KIEs we have measured in this work have been an important part of elucidating the 
mechanism and the active site geometry of FGE. Precise positioning of the reactive oxygen in the 
active site is what ultimately insures that hydrogen is abstracted only from the substrate. Although 
this may seem redundant, since the active site copper is coordinated by two cysteine residues of 
the enzyme and one of the substrate, all of which are essentially chemically equal, this feat is truly 
remarkable. All aspects of the modelled enzyme-substrate complex presented herein are fully 
consistent with the KIEs we have observed in this work. The remarkable thermostability of FGE 
has been demonstrated, with reduced stereochemical selectivity only at temperatures 
approaching the melting point of the enzyme. By showing that the KIE is on kcat, we have confirmed 
that C-H bond cleavage is fully rate-limiting and remains the rate limiting step in a series of mutants 
with increased as well as decreased catalytic rates. Furthermore, the large values we have 
obtained for the secondary KIEs have prompted us to speculate whether an unfavorable SET step 
is involved in the catalytic mechanism. This could explain the observed inflation of the KIE and 
would also be consistent with our proposed mechanism with minor corrections as in the similar 
system of galactose oxidase, where comparable effects have been observed. We anticipate that 
our work presented herein will contribute to the increased understanding of copper enzymes and 






Trityl protection of cysteine derivatives – Procedure C: The cysteine derivative (1 eq), was 
dissolved in TFA (1 ml per 40 mg of cysteine) and triphenylmethanol (1 eq) was added. The dark 
yellow solution was stirred for 2 hours at room temperature. The reaction mixture was then cooled 
to 0 °C and first set to pH 2 with 4 N NaOH (checking with pH paper), then diluted with diethylether 
(30 ml), set to pH 4 with 1 N NaOH and then to pH 5.5-6 with 10 % sodium acetate (checking with 
pH pmeter). The resulting precipitate was filtered, washed with Et2O and dried to yield the product 
as white solid, which was used in the next step without further purification. 
Fmoc protection of cysteine derivatives – Procedure D: The trityl-protected cysteine derivative 
from Procedure A (1 eq) was dissolved in water (1 ml per 25 mg of cysteine) and triethylamine 
(2.5 eq). To this was drop-wise added a solution of Fmoc-OSu (1.05 eq) in acetonitrile (1 ml per 
50 mg of cysteine) and the colorless solution was stirred for 3 hours at room temperature. The 
organic solvent was removed in vacuo and the milky suspension was set to pH 3.5 with 15 % 
acetic acid (checking with pH paper) and extracted with 3 x EtOAc. The combined organic layers 
were dried over Na2SO4, concentrated and purified by flash column chromatography (DCM/MeOH 
100:0 → 98:2), to give the pure product as colorless solid. Analysis of the pure compounds was 







Synthesis of (4R)-methyl 2-(tert-butyl)thiazolidine-4-carboxylate (84). 
 
To a solution of L-cysteine methyl ester HCl (3.535 g, 20.59 mmol, 1 eq) in pentane (60 ml) was 
added pivalaldehyde (4.47 ml, 41.19 mmol, 2 eq) and Triethylamine (3.14 ml, 22.65 mmol, 1.1 eq) 
and the white suspension was heated to 50 °C under reflux and N2-atmosphere in a Dean-Stark 
trap and the reaction was stirred for 20 h. The suspension was filtered, the filter cake was washed 
with ether and the filtrate was evaporated to dryness to give the desired product (4.368 g, 20.41 
mmol, 99 %, purity: 95 %) as slightly yellow oil. 1H NMR (400 MHz, CDCl3) Main isomer (70 %): δ 
4.49 (s, 1H), 3.91 – 3.87 (m, 1H), 3.79 (s, 3H), 3.28 (dd, J = 10.4, 6.7 Hz, 1H), 2.81 – 2.69 (m, 
1H), 1.09 (s, 9H). Second isomer (30 %): δ 4.56 (s, 1H), 4.26 – 4.16 (m, 1H), 3.77 (s, 3H), 3.19 – 
3.10 (m, 1H), 3.09 – 3.01 (m, 1H), 1.00 (s, 9H). MS m/z calcd. for C9H18NO2S [M+H]+ 204.1, found 
204.1 . 
   
Synthesis of (2R,4R)-dimethyl 2-(tert-butyl)thiazolidine-3,4-dicarboxylate (85). 
 
To a solution of 84 (4.187 g, 20.41 mmol, 1 eq) and K2CO3 (16.926 g, 122.47 mmol, 6 eq) in dry 
acetone (35 ml), was added methyl chloroformate (6.32 ml, 81.64 mmol, 4 eq) and the reaction 
was stirred under reflux at 60 °C under N2 for 18 h. The organic solvent was evaporated and the 
residue was treated with water. The aqueous layer was extracted with 3 x EtOAc, the organic 
fractions were combined, dried over Na2SO4 and concentrated to yield 85 (5.652 g, 20.33 mmol, 
99 %, purity: 94 %) as clear orange oil. 1H NMR (400 MHz, CDCl3) δ 5.07 (br s, 1H), 4.78 (br s, 
1H), 3.77 (s, 3H), 3.73 (s, 3H), 3.33 – 3.20 (m, 2H), 1.02 (s, 9H). MS m/z calcd. for C11H20NO4S 





Figure 107 NOESY-NMR spectrum (600 MHz, CDCl3) of the product with the desired stereochemistry, the arrows 
indicate the interaction between the different hydrogen atoms. 
 
Synthesis of (2R,4R)-dimethyl 2-(tert-butyl)thiazolidine-3,4-dicarboxylate 1-oxide (86) 
 
To a solution of 85 (5.334 g, 20.33 mmol, 1 eq) in acetic acid (25 ml), was carefully added 
hydrogen peroxide (2.29 ml, 22.36 mmol, 1.1 eq) and the light yellow solution was stirred at room 
temperature for 18 h. The solvent was evaporated and the crude product was purified by flash 
chromatography (pentane/EtOAc, 3:7) to give 86 as slightly yellow oil (4.996 g, 18.01 mmol, 89 
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%). 1H NMR (400 MHz, CDCl3) δ 5.34 (br s, 1H), 5.00 (br d, J = 50.6 Hz, 1H), 3.81 (s, 3H), 3.77 
(s, 3H), 3.54 – 3.48 (m, 1H), 3.14 – 3.08 (m, 1H), 1.08 (s, 9H). MS m/z calcd. for C11H20NO5S 
[M+H]+ 278.1, found: 278.1. 
 
Synthesis of (R)-dimethyl 2-(tert-butyl)thiazole-3,4(2H)-dicarboxylate (87) 
 
To a solution of 86 (4.996 g, 18.01 mmol, 1 eq) in dry DCM (60 ml) cooled to 0 °C, was carefully 
added TBDMS triflate (4.97 ml, 21.61 mmol, 1.2 eq) and the yellow solution was stirred under N2. 
After 15 min, triethylamine (3.00 ml, 21.61 mmol, 1.2 eq) was added and the orange solution was 
stirred for 72 h at room temperature. Reaction control by TLC showed remaining starting material, 
hence an additional portion of TBDMS triflate (2.48 ml, 10.81 mmol, 0.6 eq) was added, followed 
after 15 min by triethylamine (1.50 ml, 10.81 mmol, 0.6 eq) and the solution was stirred for 24 h at 
room temperature. Reaction control by TLC showed remaining starting material, hence an 
additional portion of TBDMS triflate (1.24 ml, 5.40 mmol, 0.3 eq) was added, followed after 15 min 
by triethylamine (0.75 ml, 5.40 mmol, 0.3 eq) and the solution was stirred for 24 h at room 
temperature. Reaction control by TLC showed no remaining starting material. The solvent was 
evaporated and the oily residue was filtered over a small pad of silica using Et2O as eluent and 
the filtrate was evaporated. The crude product was purified by flash column chromatography 
(pentane/EtOAc 95:5) to give 87 (2.316 g, 8.93 mmol, 50 %) as colorless oil. 1H NMR (400 MHz, 
CDCl3) δ 6.89 (s, 1H), 5.52 (s, 1H), 3.79 (s, 3H), 3.77 (s, 3H), 0.95 (s, 9H). MS m/z calcd. for 









Synthesis of (4R,5R)-4,5-[2H]2 (R)-dimethyl 2-(tert-butyl)thiazole-3,4(2H)-dicarboxylate (88) 
 
To a solution of 87 (1.105 g, 4.26 mmol, 1 eq) in AcOD-d4 (8 ml), was added 10 % Pd/C (453 mg, 
0.43 mmol, 10 mol %) and the black suspension was stirred under D2 (50 bar) for 12 days at 
ambient temperature in a parr bomb. Reaction control by 1H-NMR showed quantitative conversion 
of starting material. The reaction mixture was filtered over a pad of celite, the filter cake was 
washed with toluene and the filtrate was evaporated then co-evaporated to dryness twice with 
toluene to give the product (1.072 g, 4.07 mmol, 96 %) as light brown oil. 1H-NMR (400 MHz, 
AcOD-d4) δ 5.09 (br s, 1H), 3.77 (s, 3H), 3.73 (s, 3H), 3.20 (s, 1H), 1.02 (s, 9H). MS m/z calcd. 
for C11H18D2NO4S [M+H]+ 264.1, found 264.1, C11H17D2NNaO4S [M+Na]+ 286.1, found 286.2. 
 
Synthesis of (2R,3R)-2,3-[2H]2-cysteine (89) 
 
A solution of 88 (1.052 g, 3.99 mmol, 1 eq) in 6 M HCl (30 ml) was stirred under reflux for 3 days 
under N2-atmosphere. The solvent was evaporated to give the crude product (674 mg, ca. 60 % 
pure*, 2.53 mmol, 63 %) as light brown solid. MS m/z calcd. for C3H6D2NO2S [M+H]+ 124.0, found 
124.1. 
 
Synthesis of S-trityl-(2R,3R)-2,3-[2H]2-cysteine (91) 
 
Using procedure C and starting with 89 (638 mg, 4.00 mmol), this product was obtained as off-
white solid (804 mg, 2.20 mmol, 55 %). 1H NMR (400 MHz, DMSO-d6) δ 7.36-7.23 (m, 15H), 2.37 
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(s, 1H). MS m/z calcd. for C22H19D2NNaO2S [M+Na]+ 388.1, found 388.3.  Analytical RP-UHPLC: 
tR = 2.508 min (A/B 99:1 → 2:98 in 5.6 min, λ = 254 nm). 
 
Synthesis of S-trityl-N-Fmoc-(2R,3R)-2,3-[2H]2-cysteine (90) 
 
Using procedure D and starting with 91 (791 mg, 2.16 mmol), this product was obtained as slightly 
yellow solid (954 mg, 1.62 mmol, 75 %). MS m/z calcd. for C37H29D2NNaO4S [M+Na]+ 610.2, found 
610.2. Analytical RP-UHPLC: tR = 4.821 min (A/B 99:1 → 2:98 in 5.6 min, λ = 254 nm). 
 
Synthesis of S-trityl-DL-3,3-[2H]2-cysteine (92) 
 
Using procedure C and starting with D/L-[3,3-2H2]-Cysteine (200 mg, 1.62 mmol), this product was 
obtained as white solid (590 mg, 1.61 mmol, 99 %). 1H NMR (400 MHz, DMSO-d6) δ 7.36-7.24 
(m, 15H), 2.92 (s, 1H).  MS m/z calcd. for C22H21NNaO2S [M+Na]+ 388.1, found 388.3. Analytical 
RP-UHPLC: tR = 2.526 min (A/B 99:1 → 2:98 in 5.6 min, λ = 254 nm). 
 
Synthesis of S-trityl-N-Fmoc-DL-3,3-[2H]2-cysteine (93) 
 
Using procedure D and starting with 92 (590 mg, 1.61 mmol), this product was obtained as white 
solid (700 mg, 1.19 mmol, 74 %). MS m/z calcd. for C37H29D2NNaO4S [M+Na]+ 610.2, found 610.2. 




Synthesis of S-trityl-DL-cysteine (94) 
 
Using procedure C and starting with D/L-cysteine (242 mg, 2.00 mmol), this product was obtained 
as white solid (532 mg, 1.46 mmol, 73 %). 1H NMR (400 MHz, DMSO-d6) δ 7.36-7.23 (m, 15H), 
2.93-2.90 (m, 1H), 2.60-2.56 (m, 1H), 2.42-2.36 (m, 1H).  MS m/z calcd. for C22H21NNaO2S 
[M+Na]+ 386.1, found 386.3. Analytical RP-UHPLC: tR = 2.524 min (A/B 99:1 → 2:98 in 5.6 min, λ 
= 254 nm). 
 
Synthesis of S-trityl-N-Fmoc-DL-cysteine (95) 
 
Using procedure D and starting with 94 (532 mg, 1.46 mmol), this product was obtained as white 
solid (703 mg, 1.20 mmol, 82 %). MS m/z calcd. for C37H31NNaO4S [M+Na]+ 608.2, found 608.2. 





General Procedure for Peptide Synthesis (Abz-SALCSPTRA-NH2) 
Synthesis 
Peptides were synthesized by standard Fmoc-SPPS procedure with a synthesis robot (Syro I, 
MultiSynTech). Rink amide resin (0.41 or 0.79 mmol/g) purchased from Novabiochem and Fmoc-
protected amino acids purchased from Bachem were used. HCTU was used as the coupling 
agent. All amino acids were added as 4 eq. except lab synthesized Fmoc-Cys(Trt)-OH derivatives 
(marked in red), which were added as 1.3 eq. For the latter, reaction time was extended from one 
to two hours. 
Cleavage and Purification 
Cleavage and side-chain deprotection were carried out in TFA /TIPS/EDT/H2O (94:2.5:2.5:1) 
during 5-12 h. The crude peptide was separated from the resin by filtration and precipitated in 
Et2O, which was removed by centrifugation. The peptide was then resuspended in Et2O, which 
was again removed by centrifugation. The crude product was allowed to dry, dissolved in 
water/MeCN and purified by preparative RP-HPLC and lyophilized. All yields are calculated as 
double TFA-salts. 
Characterization 
Peptides were characterized by analytical RP-HPLC and ESI-MS, measuring in the positive ion 
mode. For characterization by analytical RP-HPLC the following elution solutions were used: A = 
MeCN, B = mQ-deionized H2O with 1 % MeCN and 0.1 % TFA. 
 
(Abz-SALCSPTRA-NH2) C = L-cysteine (Pep1) 
Pep1 was obtained as fluffy white solid after RP-HPLC (7 mg, 6.84 µmol, 4 %). Analytical RP-
HPLC: tR = 15.547 min (A/B 15:85 → 20:80 in 23 min, λ = 310 nm). MS m/z calcd. for 
C43H71N14O13S [M+H]+ 1023.5040, found 1023.5030. m/z calcd. for C43H72N14O13S [M+2H]2+ 






(Abz-SALCSPTRA-NH2) C = (2R,3R)-2,3-[2H]2-cysteine (Pep2) 
Pep2 was obtained as fluffy white solid after RP-HPLC (150 mg, 119.7 µmol, 12 %). Analytical 
RP-HPLC: tR = 15.404 min (A/B 15:85 → 20:80 in 23 min, λ = 310 nm). MS m/z calcd. for 
C43H69D2N14O13S [M+H]+ 1025.5166, found 1025.5161. for C43H70D2N14O13S [M+H]+ 513.2619, 
found 513.2621. 
 
(Abz-SALCSPTRA-NH2) C = DL-cysteine (Pep3) 
Pep3 was obtained as fluffy white solid after RP-HPLC (145 mg, 115.7 µmol, 24 %). Analytical 
RP-HPLC: tR = 15.511 min and 16.520 min (A/B 15:85 → 20:80 in 23 min, λ = 310 nm). MS m/z 
calcd. for C43H71N14O13S [M+H]+ 1023.5040, found 1023.5043. m/z calcd. for C43H72N14O13S 
[M+2H]2+ 512.2557, found 512.2562. 
 
(Abz-SALCSPTRA-NH2) C = DL-3,3-[2H]2-cysteine (Pep4) 
Pep4 was obtained as fluffy white solid after RP-HPLC (128 mg, 102.1 µmol, 14 %). Analytical 
RP-HPLC: tR = 15.453 min and 16.441 min (A/B 15:85 → 20:80 in 23 min, λ = 310 nm). MS m/z 
calcd. for C43H69D2N14O13S [M+H]+ 1025.5166, found 1025.5163. for C43H70D2N14O13S [M+2H]2+ 





4.6.2 Kinetic Assays 
All reaction rates were determined by HPLC-based assays, using a RP-HPLC with a standard 
method (Table 18) to track product formation. Samples were quenched in appropriate intervals by 
adding 25 μL of the reaction mixture to 25 μL of 7.5 M Urea containing 1 % TFA. The samples 
were analyzed by RP-HPLC and the rate was determined by plotting product formation against 
the reaction time, from which the absolute rate was determined by extracting the slope of the plot 
and subsequent division by the enzyme concentration. 
Table 18 Standard method for HPLC analysis of EgtB reaction products and starting materials; Solvent A: H2O, 1 % 
MeCN, 0.1 % TFA; Solvent B: MeCN, 0.1 % TFA. Flow rate 1 mL/min. 























Unless noted otherwise, conditions were: 50 μM Pep1-4, 2 mM DTT, 50 mM EDTA, 50 mM NaCl, 
50 mM phosphate pH 8, 0.5 μM FGE. Prior to initiation of the assay with the enzyme, the latter 





4.6.3 Protein Production 
FGEwt, FGE4C,  FGES266A  and FGEW84R were produced and kindly provided by Matthias Knop. All 
enzymes were expressed in E. coli BL21 cells and purified using Ni2+ NTA agarose beads (Qiagen) 
following standard procedures.249  
 
Figure 108 SDS-page picture of FGE variants after Ni-NTA affinity chromatography. M - Molecular weight marker;  A - 
FGEwt; B - FGE4C.  






m/z (FGEwt): calc.: 35308.1 Da, measured: 35306.5 Da 
Ɛ280(FGEwt) = 93390 M-1cm-1 
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m/z (FGE4C): calc.: 35195.8 Da, measured: 35195.8 Da 
Ɛ280(FGE4C) = 93390 M-1cm-1 
 
 
Figure 109 SDS-page picture of FGE variants after Ni-NTA affinity chromatography. M - Molecular weight marker;  A+B 











m/z (FGES266A): calc.: 35292.1 Da, measured: 35290.4 Da 
Ɛ280(FGES266A) = 93390 M-1cm-1 
 






m/z (FGEW84R): calc.: 35278.1 Da, measured: 35276.9 Da 





5 Final Conclusions 
In this thesis, a variety of synthetic probes and a combination of analytical techniques have been 
used to investigate enzyme mechanisms. 
Combining 13C-labelled substrates with NMR spectroscopy and comparison of our findings to X-
ray crystal structures has enabled the characterization of two molecular strategies of the SAM-
dependent methyl transferase EgtD.  This enzyme employs these in order to activate the methyl 
donor as well as the acceptor during catalysis. The first of which consists of interactions of active 
site enzyme residues with the transferred methyl group via C-H∙∙∙O bonding, enhancing the 
electrophilicity of this group on the donor. The second strategy involves increasing the 
nucleophilicity of the accepting amine via unconventional n→σ* interactions between active-site 
carbonyl groups and the methyl-group carbon of the acceptor. We anticipate that our 
measurements will inspire similar research into other methyltransferases and analogous non-
enzymatic systems. 
Investigation of the sulfoxide synthase EgtB in combination with two inhibitors has provided us 
with new insights into the factors determining the bifunctional nature of this enzyme. Specifically, 
by combining kinetic data with X-ray crystal structures we support a plausible hypothesis for the 
role of the key active site residue Tyr377. This residue has been the subject of much debate 
recently, with different propositions based on kinetic and computational studies. We suggest that 
active site acidity is key for the specificity of EgtB and that the role of Tyr377 is to suppress 
unwanted side-reactions. These results provide further points of discussion for this highly 
interesting system. 
Finally, in the oxidation of cysteine to formylglycine by FGE, kinetic experiments using deuterium-
labelled substrates have revealed a significant KIE on C-H bond cleavage, defining this as the 
rate limiting step of the reaction. By installing a deuterium label in an enantioselective manner, we 
have been able to elucidate the precise geometry of this cleavage step and create a model of the 
active site in the Michaelis-complex, consistent with all the current data. Furthermore, the 
presence of a surprisingly large secondary KIE has prompted us to re-examine the proposed 
catalytic mechanism and contemplate the integration of a single electron transfer step as a crucial 
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7.1 General Experimental 
All reagents used were purchased from commercial sources without further purification. All 
solvents used in reactions were purchased in HPLC-grade quality and used as such. Dry solvents 
were purchased in HPLC-grade quality and used as such. Chromatographic purifications (flash) 
were performed with SiliaFlash P60 from Silicycle (40-63 um; (230-400) mesh). Preparative RP-
HPLC of peptides was performed on a Shimadzu system (SIL-10AD injector, LC-10AT liquid 
chromatograph, DGU-14A degasser, SDP-10AV UV-detector, SCL-10A system controller) with a 
Purospher® STAR RP-18 endcapped LiChroCART® column (250 x 10 mm, particle size 5 µm, 
Merck), flow rate 4.9 ml/min. Eluents were A: acetonitrile and B: water/acetonitrile/TFA 
(1000:10:1), peptides were detected by UV absorption at 310 nm. Analytical RP-HPLC was 
performed on an Agilent 1100 Series system with a LiChrospher® 100 RP-18e-column (250 x 4 
mm, particle size 5 µm, Merck), flow rate was 1 ml/min. Eluents were A: acetonitrile and B: 
water/acetonitrile/TFA (1000:10:1), peptides were detected by UV absorption at 310 nm. 
UHPLC/MS-measurements were carried out on an Agilent 1290 Infinity system with a Zorbax 
Eclipse Plus C-18-column (2.1 x 50 mm; particle size 1.8 µm; Agilent), flow rate 0.4 ml/min, 
coupled to an Agilent 6130 quadrupol-MS. Eluents were A: acetonitrile and B: 
water/acetonitrile/TFA (1000:10:1). Compounds were detected at 254 nm. Reaction mixtures 
containing highly polar compounds were analyzed by cation-exchange HPLC (20 mM phosphoric 
acid pH 2 as the mobile phase) on a Luna 5u SCX column (100 Å, 150 x 4 mm, Phenomenex). 
The compounds were eluted in NaCl gradient.  ESI-MS measurements were performed on a 
Bruker Esquire 3000plus, measuring in the positive ion mode. Centrifugation during peptide 
synthesis was carried out on an Allegra X-15R from Beckmann Coulter. pH values were measured 
on a Seven Easy pH meter from Mettler Toledo. Absorbance was measured on a Nanodrop 2000 
Spectrophotometer from Thermo Scientific. Solid Phase Peptide Synthesis was performed on a 
Syro I from Biotage. NMR spectra were acquired on a Bruker 400 MHz or a Bruker 500 MHz 
instrument. 1H and 13C chemical shifts are quoted relative to solvent signals.261 Multiplicity is 
reported as follows: s – singlet, d – doublet, dd – doublet of doublet, t – triplet, q – quartet, quin – 






NMR Experiments 400 MHz 
All NMR experiments were performed on a Bruker Avance III NMR spectrometer operating at 400 
MHz proton frequency. The instrument was equipped with a direct observe 5-mm BBFO smart 
probe. The experiments were performed at 295 K and the temperature was calibrated using a 
methanol standard showing accuracy within +/- 0.2 K. 
 
NMR Experiments 500 MHz 
All NMR experiments were performed on a Bruker Avance III NMR spectrometer operating at 500 
MHz proton frequency. The instrument was equipped with a indirect 5-mm BBI probe. The 
experiments were performed at 298 K and the temperature was calibrated using a methanol 
standard showing accuracy within +/- 0.2 K. 
 
NMR Experiments 600 MHz cryo 
All NMR experiments were performed on a Bruker Avance III HD four-channel NMR spectrometer 
operating at 600.27 MHz proton frequency. The instrument was equipped with a cryogenic 5mm 
four-channel QCI probe (H/C/N/F). with self-shielded z-gradient. The experiments were performed 
at 298 K and the temperature was calibrated using a methanol standard showing accuracy within 







2A-DMH 2-amino Nα,Nα-dimethyl histidine 
2M-DMH 2-methyl Nα,Nα-dimethyl histidine 
4-BMC  4-Bromomethyl-7-methoxycoumarin 
Abz  Anthranilic acid 
ATP Adenosine triphosphate 
CDO  Cysteine dioxygenase 
DCM  Dichloromethane 
DFT  Density functional theory 
DIPEA Diisopropylethylamine 
DMF  Dimethylformamide 
DMH  Nα,Nα-dimethyl histidine 
EDT 1,2-Ethanedithiol 
EDTA  Ethylenediaminetetraacetic acid 
EgtBTh2 Sulfoxide synthase from Candidatus chloracidobacterium thermophilum B 
EgtBwt  Sulfoxide synthase from Mycobacterium thermoresistibile 
ESI  Electrospray ionization 
ESI-MS Electrospray ionization mass spectrometry 
ET  Ergothioneine 
FGly  Formylglycine 
Fmoc Fluorenylmethyloxycarbonyl 
HAT  Hydrogen atom transfer 
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HCTU  O-(1H-6-Chlorobenzotriazole-1-yl)-1,1,3,3-tetramethyluronium 
hexafluorophosphate 
HPLC  High performance liquid chromatography 
HRMS High resolution mass spectrometry 
IE-HPLC Ion exchange high performance liquid chromatography 
KIE  Kinetic isotope effect 
LDA  Lithium diisopropylamide 
MMH  Nα-methyl histidine 
NHI  Non-heme iron (enzyme) 
NMR  Nuclear magnetic resonance 
OA  Ovothiol A 
QM/MM Quantum mechanics/molecular modelling 
SAH S-Adenosyl homocysteine 
SAM S-Adenosyl methionine 
SET  Single electron transfer 
SPPS Solid phase peptide synthesis 
TBDMS tert-Butyldimethylsilyl 
TCEP  Tris(2-carboxyethyl)phosphine  
TES  Triethylsilane 
TFA  Trifluoroacetic acid 
THF  Tetrahydrofurane 
TIPS Triidopropylsilane 
TLC  Thin layer chromatography 
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TMH  Nα,Nα,Nα-trimethyl histidine 
Trt  Triphenylmethyl 
Ts  Tosyl 
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